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Traumatic injury is a major global health problem, and one of the main causes of death and 
disability worldwide [1,2]. It accounts for 9.6% of global mortality and major trauma in particular 
was found to be the most important cause of long-term functional limitations in adults younger 
than 45 years [3,4]. Moreover, the disease burden of trauma is high and traumatic injuries rank 
among the five most costly medical conditions worldwide [5]. To illustrate, traumatic injuries 
cost the global population about 300 million years of healthy life per year, equaling 11% of the 
total number of disability adjusted life years (DALYs) experienced worldwide [6]. Furthermore, 
it is recognized that direct medical costs as well as lost productivity costs increase with injury 
severity [7]. During the last decades, trauma care improved substantially and mortality due to 
traumatic injury decreased accordingly [8,9]. Consequently, the focus of trauma care has moved 
from reducing mortality to improving quality of life and outcome, which in turn resulted in a 
growing interest in improving the quality of trauma rehabilitation [10]. 
Fracture healIng and treatment
Most trauma patients have one or more fractures due to their trauma. A fracture is a complete 
or incomplete break in a bone, mostly as a result of an external force like a fall, an accident, or a 
sports-injury. Fractures are classified by describing the bone, the segment of the fractured bone, 
the fracture line (e.g. linear, oblique, transverse, longitudinal, spiral) and whether the fracture 
is dislocated or not [11]. Additionally, it is important to identify whether a fracture is open or 
closed and if accompanied neurological- and/or vascular damage occurred. Fractures have a 
major impact on a patient’s functional status and health-related quality of life (HR-QOL) and the 
accompanying damage of soft tissue has a significant impact on treatment and outcome [12]. 
Treatment depends on the aforementioned fracture characteristics and patient characteristics, 
such as age, comorbidity, health status and activity level prior to the injury. Following the “damage 
control” phase in the emergency situation, including control of blood loss and monitoring vital 
signs, the primary goal of fracture treatment is reduction of the fracture, meaning realignment 
of the bone in its original position. Moreover, depending on fracture type, degree of (soft 
tissue) damage, and patient characteristics, the trauma surgeon decides upon the most optimal 
treatment strategy for a specific fracture. Treatment can be conservative (e.g. with a plaster, a 
sling or a limited weight-bearing policy) or surgical, which in most cases means intramedullary 
nailing or open reduction and internal fixation (ORIF) with plates and screws.
12
Chapter 1
A fracture needs stability and an optimal biological situation to heal [13]. Roughly speaking, 
there are two pathways through which a fracture can heal. The first pathway, secondary (or 
indirect) bone healing, occurs in four fluent stages, all of which have considerable overlap, i.e. 
1) hematoma formation, 2) fibrocartilaginous callus formation, 3) bony callus formation, and 
4) bone remodeling (Figure 1.1). This recovery pathway typically occurs in conservatively treated 
fractures and after operative treatment with intramedullary nailing, during which some micro-
motion occurs at the fracture site [14]. 
Figure 1.1 Secondary (or indirect) fracture healing.
Figure 1.2 Primary (or direct) fracture healing.
The second pathway, primary (or direct) bone healing, needs a rigid fixation of fracture ends and 
can only occur by direct remodeling of lamellar bone, the Haversian canals and blood vessels 
(Figure 1.2). Primary fracture healing occurs without callus formation and typically occurs when 
fracture ends are rigidly fixated with a plate and screws and usually takes a few months up to one 
year (or more) [15]. During the trauma rehabilitation process, it is of utmost importance that the 
treating physical therapists have specific knowledge of fracture treatment and the stages of fracture 


















trauma and Fracture rehabIlItatIon
Van Beeck et al. identified four stages of trauma recovery, i.e. 1) the acute treatment phase, 
2) the rehabilitation phase, 3) the adaption phase, and 4) the stable end situation [16]. 
For physical therapists treating trauma patients it is important to deal with each phase of recovery 
in an appropriate way. As indicated above, in-depth knowledge of fracture classification, fracture 
treatment, and the process of normal fracture healing is needed. To illustrate, in the case of 
secondary fracture healing, micro-motion and weight-bearing enhance the healing process. 
However, too much motion and/or load is known to possibly result in delayed healing or even 
non-union [17]. On top of that, it is important that physical therapists are able to recognize 
signs of abnormal fracture healing and other possible complications in order to timely adapt 
their treatment plan and inform the responsible trauma surgeon. In doing so, they will be able 
to give – within a certain margin – an estimate of a trauma patient’s length and outcome of 
the rehabilitation process. This is important, because it is recognized that managing trauma 
patients’ expectations is a critical element of their rehabilitation process and necessary to 
achieve an optimal outcome [18]. Hence, rehabilitation of fractures is about guiding and coaching 
the trauma patient through the complex fracture healing process as well as finding the right 
balance between undertreatment and overtreatment. A helpful tool during this process is the 
International Classification of Functioning, Disability and Health (ICF) model, because its provides 
a framework to understand the extent of problems due to physical disorders (e.g. fractures) [19]. 
The ICF model includes environmental and personal factors in addition to function, activities 
and participation (Figure 1.3). During trauma- and fracture rehabilitation, physical therapists 
need to make sure that every domain of the ICF model is addressed and related to one another.
















organIzatIon oF trauma care
Traditionally, the organization of trauma care focused on pre-hospital and in-hospital care 
more than on the rehabilitation phase, because trauma patients’ survival was the first and 
most important goal [20]. Early rehabilitation was first mentioned as an important link in the 
trauma chain of survival in 2002 during the TraumaCare conference in Stavanger, Norway [21]. 
As illustrated in Figure 1.4, the trauma chain of survival consists of four links, with the last one 
being early rehabilitation that is aimed at restoring a trauma patient’s HR-QOL.
Figure 1.4 The trauma chain of survival.
In recent decades, mortality of severe trauma patients decreased with the development of 
specialized trauma centers using Advanced Trauma Life Support (ATLS®) guidelines [8,9]. 
To illustrate, mortality due to traumatic injury decreased with 15–25% [8,9]. Consequently, the 
focus of trauma care shifted from reducing mortality to improving trauma patients’ HR-QOL 
and outcome, which in turn resulted in a growing interest in improving the quality of trauma 
rehabilitation [10]. However, rehabilitation after trauma is challenging, for several reasons. 
First, the variety in cause, impact, and severity of traumatic injuries is large. Second, the trauma 
population differs widely in terms of patient characteristics, such as age, gender, socio-economic 
status and health status prior to the injury. Third, because of this wide variety in trauma patients’ 
sociodemographic, injury-related, and physical determinants, recovery after injury is complex and 
is typically characterized by a large variety of recovery trajectories [22]. And fourth, whereas the 
acute care of trauma patients is systematically and concisely organized (e.g. through the Advanced 
Trauma Life Support® [ATLS®] program [23] and the existence of the AO/OTA classification system 
[11]), this is not the case for trauma rehabilitation, which seems to be a rather unexplored area. 
There is a lack of programs and guidelines for the rehabilitation of trauma patients following 




trauma patients who typically needed an inpatient rehabilitation program [24]. Hence, it seems 
to be of great importance to develop patient-specific rehabilitation plans to improve outcomes, 
which might possibly be accomplished by formulating an individual rehabilitation plan for every 
single patient [22,25]. 
After being discharged from a hospital, the majority of Dutch trauma patients rehabilitated with 
the help of a primary care physical therapist, but their rehabilitation treatment was rarely based 
on trauma-specific guidelines and/or interdisciplinary coordination (e.g. between the physical 
therapist and the treating trauma surgeon). Although it is recognized that post-clinical care 
organized in primary care networks of experienced and specialized healthcare providers results 
in better clinical outcomes, this was typically lacking for trauma patients [26,27].
the tranSmural trauma care model
To contribute to the improvement of trauma rehabilitation, this thesis describes the development 
of the Transmural Trauma Care Model (TTCM), a joint initiative of hospital-based physical 
therapists and trauma surgeons, that aimed to improve trauma patients’ outcomes after mild, 
moderate or severe injury, by refining the organization and quality of the rehabilitation process.
The TTCM consists of four components, all of which are linked to one another (Figure 1.5).










team at the 
outpatient clinic Secured email traffic
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Chapter 1
1. a multidisciplinary consultation hour at the outpatient clinic for trauma patients. A trauma 
surgeon and a trauma-specialized hospital-based physical therapist examine the patient and 
focus on their own professional domain. Trauma surgeons evaluate the bone- and wound- 
healing process and act as chief consultant. The physical therapist assesses physical function 
and acts as case manager throughout the rehabilitation process.
2. coordination and individual functional goal setting for each patient by the multidisciplinary 
hospital-based team. The hospital-based team coordinates the patients’ rehabilitation 
process in primary care. In a shared-decision making process, functional rehabilitation goals 
are determined, which are repeatedly updated and adapted during the rehabilitation period. 
To support this process, 10 rehabilitation protocols for the most common fractures exist. 
3. a network of specialized primary care physical therapists. This “Network Trauma 
Rehabilitation VUmc” consists of 40 specialized primary care physical therapists, each working 
in a primary care practice in the region of Amsterdam. They are specifically trained by the 
hospital-based team (www.traumarevalidatie.nl).  
4. Secured email traffic between the hospital-based physical therapist and the primary care 
network physical therapist. A secured email system (“Zorgmail”) for healthcare professionals 
is used for communication between the hospital-based physical therapist and the primary 
care network physical therapist throughout the rehabilitation process. For this purpose, the 
electronic patient records of both hospital and primary care practices were linked.
aImS oF the theSIS
In this thesis the development of the Transmural Trauma Care Model (TTCM) is described. 
The primary aim was to assess the effectiveness and cost-effectiveness of the TTCM within a 
controlled-before-and-after study. Secondary aims included the assessment of the TTCM’s reach, 
dose delivered, dose received, and fidelity, supplemented by identifying possible barriers and 
facilitators associated with the implementation of the TTCM. Additionally, data collected in the 
context of this study were used to explore the association of specific trauma- and fracture-related 
factors with disease-specific HR-QOL, functional outcome, and costs and to further improve the 
TTCM. After receiving additional funding from ZonMw (grant number: 80-85200-98-91009) we 
are now in the process of assessing the generalizability and validity of our initial findings on the 




outlIne oF the theSIS
chapter 2 describes the study protocol of the controlled-before-and-after study assessing 
the effectiveness and cost-effectiveness of the TTCM and describes the outline of the process 
evaluation.
chapter 3 presents the results of the controlled-before-and-after study that assesses the 
effectiveness of the TTCM in trauma patients with at least one fracture, compared to regular 
care in terms of HR-QOL, pain, functional status, patient satisfaction, and perceived recovery. 
chapter 4 presents the results of the economic evaluation that was aimed at evaluating the 
cost-effectiveness of the TTCM from a societal perspective compared to regular care. 
chapter 5 describes the results of the mixed-methods process evaluation that provides insight 
in the possible barriers and facilitators associated with the implementation of the TTCM and in 
its reach, dose delivered, dose received, and fidelity. 
chapter 6 is aimed at assessing the association of specific trauma- and fracture-related factors 
with disease-specific HR-QOL, functional outcome, and costs in trauma patients with at least 
one fracture.
chapter 7 describes the study protocol of a multicenter trial, which is based on the results of 
chapter 3, 4, 5 and 6 of this thesis. The multicenter trial aims to assess the effectiveness and 
cost-effectiveness of an improved version of the TTCM compared to regular care, on a wider 
scale and using an improved design.
chapter 8 presents a general discussion and gives recommendations for clinical practice as well 
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background: Improved organization of trauma care in the acute phase has reduced mortality 
of trauma patients. However, there has been limited attention for the optimal organization of 
post-clinical rehabilitation of trauma patients. Therefore we developed a Transmural Trauma 
Care Model (TTCM). This TTCM consists of four equally important components: 1) intake and 
follow-up consultations by a multidisciplinary team consisting of trauma surgeon and hospital 
based trauma physical therapist, 2) coordination and individual goal setting for each patient 
by this team, 3) primary care physical therapy by specialized physical therapists organized in 
a network and 4) E-health support for transmural communication and treatment according 
to protocols. The aim of the current study is to assess the cost-effectiveness of the TTCM.
Methods: Patients will be recruited from the outpatient clinic for trauma patients of the VU 
University Medical Center (VUmc) if they have at least one fracture and were discharged 
home. A controlled-before-and-after study design will be used to compare the TTCM with 
regular care. Measurements will take place after the first outpatient clinical visit and after 
3, 6 and 9 months. Prior to the implementation of the TTCM, 200 patients (50 patients per 
time point) will be included in the control group. After implementation 100 patients will be 
included in the intervention group and prospectively followed. Between-group comparisons 
will be made separately for each time point. In addition, the recovery pattern of patients in 
the intervention group will be studied using longitudinal data analysis methods. Effectiveness 
will be evaluated in terms of health-related quality of life (HR-QOL), pain, functional status, 
patient satisfaction, and perceived recovery. Cost-effectiveness will be assessed from a 
societal perspective, meaning that all costs related to the TTCM will be taken into account 
including intervention, health care, absenteeism, presenteeism and unpaid productivity. 
Additionally, a process evaluation will be performed to explore the extent to which the TTCM 
was implemented as intended, and to identify possible facilitators and barriers associated 
with its implementation. 
Discussion: This planned research will give insight into the feasibility of the TTCM model 
in clinical practice and will give a first indication of the cost-effectiveness of the TTCM and 





Trauma accounts for 9.6% of global mortality and is the leading cause of death during the first 
four decades of life [1,2]. Since trauma patients are typically relatively young, the amount of 
Disability-Adjusted Life Years (DALYs) lost due to trauma, is larger than from any other disease 
and causes an important part of worldwide morbidity [3]. Furthermore, major trauma has shown 
to be the most important cause of long-term functional limitations in adults aged younger than 
45 years [4]. 
The majority of trauma patients have one or more fractures due to their trauma, sometimes in 
combination with organ system injuries. Fractures of the lower extremities in particular have a 
major impact on functional status and health-related quality of life (HR-QOL) [5,6]. Moreover, the 
economic burden of trauma to society is extensive due to the associated high direct as well as 
indirect costs (e.g. absenteeism costs). To illustrate, the total costs per patient with an operatively 
treated vertebral fracture is estimated to be EUR66,000, of which the majority (i.e. EUR47,000) 
is due to increased absenteeism [7]. Due to the major impact of trauma on mortality, morbidity, 
and (societal) costs, there has been increased interest in the organization of trauma care over 
the last three decades. In the literature it is frequently mentioned that trauma care is a chain of 
services, consisting of pre-hospital care, resuscitation and in-hospital care. During the last two 
decades, an improved organization of pre-hospital and in-hospital care by developing specialized 
trauma centers using Advanced Trauma Life Support (ATLS®) guidelines, has led to a 15–25% 
decrease in mortality of severe trauma patients [8-11]. Since mortality has decreased significantly 
due to this re-organization of trauma care, it has been suggested that the focus of trauma care 
should shift to improving quality of life and outcome, rather than on survival of trauma patients, 
because further improvements in survival rates are likely to be small [8,11]. To improve quality of 
life and outcome among trauma patients, more attention for optimizing the rehabilitation phase 
is crucial. Even though numerous studies investigated the outcome of trauma patients, none of 
these studies focused on the organization and content of post-clinical trauma care. It is recognized 
that serious gaps exist between patients’ transition from acute care to rehabilitation and their 
return to society [12-14]. Therefore the limited focus on post-clinical trauma care is remarkable. 
Recently the American Trauma Society developed a post-clinical psychological support program, 
including self-management and peer support to improve the trauma patients’ psychosocial 
outcomes [15]. Nonetheless, there is limited attention for optimizing the organization of the 
post-clinical physical rehabilitation of trauma patients in primary care, which may have led to an 
inefficient and/or suboptimal rehabilitation process. After being discharged from a hospital, the 
majority of Dutch trauma patients rehabilitates in the primary care setting (i.e. treatment by a 
24
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primary care physical therapist). In contrast to secondary and tertiary care, however, guidelines 
and protocols, as well as an interdisciplinary coordination, are lacking in primary care. 
Previous research in other patient groups indicates that post-clinical care organized in networks 
of experienced and specialized healthcare providers is likely to result in better clinical outcomes 
and lower costs compared to regular care models [16]. Furthermore, a recent feasibility study 
among osteoarthritis patients showed improvements in health-related quality of life, function, 
and patient satisfaction when primary care was coordinated by a clinical case manager (mostly 
a hospital based physical therapist or nurse practitioner) who was in close contact with the 
surgeon [17]. However, whether such an organization of the post-clinical rehabilitation process 
of trauma patients also leads to improved treatment outcomes is currently unknown. 
The aforementioned considerations led us to develop a new Transmural Trauma Care Model 
(TTCM) for trauma patients with at least one fracture, aiming to improve patient outcomes by 
refining the organization and quality of the post-clinical rehabilitation process. The TTCM is a joint 
initiative of hospital based physical therapists and trauma surgeons working closely together in the 
development of TTCM. The TTCM consists of four equally important components: 1) intake and 
follow-up consultations by a multidisciplinary team consisting of a trauma surgeon and a highly 
specialized hospital based trauma physical therapist, 2) coordination and individual goal setting 
for each patient by this team, 3) primary care physical therapy by specifically trained trauma 
physical therapists organized in a network and 4) E-health support for transmural communication 
(between hospital based trauma physical therapist and primary care based physical therapist) and 
treatment according to protocols. To gain insight to the new care models’ cost-effectiveness a 
controlled-before-and-after study will be conducted [18]. This article describes the study protocol.
The proposed study aims to answer the following research questions: 
1. Is the TTCM effective in terms of HR-QOL, pain, functional status, patient satisfaction and 
perceived recovery compared to regular care in trauma patients with at least one fracture?
2. Is the TTCM cost-effective from a societal perspective (including intervention costs, health 
care costs, absenteeism, presenteeism and unpaid productivity) compared to regular care?
3. What is the recovery pattern of patients receiving the TTCM in terms of HR-QOL, pain, 
functional status, patient satisfaction and perceived recovery during the nine-month follow-
up period? 
4. What are the barriers and facilitators associated with the implementation of the TTCM?






To answer the research questions, a modified controlled-before-and-after study will be conducted 
at the outpatient clinic for trauma patients of the VU University Medical Center (VUmc), 
Amsterdam, The Netherlands. The modification of the original study design – in which both 
control group and intervention group are observed prospectively – is that in our design only the 
intervention group will be prospectively followed. This modification is required due to the limited 
resources available. Prior to the implementation of the TTCM, data of 200 control patients who 
received care as usual will be collected during an inclusion period of 4 months. The control group 
will consist of 4 clusters of patients who either had their first consultation at the outpatient clinic 
for trauma patients of the VUmc 0 (i.e. baseline), 3, 6 or 9 months ago. Per cluster, we aim to 
include approximately 50 patients, all of whom will be asked to fill out an online questionnaire 
once after providing informed consent. After implementing the TTCM, patients who enter the 
outpatient clinic for trauma patients of the VUmc and meet the inclusion criteria will be asked 
to participate in the intervention group of the study. Patients in the intervention group will be 
prospectively followed for 9 months (n=100) and will be asked to fill out online questionnaires 
at baseline, 3, 6 and 9 months after their first consultation at the outpatient clinic for trauma 
































A total of 300 trauma patients will be included in the study. Both operatively and non-operatively 
treated patients will be included, irrespective of whether or not they were admitted to the 
hospital. In order to be eligible for inclusion, trauma patients have to meet the following inclusion 
criteria: having at least one traumatic fracture, being aged >18 years, and being able to fill out 
online questionnaires. In both the intervention- and control group, the duration between the 
patients’ actual trauma and their first consultation at the outpatient clinic for trauma patients can 
vary, depending on the treatment that was selected at the emergency department (i.e. admitted 
to hospital or sent home). Patients will be excluded if they have red flags (i.e. traumatic brain 
injury, pathological fractures, and/or cognitive limitations), if they do not speak Dutch, if their 
rehabilitation process takes place in a tertiary care facility, and/or when patients live outside 
the catchment area of the VUmc.
recruitment 
Control group
Control group patients will be identified from hospital records. All eligible patients will be 
contacted by phone by one of the investigators. At this point, patients receive further information 
about the study, and in- and exclusion criteria will be verified by the coordinating investigator. 
Patients who are willing to participate and eligible will then receive an email containing a link 
to an online questionnaire. Clicking the link to the online questionnaire will serve as informed 
consent. Patients who do not respond within 1 week will receive a reminder email which will be 
resent after another week of not responding. If the patient does not reply to both emails one of 
the coordinating investigators will contact the patient by phone to inquire whether the patient 
is still interested and willing to participate as indicated earlier. 
Intervention group
Intervention group patients will be identified during their first consultation at the outpatient 
clinic for trauma patients. During this consultation, patients will be informed about the study 
purpose and procedures by one of the investigators. Also, in- and exclusion criteria will be verified. 
Patients who are willing to participate and are eligible will receive an email containing a link 
to an online questionnaire. Clicking the link to the online questionnaire will serve as informed 
consent. Subsequently, patients will be prospectively followed and will receive additional online 
questionnaires at 3, 6 and 9 months follow-up. Patients who do not respond within 1 week to 
one of the aforementioned online questionnaires will receive a reminder email which will be 




the coordinating investigators will contact the patient by phone to inquire whether the patient 
is still interested and willing to participate.
Intervention conditions
Regular care
Patients in the control group received regular care (i.e. trauma care that was provided at the 
VUmc prior to implementation of the TTCM). During regular care, the trauma surgeon acts as the 
chief consultant and performs the post-clinical consultations, unaccompanied by professionals 
of other disciplines. Based on personal judgement, the trauma surgeon decides if and when 
physical therapy in primary care is needed. After referral to a physical therapist, patients select 
a primary care physical therapist themselves, usually in their residential area. Moreover, during 
a patients’ treatment by a primary care physical therapist, there is typically no regular contact 
between the surgeon and the primary care physical therapist.
The Transmural Trauma Care Model (TTCM)
Patients in the intervention group will receive care according to the TTCM at the outpatient 
clinic for trauma patients at the VUmc. Pre- and in-hospital trauma care remains unchanged and 
is equal to that provided to the control group. The essence of the TTCM is a regular feedback 
loop, in which the hospital team guides the primary care team by individual goal setting for each 
patient. See Figure 2.2 for a schematic representation of the TTCM. 
The TTCM consists of four main components and will be explained below:
1. Intake and follow-up consultations by a multidisciplinary team consisting of a trauma 
surgeon and a highly specialized hospital based trauma physical therapist. The trauma 
surgeon acts as the chief consultant and is responsible for assessing the bone- and wound-
healing process and additional medical procedures, such as the prescription of medication 
and indicating surgery. The hospital based physical therapist, on the other hand, assesses 
physical function (e.g. mobility, strength, walking pattern). The trauma surgeon and hospital 
based physical therapist indicate – as a team – if and when physical therapy in primary care is 
needed.
2. Coordination and individual goal setting for each patient by the multidisciplinary hospital 
team. This hospital team coordinates the patients’ rehabilitation process. The hospital based 
trauma physical therapist acts as case manager and repeatedly sets individual goals with the 
patient during the rehabilitation period.    
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3. Primary care physical therapy by specifically trained trauma physical therapists organized 
in a network. This innovative “VUmc trauma rehabilitation network” consists of 40 physical 
therapists covering the region of Amsterdam. Patients in the intervention group with an 
indication for physical therapy treatment in primary care will be referred to one of the 
specialized trauma physical therapists of the VUmc trauma rehabilitation network. Prior to 
the implementation of TTCM, all 40 network physical therapists will follow a two-day training 
course led by trauma surgeons and hospital physical therapists. The course covers topics such 
as fracture healing, fracture treatment, complications and the most important principles of 
trauma rehabilitation. In addition, written working agreements will be discussed during the 
training course to assure optimal communication and use of IT services.
4. E-health support for transmural communication (between hospital based trauma physical 
therapist and primary care based physical therapist) and treatment according to protocols. 
For the purpose of the TTCM, an existing electronic patient record is adapted and 10 
rehabilitation protocols have been developed for the most common fractures (e.g. hip, tibia, 
ankle, proximal humerus, vertebra), which will function as guidelines for the primary care 
trauma physical therapists. The protocols are linked to a secured email device through which 
the hospital physical therapist and the primary care physical therapist will communicate 
repeatedly throughout the whole rehabilitation process.
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An overview of all outcome measurements is provided in Table 2.1.








General HR-QOL EQ5D EQ5D 5 1–3 Higher score: 
better health
Pain Numeric Pain Rating 
Scale 
NPRS 1 0–10 Higher score: 
more pain
Perceived recovery Global Perceived 
Effect 
GPE 2 1–7 Higher score: 
less recovery
Functional status Patient Specific 
Function Scale 

























RMDS 24 yes/no Sum score 0–24, 
higher score: 
more disability





GARS 18 1–4 Sum score 18–72, 
higher score: 
more restrictions
Healthcare utilization Retrospective Cost 
Questionnaires
Costs in Euros
Absenteeism PROductivity and 
DISease Questionnaire 
PRODISQ 1 Total number of 
sick leave days










1 Hours per week 





At baseline, various demographic and trauma-related characteristics will be collected for all 
patients in the control- and intervention group, including age (years), gender (male/female), level 
of education (low/middle/high), medical history (none/chronic illness/musculoskeletal disease), 
type of trauma (traffic/fall/sport), injuries (upper extremity fracture/lower extremity fracture/
vertebral fracture/multi-trauma), treatment (operatively/conservatively), length of stay (days), 
and the well validated Injury Severity Score (ISS), used to provide an overall injury severity score 
for trauma patients [19]. The ISS score takes values from 0 to 75, and patients with an ISS>16 are 
defined as multi-trauma patients. In the current study multi-trauma patients are defined as having 
an ISS>16 and/or having at least fractures in 2 or more extremities. Baseline characteristics will 
be collected using online questionnaires as well as data derived from electronic patient records.
Primary outcome measure
The primary outcome measure is general HR-QOL, measured using the Dutch version of the 
EQ-5D [20]. The EQ-5D consists of 5 questions representing 5 dimensions; mobility, self-care, 
usual activities, pain/discomfort and anxiety/depression. Each question is scored on a three-
point scale (1–3) with higher scores indicating greater severity level, resulting in a 5 digit index 
representing one of the 243 health status of the EQ-5D. Using the Dutch tariff, the participants’ 
EQ-5D health status will be converted into a utility score ranging from 0 (dead) to 1 (healthy). 
Additionally, quality adjusted life years (QALYs) will be calculated using linear interpolation 
between measurement points. The EQ-5D shows good psychometric properties in trauma 
patients with one or more fractures [21-23].
Secondary outcome measures
Secondary outcome measures include pain, perceived recovery, functional status, patient 
satisfaction, and disease-specific HR-QOL.
Pain 
Pain will be measured using an 11-point numeric rating scale (NRS) ranging from 0 (no pain) to 
10 (worst possible pain) [24]. Patients will be asked to rate their average pain over the last 7 days.
Perceived recovery 
Perceived recovery will be measured using the Global Perceived Effect Scale. In clinical practice, 
measurement of patient-rated recovery often takes the form of the question: to what extent 
have you improved (or deteriorated) since last time? This type of rating of perceived recovery 




increase the relevance of information from clinical trials to clinical practice [25]. From the 
patients’ perspective, the question is intuitively easy to understand and it allows them to rate 
those aspects of recovery that are most important to them. In the current study, patients will 
be asked the following question: “to what extend have you recovered since your trauma?” The 
GPE scale asks the patient to rate, on a 7 item scale, how much their condition has improved 
or deteriorated since their trauma. Possible answers include 1) completely recovered, 2) much 
improved, 3) slightly improved, 4) not changed, 5) slightly worsened 6) much worsened and 7) 
worse than ever [26].
Functional status 
Functional status will be measured using the Patient Specific Function Scale (PSFS), a patient 
specific outcome measure that is intended to complement the findings of generic- or condition-
specific measures [27]. Patients will be asked to identify 3 important activities that they are having 
difficulty with or are unable to perform. Subsequently, patients are asked to rate their current 
level of difficulty associated with each activity, on an 11-point numeric rating scale ranging from 
0 (“unable to perform activity”) to 10 (“able to perform activity at same level as before injury or 
problem”). The PSFS is translated and validated for the Dutch population [28].
Patient satisfaction 
Patient satisfaction will be scored using an 11-point numeric rating scale ranging from 0 (very 
dissatisfied) to 10 (excellent). Five patient satisfaction components related to the TTCM will be 
evaluated: 1) total treatment, 2) treatment at the outpatient clinic, 3) treatment in primary care, 
4) collaboration between practitioners from the hospital team and 5) collaboration between the 
hospital team and the primary care physical therapist. 
Disease-specific HR-QOL 
Disease-specific HR-QOL will be measured using one of the following disease-specific function 
scales, appropriate to the patients’ specific injury type (i.e. upper extremity fractures, lower 
extremity- and hip fractures, vertebral fractures and multi-trauma patients): 
Patients with fractures of the upper extremity will fill out the Quick Dash score, a short version 
of the Dash score (Disabilities of the Arm, Shoulder and Hand score) [29]. The Quick Dash score 
consists of 11 items, measuring physical function and symptoms on a five-point scale (1–5 with 
higher scores indicating greater difficulty) in people with any or multiple musculoskeletal disorders 
of the upper limb. A validated Dutch version is available and will be used in this study [30]. 
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Physical function in patients with hip fractures or other lower extremity fractures will be measured 
using the Lower Extremity Functional Scale (LEFS) [31]. The LEFS is a 20-item disease-specific 
questionnaire developed for measuring physical function in patients with musculoskeletal 
problems of the lower extremities. Each item is rated on a five-point scale (0–4 with higher scores 
representing higher levels of functioning). The LEFS is frequently used as outcome measure in 
patients with fractures of the lower extremity [32]. A validated Dutch version of the LEFS will 
be used in this study [33]. 
Patients with vertebral fractures will fill out the Roland Morris Disability Score (RMDS) [34]. The 
RMDS is a disease-specific self-reported questionnaire consisting of 24 items all of which contain 
2 answering categories (yes/no). The RMDS was originally developed for measuring function 
in patients with chronic low back pain, but is frequently used to evaluate outcome in patients 
with traumatic vertebral fractures (operated as well as conservatively treated). A validated Dutch 
version is available and will be used in this study [35].
Physical functioning in multi-trauma patients will be assessed using the Groningen Activity 
Restriction Scale (GARS) [36]. The GARS is an 18 item scale on daily activities, all of which contain 
4 response categories ranging from 1 to 4 representing 1 (being fully independent of other 
people) to 4 (being fully dependent of other people). The sum score provides information on the 
level of difficulty a person experiences in care taking and household activities. Recent research 
indicates good psychometric properties in a Dutch population of multi-trauma patients [37]. 
Costs
Costs will be considered from a societal perspective, meaning that all costs related to the TTCM 
will be taken into account including intervention, health care, absenteeism, presenteeism and 
unpaid productivity. Except for intervention costs, costs will be assessed using retrospective cost 
questionnaires at baseline, 3, 6 and 9 months follow-up. Recall periods of these questionnaires 
will vary between treatment groups and measurement points in order to cover the complete 
duration of follow-up. To illustrate, 3-month recall periods will be used for the intervention 
group at all measurement points, whereas recall periods of 3, 6 and 9 months will be used for 
baseline/3-month follow-up, 6-month follow-up, and 9-month follow-up for the control group, 
respectively. All costs will be converted to the same reference year using consumer price indices. 





Intervention costs will consist of all costs related to development and implementation of the 
TTCM (i.e. personnel costs, material costs, costs of the electronic patient record, educational 
costs). Intervention costs will be estimated using a bottom-up micro costing approach in which 
detailed data are collected regarding the TTCM’s units of resource use as well as their respective 
unit prices [38,39]. 
Health care utilization 
Health care utilization will include primary care (e.g. consultations at the general practitioner 
or physical therapist) and secondary care (e.g. consultations at the outpatient clinic for trauma 
patients, hospitalization) as well as the use of medication. Dutch standard costs will be used to 
value health care costs [39]. Use of medication will be valued using the G-standard of the Dutch 
Society of Pharmacy [40]. 
Absenteeism 
Absenteeism will be retrospectively assessed using the “PROductivity and DISease Questionnaire” 
(PRODISQ) asking patients to report their total number of sick leave days [41]. Absenteeism will 
be valued using age- and gender-specific price weights [39].
Presenteeism 
Presenteeism is defined as reduced productivity while at work and will be assessed using the 
World Health Organization Health and Work Performance Questionnaire [42]. Presenteeism will 
be valued using age- and gender-specific price weights [39].
Unpaid productivity losses 
Unpaid productivity losses will be assessed by asking patients for how many hours per week they 
were unable to perform their unpaid activities, such as domestic work, school and voluntary 
work. Dutch shadow prices will be used to value unpaid productivity [39].
Process evaluation
A process evaluation will be performed to explore the extent to which the TTCM was implemented 
as intended as well as the possible facilitators and barriers associated with its implementation. 
The extent to which the TTCM was implemented will be explored by assessing the four process 
evaluation components of Linnan and Steckler, including reach, dose delivered, dose received, 
and fidelity [43]. Reach is defined as the proportion of the intended target audience that 
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eventually participated in the intervention (i.e. the TTCM). Dose delivered is defined as the 
number of intended units of the intervention provided (e.g. number of scheduled consultations/
treatment sessions). Dose received is the extent to which trauma patients actively engaged in 
the intervention (e.g. number of attended consultations/treatment sessions in relation to the 
number that was scheduled). Fidelity is the extent to which the intervention was delivered as 
planned (i.e. the extent to which the intervention protocol was followed by the various care 
providers). To explore these four process evaluation components, data will be collected from 
the intervention group participants’ electronic patient records (e.g. number of secured emails, 
number of treatments in primary care, was the treatment according the protocol?).
Barriers and facilitators are defined as factors that hampered or enhanced the implementation 
of the TTCM, respectively [44]. For exploring the barriers and facilitators associated with the 
implementation of the TTCM, focus groups will be conducted among trauma patients (2 focus 
groups consisting of 5 patients each), trauma surgeons (1 focus group of 6 trauma surgeons), 
hospital based physical therapists (1 focus group of 5 hospital based physical therapists), and 
primary care network physical therapists (2 focus groups consisting of 5 primary care network 
physical therapists). Focus groups will be conducted at a time and location convenient to the 
participants. Prior to the focus groups, participants will be assured of confidentiality and will be 
asked to provide informed consent. The focus groups will be guided by 2 researchers, familiar 
with the TTCM, but not involved as care provider in the TTCM. During the focus groups, 3 round 
table discussions will be held; the first will be aimed at identifying possible facilitators, the second 
will be aimed at identifying possible barriers and the third round will be aimed at complementing 
and validating the barriers and facilitators identified in round one and two. During all round table 
discussions, a topic list will be used as a guide, but participants are allowed to discuss other 




Descriptive statistics will be used to compare baseline characteristics between control- and 





Missing data are assumed to be at random and will be imputed using Fully Conditional 
Specification and Predictive Mean Matching [45]. An imputation model will be constructed, 
including variables related to the “missingness” of data, variables that predict the outcomes, 
and all available midpoint and follow-up cost and effect measure values. The number of imputed 
data sets will be determined based on the number of participants with complete cost and effect 
measure values [46]. All of the imputed datasets will be analysed separately as specified below. 
Pooled estimates were subsequently calculated using Rubin’s rules [46].
Clinical effectiveness 
The clinical effectiveness analyses will consist of two parts. First, the TTCMs’ effectiveness in 
terms of HR-QOL, pain, perceived recovery, functional status and patient satisfaction compared 
with usual care will be explored at 3, 6 and 9 months follow-up using regression analyses. The 
four clusters of control patients (i.e. time after their first consultation at the outpatient clinic 
for trauma patients respectively 0, 3, 6 and 9 months) will be compared with the patients in the 
intervention group at the corresponding time points. Second, the recovery pattern of patients 
in of the intervention group will be studied using longitudinal data analysis in terms of HR-QOL, 
pain, perceived recovery, functional status and patient satisfaction during the nine-month follow-
up period (and while receiving the TTCM). All of the aforementioned analyses will be corrected 
for confounders if necessary (e.g. age, gender, level of education). Confounding will be checked 
by adding the potential confounding variable to the crude models, and will subsequently be 
considered to be present if the regression coefficient changes by 10% or more. All of the clinical 
effectiveness analyses will be performed in SPSS, using a level of significance of p<0.05.
Economic evaluation 
The economic evaluation will be performed from the societal perspective, meaning that all 
costs and consequences related to the intervention will be taken into account, irrespective of 
who pays or benefits. The mean difference in total costs between the intervention and control 
group will be compared to the corresponding mean difference in effects. For this, cost and 
effect differences will be estimated using seemingly unrelated regression analyses in order to 
correct for their possible correlation. To deal with the highly skewed nature of cost data, 95% 
CIs around the differences in costs will be estimated using the Bias Corrected and Accelerated 
Bootstrap method, with 5,000 replications. Incremental Cost-Effectiveness Ratios (ICERs) will 
be calculated by dividing the differences in costs by those in effects. To graphically illustrate the 
uncertainty surrounding the ICERs, bootstrapped incremental cost-effect pairs will be plotted 
on cost-effectiveness planes [47]. A summary measure of the joint uncertainty of costs and 
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effects will be presented using cost-effectiveness acceptability curves, indicating the probability 
of an intervention being cost-effective in comparison with the control condition for a range of 
willingness-to-pay values (i.e. the maximum amount of money decision-makers are willing to pay 
per unit of effect gained) [48]. To test the robustness of the results, various sensitivity analyses 
will be performed [49]. All of the economic evaluation analyses will be performed in STATA, using 
a level of significance of p<0.05.
Process evaluation
Using Nvivo, data derived from the focus groups will be analyzed in accordance to the constant 
comparative approach. That is, analytic categories will be inductively established by constantly 
comparing and checking items with the rest of the data [50]. By starting with open coding, 
descriptive themes and subthemes will be generated by one researcher. The final codes will 
subsequently be developed through discussion between two independent researchers. During 
these discussions, similar codes will be grouped into analytical categories and the different 
properties of these categories will be explored as well as the relationships between them (i.e. 
selective coding) [51]. Using SPSS, summary statistics will be prepared to evaluate the new care 
model’s reach, dose delivered, dose received, and fidelity.
Discussion
Traumatic fractures are common and pose a substantial economic burden to society. Nonetheless, 
little is currently known about how to optimally organize the post-clinical rehabilitation process 
for trauma patients transferred from hospital to primary care. Therefore, the TTCM for the post-
clinical rehabilitation of trauma patients was developed at the VUmc, which aims to improve 
HR-QOL, functional outcome and patient satisfaction of trauma patients, by organizing the post-
clinical rehabilitation in an innovative and more efficient way. Within the available resources, the 
aforementioned modified controlled before and after design was regarded as the most optimal 
research design at this stage. The study aims to provide insight into the new care models’ cost-
effectiveness and aims to provide clues as to how to further optimize the TTCM so it is “ready-to-
implement” in other hospitals, which can possibly serve as a starting point for a future pragmatic 
(multicenter) controlled randomized trial. We are of the opinion that even though the applied 
modified controlled before and after design might bear on the internal validity of the current 
study findings (e.g. due to selection bias), it does not negate the value of its results. Another 
possible limitation of the proposed study might be the difficulty to identify what components 




be the result of better educated physical therapists in primary care, but could also be due to the 
introduction of multidisciplinary consultations at the outpatient clinic for trauma patients. In 
the current study, a pragmatic design will be applied, in which the TTCM is evaluated as whole. 
Future research will therefore be needed to provide insight into which TTCM component is 
accountable for which specific effect. 
Despite the shortcomings of the study we aim to provide insight in organizing the post-clinical 
rehabilitation process for trauma patients in a more efficient way and consequently contribute 
to better clinical outcomes and reduced societal costs.
Funding
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The Transmural Trauma Care Model (TTCM) 
for the rehabilita� on of trauma pa� ents 
is eff ec� ve in improving pa� ent related 
outcome measures: 





background: The Transmural Trauma Care Model (TTCM) is a refined post-clinical rehabilita-
tion approach, in which a multidisciplinary hospital-based team guides a network of primary 
care physical therapists in the treatment of trauma patients. The objective of this study was 
to assess the effectiveness of the TTCM compared to regular care.
Methods: A controlled-before-and-after study was performed in a level 1 trauma center. 
The TTCM includes four elements: 1) a multidisciplinary team at the outpatient clinic, 2) 
coordination and individual goal setting for each patient by this team, 3) a network of primary 
care physical therapists, 4) E-health support for transmural communication. Intervention 
group patients were prospectively followed (3, 6 and 9 months). The control group consisted 
of 4 clusters of patients who either had their first consultation at the outpatient clinic 0, 3, 6 
or 9 months ago. Outcomes included generic- and disease-specific health-related quality of 
life (HR-QOL), pain, functional status, patient satisfaction, and perceived recovery. Between-
group comparisons were made using linear regression analyses. The recovery pattern of 
intervention group patients was identified using longitudinal data analysis methods. 
results: A total of 83 participants were included in the intervention group. In the control 
group, 202 participants were included (68 in the baseline cluster, 26 in the 3-month cluster, 
51 in the 6-month cluster, 57 in the 9-month cluster). Between-group differences were 
statistically significant in favor of the intervention group for disease-specific HR-QOL at 9 
months, pain at 6 and 9 months, functional status at 6 and 9 months, patient satisfaction 
at 3, 6 and 9 months, and perceived recovery at 6 months. No significant differences were 
found between groups for generic HR-QOL at any time point. Generic HR-QOL, disease-
specific HR-QOL, pain, and functional status significantly improved in a linear fashion among 
intervention group patients during the nine-month follow-up period. 
conclusions: This study provides preliminary evidence that the TTCM is effective in improving 
patient-related outcome measures, such as disease-specific HR-QOL, pain and functional 
status. A multicenter, and ideally randomized controlled trial, is required to confirm these 
results.
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bAckground
Traumatic injury-related mortality accounts for almost 10% of the global annual mortality. 
Moreover, major trauma accounts for the highest mortality rate among people under 40 years 
of age, compared to any other disease [1,2]. As a consequence, traumatic injury is responsible 
for the highest loss of Disability-Adjusted Life Years (DALYs) worldwide. Each year, trauma costs 
the global population about 300 million years of healthy life, equaling 11% of DALYs lost [3]. 
Furthermore, in adults younger than 45 years, major trauma is the most important cause of 
long-term functional limitations [4]. 
Many trauma patients have more than one fracture. Fractures, and those of the lower extremities 
in particular, significantly impact a patient’s functional status and health-related quality of life (HR-
QOL) [5,6]. On top of that, the economic burden of trauma to society is extensive, for example, 
the societal cost of an operatively treated vertebral fracture was estimated at EUR66,000 per 
patient [7]. Furthermore, Fakhry et al. showed that trauma patients represent a significant and 
increasing institutional cost, of which ICU costs per trauma patient were the largest single category 
[8]. During the last decades, a significant decrease in mortality has been achieved among severe 
trauma patients through the optimization of pre-hospital and in-hospital trauma care [9-12]. As 
further reductions in mortality rates are therefore expected to be trivial, the focus of trauma care 
has shifted from aiming to reduce mortality rates to aiming to improve trauma patients’ HR-QOL 
and outcome [9-12]. As a consequence, HR-QOL has become one of the most important outcome 
measures in studies among severely injured trauma patients [13,14], whereas relatively few studies 
have focused on measuring HR-QOL amongst mildly to moderately injured patients [15,16].   
To further improve outcome and HR-QOL among mild, moderate, and severe trauma patients, 
increased attention is required for optimizing the rehabilitation process after in-hospital trauma 
care [17-19]. Research among other patient groups indicates that an improved organization 
of the post-clinical rehabilitation process can lead to better outcomes [20-22]. For example, 
a study in patients with Parkinson’s disease indicates that a post-clinical care model in which 
rehabilitation is organized in a network of experienced and specialized healthcare providers results 
in better clinical outcomes and lower costs compared to regular care models [20]. Furthermore, 
a feasibility study among patients with hip or knee osteoarthritis found a care model, in which 
primary care providers were guided by a clinical case manager, to significantly improve patients’ 
outcome and HR-QOL [21]. 
Given the above, we developed a new Transmural Trauma Care Model (TTCM) for trauma patients. 
The core of the TTCM is a continuous feedback loop, in which a multidisciplinary hospital-based 
team supervises a network of primary care physical therapists. 
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The aim of the current study is to assess the following research questions: 
1. What is the effectiveness of the TTCM on HR-QOL (generic- and disease-specific), pain, 
functional status, patient satisfaction and perceived recovery, compared to regular care, in 
trauma patients with at least one fracture?
2. What is the recovery pattern of trauma patients receiving the TTCM, during the nine-month 
follow-up period, regarding HR-QOL (generic- and disease-specific), pain and functional 
status?
Methods
The study-protocol of the current study, with detailed descriptions of its design and methods, has 
been published elsewhere [23]. Alongside the present study (assessing the effectiveness of the 
TTCM), the cost-effectiveness of the TTCM was evaluated in an economic evaluation, of which the 
results were recently published [24]. Some parts of the method section below are overlapping 
with the aforementioned publications (i.e. patients, inclusion procedure, intervention- and 
control conditions and outcome measures). An abridged version of the earlier published study 
protocol, is presented below.
design 
A modified controlled-before-and-after study was conducted at the outpatient clinic for trauma 
patients of the Amsterdam UMC, Vrije Universiteit Amsterdam (VUmc), The Netherlands [23,24]. 
In a true controlled-before-and-after study both study groups are prospectively followed [25]. 
However, in the present study, only the intervention group was prospectively followed, while 
control group data were collected cross-sectionally. 
From January to March 2014, control group data were collected among patients who received 
regular care. The control group consisted of 4 clusters of patients. The baseline, 3-month, 
6-month, and 9-month clusters contained patients who had their first consultation at the 
outpatient clinic within one week ago, or 3 months ago, 6 months ago, and 9 months ago, 
respectively. All control group patients were only measured once at the time point that 
corresponds to the cluster they belong to.
From April to May 2014, the TTCM was implemented. Subsequently, intervention group partici-
pants were recruited from June 2014 to April 2015, after which they received care according 
to the TTCM. All intervention group patients were prospectively followed for 9 months with 
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measurements at baseline and 3, 6 and 9 months after their first consultation at the outpatient 





























The medical ethics committee of the VUmc assessed the present study, and decided that the 
Dutch Medical Research Involving Human Subjects Act (WMO) was not applicable (registered 
under number 2013.454). All participants gave informed consent. The trial is registered at the 
Dutch Trial Register (NTR5474) and adheres to CONSORT guidelines. 
Patients
Operatively and non-operatively treated trauma patients were included, regardless of whether 
or not they were admitted to the hospital. Eligible patients had to have at least one traumatic 
fracture (i.e. upper and lower extremity fractures, spinal fractures, hip fractures), had to be 18 
years or older, had to rehabilitate in primary care and had to be able to fill out Dutch online 
questionnaires. Patients were excluded if they had non-traumatic (pathological) fractures, or 
traumatic brain injury, or cognitive limitations. Furthermore patients were excluded if their 
rehabilitation occurred in a clinical tertiary care setting, or if they lived more than 30 kilometres 
away from the VUmc. 
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The recruitment procedure of potential participants took place as earlier described in the study-
protocol [23,24]. Control group participants were selected from the central trauma registry of the 
trauma region “North West Netherlands”. All sequential patients were contacted by telephone 
by one of the investigators and received information about the study’s purpose and procedures. 
In- and exclusion criteria were verified by the principle investigator, after which patients were 
allocated to their respective cluster. Eligible patients who were willing and able to participate 
received an email inclosing a link to an online questionnaire. Clicking the link to the online 
questionnaire served as informed consent. A reminder email was send after 1 week and again 
after another week of non-responding. In case of patient’s not replying to both emails, one of 
the coordinating investigators contacted the patient by telephone.
Intervention group participants were identified during their first consultation at the outpatient 
clinic as described in the study protocol [23,24]. Potentially eligible patients were informed 
about the study’s purpose and procedures by one of the investigators and in- and exclusion 
criteria were verified. Eligible patients who were willing and able to participate received an email 
inclosing a link to the first online questionnaire. Clicking the link to the online questionnaire 
served as informed consent. A reminder email was send after 1 week and, if necessary, again 
after another week of non-responding. One of the coordinating investigators contacted the 
patient by telephone, in case of patient’s not replying to both reminder emails. Then, patients 
were prospectively followed, with measurements at 3, 6, and 9 months follow-up. 
Intervention conditions
Pre- and in-hospital trauma care was similar for both study groups, the intervention phase started 
at the outpatient clinic for trauma patients.
The Transmural Trauma Care Model (TTCM)
Patients in the intervention group received care according to the TTCM. A detailed description of 
the TTCM can be found elsewhere [23,24]. In brief, the TTCM consists of four main components: 
1. A multidisciplinary team at the outpatient clinic for trauma patients. The team consists of 
a trauma surgeon and a trauma-specialized hospital-based physical therapist. The trauma 
surgeon evaluated the bone- and wound-healing process. The physical therapist assessed 
physical function.
2. Coordination and individual goal setting for each patient by the multidisciplinary team. The 
hospital-based team coordinated the patients’ rehabilitation process in primary care by 
repeatedly defining individual goals in close cooperation with the patient. To supplement 
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this process, 10 rehabilitation protocols were developed for the most common fractures (e.g. 
hip fractures, tibial plateau fractures). These protocols were customized for each individual 
patient by the hospital-based physical therapist, who acted as case manager throughout the 
rehabilitation process.
3. An educated and trained network of 40 specialized primary care physical therapists. This 
newly developed “VUmc trauma rehabilitation network” consisted of 40 specially trained, 
physical therapists, all of whom worked in a primary care private practice in the region of 
Amsterdam [26]. Patients in the intervention group were referred to one of these specialized 
trauma physical therapists. 
4. Secure email traffic between the hospital-based physical therapist and the primary care 
physical therapist during the entire rehabilitation process. A secured email system, developed 
for healthcare professionals, was connected to both the electronic patient records of the 
hospital-based physical therapist and the primary care physical therapist. 
Regular care
Patients in the control group received regular care, during which the trauma surgeon acted as 
the chief consultant. The trauma surgeon performed consultations at the outpatient clinic for 
trauma patients, and acted independent of other health care professionals. Based on the clinical 
judgment of the trauma surgeon, a patient could be referred to a primary care physical therapist, 
but there was no standardized policy for referral of control group patients. Throughout the 
patients’ rehabilitation in primary care, there was hardly any contact between trauma surgeon 
and primary care physical therapists.
outcome assessment
An overview of all outcome measurements is provided in Table 3.1. Extensive details of the 
outcome measures can be found elsewhere [23,24].
Baseline characteristics 
At baseline, all relevant demographic and trauma-related characteristics were measured (e.g. 
gender, age, medical history, ISS, the number of days between trauma and first outpatient 
consultation [TTO]). Baseline characteristics were collected using online questionnaires, 
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Primary outcome measure
The primary outcome measure was generic HR-QOL, assessed using the EQ-5D-3L [27]. The 
EQ-5D-3L consists of 5 questions covering 5 health dimensions (i.e. mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression), all of which contain 3 severity levels. Using 
the Dutch tariff, the participants’ EQ-5D-3L health states were converted into a utility score, 
anchored at 0 (dead) and 1 (optimal health).
Secondary outcome measures
Secondary outcome measures were disease-specific HR-QOL, pain, functional status, patient 
satisfaction and perceived recovery.
Depending on the patients’ specific injury type, disease-specific HR-QOL was measured using 
one of the following disease-specific function scales:
• The Quick Dash for patients with upper extremity fractures, consisting of 11 items, measuring 
physical function and symptoms on a five-point scale. The overall score ranges from 0 to 
100 [28,29].
• The Lower Extremity Functional Scale (LEFS) for patients with hip fractures or other lower 
extremity fractures. The LEFS is a 20-item questionnaire with 5 answering options. The overall 
score ranges from 0 to 80 [30,31].
• The Roland Morris Disability Score (RMDS) for patients with vertebral fractures. The RMDS 
is a 24-item questionnaire with 2 answering categories (yes/no). The overall score ranges 
from 0 to 24 [32,33].
• The Groningen Activity Restriction Scale (GARS) for multi-trauma patients. The GARS is an 
18-item questionnaire with 4 response categories, measuring daily activities. The overall 
score ranges from 18 to 72 [34,35].
An overall disease-specific HR-QOL score (DSQOL-OA) was calculated by converting the total 
scores of the aforementioned questionnaires to a scale from 0–100. Higher scores indicated 
that patients experienced more functional problems [24].
The Numeric Pain Rating Scale (NPRS) was used to measure pain. The NPRS is an 11-point scale 
ranging from 0 (no pain) to 10 (worst possible pain) [36]. 
Functional status was measured using the Patient Specific Function Scale (PSFS) [37,38]. Patients 
identified 3 important activities that they were having difficulty with. Per activity, they were 
asked to rate their present level of difficulty associated with each activity on a 0–100 mm Visual 
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Analogue Scale (VAS) ranging from 0 (“able to perform activity at same level as before injury or 
problem”) to 100 (“unable to perform activity”). The activity that was first mentioned by the 
participants, was used for statistical analysis.
Patient satisfaction was examined on an 11-point Numeric Rating Scale (NRS) ranging from 
0 (very dissatisfied) to 10 (excellent). Three patient satisfaction components related to the 
TTCM were evaluated: 1) the over-all treatment, 2) treatment located at the outpatient clinic, 
3) collaboration between the multidisciplinary team at the outpatient clinic and the primary 
care physical therapist. 
Perceived recovery was examined using the Global Perceived Effect (GPE) scale. The GPE quantifies 
a patient’s subjective improvement on a 7-item scale, ranging from “worse than ever” (1) to 
“completely recovered” (7) [39]. Success of treatment was achieved when a patient reported 6 
or 7 points meaning respectively “much improved” or “completely recovered”. 
data analysis
The current data analysis section is highly comparable to the version previously described in 
the study protocol [23].
Descriptive statistics
Descriptive statistics were used to compare baseline characteristics between study groups. 
Handling missing data
Missing data were imputed using Multiple Imputation by Chained Equations [40]. An imputation 
model was built, including variables predicting the outcomes, variables that are related to the 
“missingness” of data, and furthermore, all available midpoint and follow-up effect measure 
values [40]. Ten complete data sets were created in order for the loss-of-efficiency to be below 
5% [41]. All of the imputed datasets were analysed separately as specified below. Rubin’s rules 
were used to subsequently calculate Pooled estimates [41].
Clinical effectiveness 
The clinical effectiveness analyses contained two parts. First, linear regression analyses were 
used to investigate the effectiveness of the TTCM in terms of HR-QOL (generic- and disease-
specific), pain, functional status, patient satisfaction and perceived recovery compared with 
regular care at 3-, 6- and 9-months follow-up. For this purpose, three clusters of control patients 
(i.e. 3-month cluster, 6-month cluster, and 9-month cluster) were compared with the patients in 
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the intervention group at the corresponding time points. Second, the recovery patterns of the 
intervention group patients for generic- and disease-specific HR-QOL, pain and functional status 
during the nine-month follow-up period was studied using GLM for repeated measures [42]. All 
analyses were adjusted for confounders if necessary (e.g. gender, fracture region, length of stay). 
Confounding was examined by adding the potential confounding variable to the crude models. If 
the regression coefficient changed by 10% or more, the confounding variable was considered to 
be present. Analyses were performed in SPSS Version 22, using a level of significance of p<0.05.
results
Study participants
A total of 655 trauma patients were identified as being potentially eligible for participation in the 
control group. Of them, 453 patients were excluded for various reasons (e.g. did not performed 
informed consent (n=134), not willing (n=105)). The remaining 202 patients were included in the 
control group, of which 68 in the baseline cluster, 26 in the 3-month cluster, 51 in the 6-month 
cluster, and 57 in the 9-month cluster (Figure 3.2a). For the intervention group, a total of 103 
potentially eligible patients were identified, of whom 20 were eventually excluded for several 
reasons (e.g. did not performed informed consent (n=9), no internet access (n=2)). The remaining 
83 patients were included as participants in the intervention group (Figure 3.2b).
Baseline characteristics of participants in the four control group clusters and the intervention 
group are described in Table 3.2. The majority of these characteristics were similar among 
participants. However, participants in the intervention group were younger, were more frequently 
admitted to the hospital, and had lower extremity fractures more often than their control group 
counterparts.
Clinical effects
There were no relevant between-group differences in the dependent variable generic HR-QOL 
(primary outcome measure) at all measurement points (Table 3.3). However, the mean between-
group difference in the dependent variable disease-specific HR-QOL was statistically significant in 
favor of the intervention group at 9 months (MD -7.96; 95% CI -14.17 to -1.75), but not at 3 and 
6 months. Patients in the intervention group had statistically significant less pain at 6 (MD -0.87; 
95% CI -1.44 to -0.29) and 9 months (MD -0.84; 95% CI -1.38 to -0.31) than their control group 
counterparts, but no difference in the dependent variable pain was found at 3 months. There was 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.2b Enrollment of intervention group participants.
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Figure 3.2a Enrollment of control group participants. 
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intervention group at 6 months (MD -16.49; 95% CI -24.39 to -8.60) and 9 months (MD -20.68; 
95% CI -29.20 to -12.16), but not at 3 months. Furthermore, participants in the intervention 
group were statistically significant more satisfied with their total treatment at 3 months (MD 
0.77; 95% CI 0.13 to 1.42), but not at 6 and 9 months. At all of the time points, patients in the 
intervention group were statistically significant more satisfied with the collaboration between 
primary and secondary care (3 months = MD 1.61; 95% CI 0.72 to 2.51, 6 months = MD 1.78; 
95% CI 1.03 to 2.53, and 9 months = MD 1.20; 95% CI 0.42 to 1.97). However, no statistically 
significant differences were found at any time point for the dependent variable patient satisfaction 
regarding the treatment at the outpatient clinic (Table 3.3).
Based on the Global Perceived Effect, 74.6%, 78.3%, and 84.6% of the intervention group 
patients were “completely recovered” or “much improved” at 3, 6, and 9 months, respectively. 
Of the control group patients, 53.8%, 53.3% and 75% were “completely recovered” or “much 
improved” at these time points. At 6 months this effect was statistically significant (OR 3.35; 
95% CI 1.32 to 8.49) (Table 3.4).
















3 months 74.6 53.8 2.37 (0.85 to 6.62) 2.39 (0.69 to 8.20) Age, fracture 
region, length 
of stay
6 months 78.3 53.3 2.99 (1.24 to 7.23) 3.35 (1.32 to 8.49) Fracture region
9 months 84.6 75.0 1.16 (0.46 to 2.95) 1.21 (0.45 to 3.28) Medical history, 
TTO**
* The baseline characteristics mentioned in this column were confounders (changed the regression 
coefficient with 10% or more). 
** TTO = Time between Trauma and first Outpatient consultation (days).
Recovery pattern of patients in the intervention group
During the nine-month follow-up period, generic HR-QOL (F=18.43; p=0.000), disease-specific 
HR-QOL (F=6.18; p=0.001), pain (F=17.16; p=0.000), and functional status (F=65.05; p=0.000) 
statistically significantly improved in a linear fashion among intervention group patients (Figure 




Traumatic injury poses a substantial economic burden to society. However, little is currently 
known about how to optimally organize the post-clinical rehabilitation process of trauma patients. 
Therefore, the current study developed and evaluated the TTCM, the first transmural care model 
for the rehabilitation of trauma patients in primary care [9,10,23].
Important study findings and comparison with the literature
Our results indicate that the TTCM statistically significantly improved disease-specific HR-QOL, 
functional status, patient satisfaction and perceived recovery, and reduced pain among mild, 
moderate and severe trauma patients. It is important to mention, however, that even though no 
statistically significant effects were found for generic HR-QOL, the identified mean difference can 
be regarded as clinically relevant at 6 months (MD 0.051; 95% CI -0.02 to 0.12) and 9 months (MD 
0.055; 95% CI -0.01 to 0.12). To illustrate, estimates of the minimal clinical important difference 
(MCID) for the EQ-5D range from 0.03 among patients with low back pain [43], to 0.52 in patients 
with recurrent lumbar stenosis [44]. In light of this finding it is also important to bear in mind 
Figure 3.3 Longitudinal follow-up intervention group.
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Figure 2b: Disease specific HR-QOL (DSQOL-OA) 
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Figure 2b: Disease specific HR-QOL (DSQOL-OA) 
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that the current study was not powered to detect a clinically meaningful difference in generic 
HR-QOL due to its explorative nature.
Strengths and limitations
The present study population covers a broad range in trauma patients, with an ISS ranging from 
4 to 43. This is an important strength, as the majority of studies only included major trauma 
patients with an ISS >16 [4,14,45]. Since our study population includes mild, moderate and 
severely injured patients, the TTCM is likely to be effective in the entire group of trauma patients. 
However, future research is necessary to examine whether several subgroups of trauma patients 
respond in different ways on the TTCM. 
A second important strength of this study is its clinical relevance as well as the fact that it was the 
first to develop and evaluate a transmural care model for the post-clinical rehabilitation of trauma 
patients. Other strengths include its use of a broad spectrum of measurement instruments, 
covering all domains of the International Classification of Functioning, Disability and Health 
(ICF) [46], its use of validated questionnaires, as well as its pragmatic design (i.e. daily practice 
was resembled as much as possible).  
The study also had some limitations. Even though the applied modified controlled-before-and-
after design was regarded as the most optimal research design within the available resources, it 
is susceptible to many kinds of bias. Examples of such kinds of bias are selection bias, recall bias, 
regression to the mean, the Hawthorne effect, and repeat testing bias. Of them selection bias 
is probably most likely, meaning that the study groups have a different composition regarding 
various etiological factors. A multicenter randomized controlled trial would therefore be the 
next step in order to study the TTCM’s effectiveness more robustly. In spite of the fact the 
all participating trauma patients met the same inclusion criteria, we observed some baseline 
differences in age (intervention group patients were younger) and admission to hospital (75% 
of intervention group patients were admitted to the hospital, compared to 51% in control 
group). Based on the recommendations of de Boer et al. we decided not to statistically test 
baseline differences across study groups [47]. They postulate that statistically testing of baseline 
differences ignores the fact that the prognostic strength of a variable is also important when 
the interest is in e.g. adjustment for confounding. On top of that, our study was not powered to 
detect relevant differences at baseline, so possibly relevant differences may also turn out not to 
be statistically significant. Nonetheless, if we found the addition of a certain baseline variable to 
change the regression coefficient by more than 10%, they were added to the final models. Another 
potential limitation was the absence of a sample size calculation. We based the sample size on 
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our estimate of the number of patients that could potentially be included within the time frame 
and financial constraints of this study. A sample size calculation is preferable in future research, to 
make sure that the study is not underpowered to detect clinically meaningful effect differences. 
Another limitation is the fact that we were not able to identify what components of the TTCM 
were responsible for the positive effects. To illustrate, the better functional outcomes could be 
the result of an improved communication strategy between the multidisciplinary hospital team 
and the primary care physical therapist. On the other hand, the better outcomes may have been 
the result of a better educated and more experienced network of primary care physical therapists. 
It would be interesting to identify the critical ingredient of this relatively complex intervention. 
One might also argue, however, that the sum is greater than the individual parts and therefore 
there is probably no such thing as a critical ingredient. Future research can possibly provide 
more insight into whether separate TTCM components are accountable for specific effects. 
conclusions
This study provides preliminary evidence that the TTCM is effective in improving patient-related 
outcome measures, such as disease-specific HR-QOL and functional status. A multicenter, and 
ideally randomized controlled trial, is required to confirm these results.
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Objectives: To assess the societal cost-effectiveness of the Transmural Trauma Care Model 
(TTCM), a multidisciplinary transmural rehabilitation model for trauma patients, compared 
to regular care.
Methods: The economic evaluation was performed alongside a before-and-after study, 
with a convenience control group measured only afterwards, and a 9-month follow-up. 
Control group patients received regular care and were measured before implementation 
of the TTCM. Intervention group patients received the TTCM and were measured after 
its implementation. The primary outcome was generic health-related quality of life (HR-
QOL). Secondary outcomes included disease-specific HR-QOL, pain, functional status and 
perceived recovery. 
results: Eighty-three trauma patients were included in the intervention group and 57 in the 
control group. Total societal costs were lower in the intervention group than in the control 
group, but not statistically significantly so (EUR-267; 95% CI: EUR-4,175 to 3,011). At 9 
months, there was no statistically significant between-group differences in generic HR-QOL 
(0.05; 95% CI -0.02 to 0.12) and perceived recovery (0.09; 95% CI -0.09 to 0.28). However, 
mean between-group differences were statistically significantly in favor of the intervention 
group for disease-specific HR-QOL (-8.2; 95% CI -15.0 to -1.4), pain (-0.84; 95% CI -1.42 to 
-0.26), and functional status (-20.1; 95% CI -29.6 to -10.7). Cost-effectiveness acceptability 
curves indicated that if decision-makers are not willing to pay anything per unit of effect 
gained, the TTCM has a 0.54–0.58 probability of being cost-effective compared with regular 
care. For all outcomes, this probability increased with increasing values of willingness-to-pay. 
conclusion: The TTCM may be cost-effective compared with regular care, depending on 
the decision-makers willingness to pay and the probability of cost-effectiveness that they 
perceive as acceptable.
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bAckgrOund
Traumatic injury is the leading cause of death during the first four decades of life, accounts 
for 9.6% of global mortality [1,2] and causes the biggest loss of Disability-Adjusted Life Years 
(DALYs) compared to any other disease [3]. Traumatic injury disproportionately affects younger 
individuals and, as a consequence, accounts for the highest amount of lost productive years of 
life [4]. While the direct medical costs of traumatic injury are substantial, its economic burden 
is particularly high for employers. To illustrate, in the United States, the total cost of fatal 
unintentional injury was estimated at about USD84 billion, of which the largest share was due 
to lost productivity (i.e. about USD83 billion) [4]. In the Netherlands, the total cost of trauma 
(intentional and unintentional) was estimated to be EUR6 billion, of which EUR2.6 billion were 
direct medical costs and EUR3.4 billion were lost productivity costs [5]. 
During the last three decades, an improved organization of acute trauma care has led to a 15–25% 
decrease in mortality [6-8]. As further improvements in survival rates are likely to be relatively 
small, the focus of trauma care has moved from reducing mortality to improving quality of life 
and outcome [9]. A possible means for improving trauma patients’ health-related quality of life 
(HR-QOL) and outcome may be the optimization of their rehabilitation process. We therefore 
developed the Transmural Trauma Care Model (TTCM), which aims to improve the organization, 
content, and quality of the trauma patients’ rehabilitation process. The TTCM consists of a 
continuous feedback loop, in which a multidisciplinary hospital-based team supervises a network 
of primary care physical therapists in the treatment of trauma patients [10]. Effectiveness analyses 
showed that, among trauma patients with at least one fracture, the TTCM resulted in better 
patient outcomes, such as disease-specific HR-QOL, pain and functional status, compared to 
regular care (Wiertsema et al., unpublished data).
As healthcare resources are restricted, trauma systems should not only be effective in improving 
patient outcomes, but also provide “good value for money”. The latter is assessed in an economic 
evaluation, which provides insight into a treatment’s additional cost per additional unit of health 
gained [11]. Up until now, relatively few economic evaluations evaluated the cost-effectiveness 
of trauma systems [12-14], and those aimed at the rehabilitation phase in particular. Therefore 
the current economic evaluation aimed to assess the cost-effectiveness of the TTCM for 
generic HR-QOL from a societal perspective compared to regular care. In a secondary analysis, 
the intervention’s cost-effectiveness for disease-specific HR-QOL, pain, functional status, and 




The study protocol has been published elsewhere [10]. A summary is given below.
design 
The economic evaluation was conducted alongside a before-and-after study with a convenience 
control group measured only afterwards. This clinical trial was conducted at the outpatient clinic 
of a level-1 trauma center (Amsterdam UMC, location VUmc, Amsterdam, The Netherlands) 
[15]. In contrast to a true controlled-before-and-after study, only the intervention group was 
prospectively followed, while control group data were collected cross-sectionally. That is, the 
trial’s control group consisted of 4 independent clusters of patients who either had their first 
consultation at the outpatient clinic 0, 3, 6 or 9 months ago. After implementation of the TTCM, 
one cluster of intervention group patients was prospectively followed and measured directly 
after their first consultation at the outpatient clinic (i.e. baseline), and after 3, 6 and 9 months 
(Figure 4.1). In order to capture all costs flowing from the intervention under study, the analytic 
time frame of an economic evaluation typically needs to be longer than that of an effectiveness 
study [16]. Therefore, in the present economic evaluation, only the 9-month control cluster was 
compared to the intervention group. The 9-month control cluster will be further referred to as 
the control group.
Figure 4.1 Study design of the modified controlled before and after study. 
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The medical ethics committee of the VUmc decided that the Dutch Medical Research Involving 
Human Subjects Act (WMO) was not applicable to the present study (registered under number 
2013.454). All participants gave informed consent. The trial is registered at the Dutch Trial 
Register (NTR5474).
Participants
Surgically as well as conservatively treated trauma patients were included. Eligible trauma 
patients had at least one traumatic fracture, were aged ≥18 years, rehabilitated in the primary 
care setting and were able to fill out online questionnaires in Dutch. Patients were excluded 
if they met any of the following criteria: traumatic brain injury, pathological (non-traumatic) 
fractures, cognitive limitations, rehabilitation in a tertiary care facility or living outside the 
catchment area of the VUmc. 
Control group patients were identified from the central trauma registry of the trauma region 
“North West Netherlands” and were contacted by phone by one of the investigators. They 
received further information about the study, after which the principle investigator verified the 
in- and exclusion criteria and patients were assigned to their specific cluster (based on the time 
elapsed since their first consultation). Eligible patients who were willing to participate received 
an email containing a link to the online questionnaire. Patients who did not respond within one 
week received a maximum of two reminder emails. If the patient did not reply to both emails, 
one of the coordinating investigators contacted the patient by phone.
Intervention group patients were identified during their first consultation at the outpatient clinic. 
During this consultation, patients were informed about the study by one of the investigators 
and in- and exclusion criteria were verified. In the week following the first consultation, patients 
who were willing and eligible to participate, received an email containing a link to the first online 
questionnaire. Subsequently, patients were prospectively followed and received additional online 
questionnaires at 3-, 6- and 9-month follow-up. Patients who did not respond within one week, 
received a maximum of 2 reminder emails. If the patient did not reply to both emails, one of 
the coordinating investigators contacted the patient by phone. 
Intervention conditions
Pre- and in-hospital trauma care remained unchanged and was the same for the intervention 
group and the control group. 
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The Transmural Trauma Care Model (TTCM)
Patients in the intervention group received care according to the TTCM [10]. The TTCM combined 
the following components: 
1. A multidisciplinary team consisting of a trauma surgeon and a highly-specialized hospital-
based trauma physical therapist at the outpatient clinic for trauma patients. The trauma 
surgeon acted as the chief consultant, the physical therapist assessed physical function and 
acted as case manager throughout the rehabilitation process. During a shared-decision 
making process the surgeon, physical therapist and patient determined whether and when 
physical therapy in primary care was required.
2. Coordination and individual goal setting for each patient by this hospital-based team in 
combination with treatment according to customized protocols. The hospital-based team 
coordinated the patients’ rehabilitation process by repeatedly defining individual goals with 
the patient during the rehabilitation period. For the purpose of the TTCM, 10 rehabilitation 
protocols were developed for the most common fractures (e.g. hip fractures, tibial plateau 
fractures). 
3. A network of 40 specialized primary care physical therapists. This so called “VUmc trauma 
rehabilitation network” consisted of 40 physical therapists covering the region of Amsterdam 
(www.traumarevalidatie.nl) (17). The 40 primary care physical therapists participating in the 
trauma network were trained and educated during a two-day course led by trauma surgeons 
and hospital-based physical therapists, specialized in trauma care. 
4. E-health support for transmural communication between the hospital-based trauma physical 
therapist and the primary care physical therapist. The hospital-based physical therapist and 
the primary care physical therapist communicated repeatedly throughout the rehabilitation 
process using secured email (especially developed for health care professionals).
Regular care
Patients in the control group received regular post-clinical care during which the trauma surgeon 
acted as the chief consultant and performed the post-clinical consultations, unaccompanied by 
any allied health care professionals. The trauma surgeon decided whether and when physical 
therapy in primary care was needed. During a patients’ rehabilitation, there was no regular 
contact between the surgeon and the primary care physical therapist.
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Outcome measures
Various demographic and trauma-related characteristics were assessed for all patients (e.g. age, 
gender, medical history, ISS, time between trauma and first outpatient consultation [TTO]). These 
characteristics were collected using online questionnaires, supplemented by data derived from 
electronic patient records.
The primary outcome was generic HR-QOL. Secondary outcomes included disease-specific 
HR-QOL, pain, functional status, and perceived recovery. In the intervention group, outcome 
measures were assessed at 0, 3, 6 and 9 months after patients’ first consultation at the outpatient 
clinic. In the control group, outcome measures were solely assessed at 9 months after the 
patients’ first consultation at the outpatient clinic.
Generic HR-QOL was measured using the EQ-5D-3L [18]. Using the Dutch tariff, the participants’ 
EQ-5D-3L health states were converted into a utility score, anchored at 0 (dead) and 1 (optimal 
health). As control group participants were only measured once, we were not able to estimate 
quality adjusted life years and include them as an outcome measure in the current economic 
evaluation. Nonetheless, generic HR-QOL can still be regarded as a preference-based measure, 
as utility values were based on the preferences of the Dutch population.
Disease-specific HR-QOL was measured using four disease-specific function scales, appropriate to 
the patients’ specific injury type. The Quick Dash score was filled out by patients with fractures of 
the upper extremity [19,20]. The Lower Extremity Functional Scale (LEFS) was used in patients with 
hip fractures or other lower extremity fractures [21,22]. The Roland Morris Disability Score (RMDS) 
was filled out by patients with vertebral fractures [23,24]. The Groningen Activity Restriction 
Scale (GARS) was used in multi-trauma patients [25]. An overall disease-specific HR-QOL score 
was calculated by converting the overall scores of the four abovementioned questionnaires to 
a scale from 0–100, with higher scores representing more functional problems. 
Pain was measured using an 11-point numeric pain rating scale (NPRS), ranging from 0 (no pain) 
to 10 (worst possible pain) [26]. 
Functional status was measured using the Patient Specific Function Scale (PSFS) [27,28]. Patients 
had to identify 3 important activities that they are having difficulty with and were requested to 
rate their current level of difficulty associated with each activity on an 0–100 mm visual analogue 
scale (VAS) ranging from 0 (“able to perform activity at same level as before injury or problem”) 
to 100 (“unable to perform activity”). Only the activity that was first mentioned by the patient 
was used in the economic evaluation. 
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Perceived recovery was measured using the Global Perceived Effect (GPE) scale. Patients were 
asked to rate how much their condition has improved or deteriorated since their trauma on 
a 7-item scale [29]. Success of treatment was achieved when a patient reported to being 
“completely recovered” or “much improved”.
cost measures
Costs were measured from a societal perspective, including intervention, health care, 
absenteeism, presenteeism and unpaid productivity costs. Intervention costs included all costs 
related to the additional time investments of the hospital-based trauma physical therapist 
(estimated at 15 minutes per outpatient clinic consultation) and the specialized primary care 
physical therapist (estimated at 5 minutes per outpatient clinic consultation), as well as the 
cost of hosting and maintaining the transmural communication system. The costs associated 
with the TTCM’s development (e.g. training costs) were excluded, as these costs will become 
negligible after implementing the intervention broadly [30,31]. All other cost categories were 
assessed using online cost questionnaires, supplemented by hospital records if available (e.g. 
for imaging procedures). In order to cover the complete duration of follow-up, recall periods of 
the online questionnaires varied between treatment groups and measurement points. For the 
intervention group, 3-month recall periods were used at baseline, 3, 6 and 9 months follow-up 
and costs were added together to get an estimate of the total costs during the 9-month follow-
up period. For the control group, a recall period of 9 months was used at 9-month follow-up. 
Health care utilization included the use of primary care (e.g. consultations at the general 
practitioner or physical therapist) and secondary care (e.g. consultations at the outpatient clinic 
for trauma patients, hospitalization) as well as the use of medication. Dutch standard costs were 
used to value health care costs [31]. Medication use was valued using the G-standard of the 
Dutch Society of Pharmacy [32]. 
Absenteeism was assessed using the “PROductivity and DISease Questionnaire” (PRODISQ). 
Patients were asked to report their total number of sick leave days [33]. Absenteeism was valued 
using age- and gender-specific price weights [31].
Presenteeism was defined as reduced productivity while at work and was assessed using the 
World Health Organization Health and Work Performance Questionnaire [34]. Presenteeism was 
valued using age- and gender-specific price weights [31].
Unpaid productivity losses were assessed by asking patients for how many hours per week they 
were unable to perform unpaid activities, such as domestic work, school and voluntary work. A 
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recommended Dutch shadow price was used to value unpaid productivity. The Dutch shadow 
price was calculated in accordance with the opportunity good method and was estimated to 
be EUR12.50 per hour in 2009 [31].
All costs were presented in Euros and converted to the same reference year (i.e. 2014) using 




Descriptive statistics were used to compare baseline characteristics between intervention and 
control group participants. 
Handling missing data
Missing data were imputed using Multiple Imputation by Chained Equations [35]. Two imputation 
models were constructed, including one for the intervention group and one for the control group. 
Both imputation models included variables related to the “missingness” of data, variables that 
predicted the outcomes, and all available midpoint and follow-up cost and effect measure values 
[35]. Ten complete data sets were created in order for the loss-of-efficiency to be below 5% [36]. 
Imputed datasets were analysed separately as specified below, after which pooled estimates 
were calculated using Rubin’s rules [36].
Economic evaluation 
Cost-effectiveness analyses were performed according to the intention-to-treat principle. Cost 
and effect differences were estimated using seemingly unrelated regression analyses in order to 
correct for their possible correlation. Cost and effect differences were corrected for confounders. 
Confounding was checked by adding the potential confounding variable to the crude models, 
and was subsequently considered to be present if the regression coefficient changed by 10% 
or more. To deal with the highly skewed nature of cost data, 95% CIs around the differences in 
costs were estimated using the Bias Corrected and Accelerated Bootstrap method, with 5,000 
replications. Incremental Cost-Effectiveness Ratios (ICERs) were calculated by dividing the 
differences in costs by those in effects. To graphically illustrate the uncertainty surrounding the 
ICERs, bootstrapped incremental cost-effect pairs were plotted on cost-effectiveness planes 
[37]. A summary measure of the joint uncertainty of costs and effects was presented using 
Cost-Effectiveness Acceptability Curves (CEACs), which indicate the probability of an intervention 
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being cost-effective in comparison with the control condition for a range of willingness-to-pay 
values (i.e. the maximum amount of money decision-makers are willing to pay to gain one extra 
unit of effect) [38]. Two one-way structural sensitivity analyses were performed to test the 
robustness of the results; 1) applying the healthcare perspective (i.e. only costs accruing to the 
Dutch healthcare system were included), and 2) excluding presenteeism costs [11]. All analyses 
were performed in STATA, using a level of significance of p<0.05.
results
Study participants
Eighty-three trauma patients were enrolled in the intervention group and 57 in the control group 
(Supplementary Figure S4.1). Most baseline characteristics were similar among intervention 
and control group patients. However, patients in the intervention group were slightly younger, 
were more frequently admitted to a hospital, received surgery more frequently, and had a 
longer time between trauma and their first outpatient consultation than their control group 
counterparts (Table 4.1). A total of 107 patients (76%) had complete effect data at nine months 
follow-up (i.e. 52 intervention group patients and 55 control group patients) and 62 patients 
(44%) had complete cost data on all measurement points (i.e. 17 intervention group patients 
and 45 control group patients).
Effectiveness
At 9 months, there was no statistically significant difference in the primary outcome generic HR-
QOL between the intervention group and control group. As for the secondary outcomes, mean 
between-group differences were statistically significantly in favor of the intervention group for 
disease-specific HR-QOL, pain and functional status, but not for perceived recovery (Table 4.2).
costs
On average, the cost of the TTCM was EUR272 (SEM=EUR4) per patient. Secondary healthcare, 
presenteeism, and total societal costs were lower in the intervention group than in the control 
group, while primary healthcare, medication, absenteeism and unpaid productivity costs were 
higher in the intervention group than in the control group. Of them, only the difference in 
secondary healthcare costs was statistically significant (Table 4.3).
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Economic evaluation
Primary outcome: generic HR-QOL
The main analysis results for generic HR-QOL indicated that the TTCM dominated regular care 
(i.e. less costly and more effective) (Table 4.2). The CEAC in Supplementary Figure S4.2 indicates 
that the TTCM has a 0.58 probability of being cost-effective compared with usual care if decision-
makers are not willing to pay anything per utility gained, increasing to a maximum of 0.90 at a 
willingness-to-pay of EUR55,000/utility gained.  
table 4.1 Baseline characteristics (patient- and trauma-related)
Characteristics Intervention group
Mean (SD) or frequency (%)
Control group
Mean (SD) or frequency (%)
N 83 57
Age 43.4 (15.6) 50.5 (17.9)
Gender (M/F) 39/44 (47/53%) 26/31 (46/54%)
Education level
Low 7 (8.4%) 6 (11.1%)
Middle 19 (22.9%) 16 (29.6%)
High 57 (68.7%) 32 (59.3%)
Medical history 
None 53 (63.9%) 30 (52.6%)
Chronic 14 (16.9%) 13 (22.8%)
Musculoskeletal 16 (19.3%) 14 (24.6%)
Trauma type
Traffic 44 (53.0%) 25 (43.9%)
Work-related 0 2 (3.5%)
Fall 27 (32.5%) 17 (29.8%)
Sports 11 (13.3%) 9 (15.8%)
Other 1 (1.2%) 4 (7.0%)
Fracture region
Upper extremity 31 (37.3%) 25 (43.9%)
Lower extremity 41 (49.4%) 19 (33.0%)
Vertebral 7 (8.4%) 1 (1.8%)
Multitrauma 4 (4.8%) 12 (21.1%)
ISS 7.9 (range 4–26, SD 4.4) 8.6 (range 4–29, SD 6.3)
Admission hospital 62 (75.0%) 29 (51.0%)
Length of stay (days) 7.1 (6.1) 10.0 (11.4)
Surgery 53 (64.0%) 21 (37.0%)
TTO (days)* 24.3 (14.3) 14.6 (14.7)















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Secondary outcomes: disease-specific HR-QOL, pain, perceived recovery, and functional status
The main analysis results for disease-specific HR-QOL indicated that the TTCM dominated 
regular care (i.e. less costly and more effective) (Table 4.2). Please note that a lower score in 
disease-specific HR-QOL indicates an improvement. The CEAC in Supplementary Figure S4.2 
indicates that the TTCM has a 0.55 probability of being cost-effective compared with regular care 
if decision-makers are not willing to pay anything per 1-point improvement in disease-specific 
HR-QOL, increasing to 0.95 at a willingness-to-pay of EUR700/point improvement.  
The main analysis results for pain indicated that the TTCM dominated regular care (i.e. less costly 
and more effective) (Table 4.2). Please note that a lower pain score indicates an improvement. 
The CEAC in Supplementary Figure S4.2 indicates that the TTCM has a 0.54 probability of being 
cost-effective compared with regular care if decision-makers are not willing to pay anything 
per 1-point improvement in pain, increasing to 0.95 at a willingness-to-pay of EUR3,500/point 
improvement.  
The main analysis results for perceived recovery indicated that the TTCM dominated regular 
care (i.e. less costly and more effective) (Table 4.2). The CEAC in Supplementary Figure S4.2 
indicates that the TTCM has a 0.54 probability of being cost-effective compared with regular 
care if decision-makers are not willing to pay anything per recovered patient, increasing to a 
maximum of 0.85 at a willingness-to-pay of EUR50,000/recovered patient.  
The main analysis results for functional status indicated that the TTCM dominated regular care 
(i.e. less costly and more effective) (Table 4.2). Please note that a lower score in functional status 
indicates an improvement The CEAC in Supplementary Figure S4.2 indicates that the TTCM has 
a 0.57 probability of being cost-effective compared with regular care if decision-makers are 
not willing to pay anything per point improvement in functional status, increasing to 0.95 at a 
willingness-to-pay of EUR125/point improvement. 
One-way sensitivity analyses
When the healthcare perspective was applied, the mean difference in total costs was larger 
than in the main analysis (e.g. EUR-491 versus EUR-237 for general HR-QOL), and still in favor 
of the intervention group. This resulted in higher probabilities of the TTCM being cost-effective 
compared with the main analysis (Table 4.2). When excluding presenteeism costs, total costs 
were higher in the intervention group than in the control group. This finding was in contrast to 
the main analysis, and resulted in lower probabilities of the TTCM being cost-effective (Table 4.2).
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discussiOn
Traumatic injury is the most important cause of long-term functional limitations in adults younger 
than 45 years [39] and poses a substantial economic burden to society [40]. As healthcare 
resources are restricted, trauma systems should not only be effective in improving patient 
outcomes, but also provide “good value for money”. Therefore, the current economic evaluation 
aimed to assess the cost-effectiveness of the TTCM for generic HR-QOL from a societal perspective 
compared to regular care. In a secondary analysis, the intervention’s cost-effectiveness for 
disease-specific HR-QOL, pain, functional status, and perceived recovery was assessed.
Main findings
Results indicated that the TTCM statistically significantly improved disease-specific HR-QOL and 
functional status, and reduced pain, compared with regular care. Between-group differences in 
generic HR-QOL, perceived recovery, and total costs were in favour of the intervention group 
as well, but not statistically significantly so. On average, the TTCM dominated regular care for 
all outcomes. CEACs indicated that if decision-makers are not willing to pay anything per unit 
of effect gained, the TTCM has a 0.54–0.58 probability of being cost-effective compared with 
usual practice. For all outcomes, this probability increased to relatively high levels with increasing 
values of willingness-to-pay (e.g. to 0.95 at a willingness-to-pay of EUR700/point improvement 
on a NRS). However, as it is unknown what decision-makers are currently willing-to-pay per unit 
of effect gained, strong conclusions cannot be made about the cost-effectiveness of the TTCM. 
Nonetheless, decision-makers need to understand the role that rehabilitation, job retraining, 
and injury prevention play in dealing with the tremendous economic impact of traumatic injury 
to society and they can use the present results to consider whether the TTCM provides “good 
value for money” at an acceptable probability of cost-effectiveness. 
Comparison with the literature
Even though extensive research has been done on the quality and organization of pre- and in-
hospital trauma care, relatively few economic evaluations have evaluated the cost-effectiveness of 
regionalized trauma systems [12-14], and those aimed at the rehabilitation phase in particular. A 
recent study assessed the cost-effectiveness of several care pathways for inpatient rehabilitation 
in severe trauma patients [41]. All participants were treated in a specialized trauma hospital, 
but the group that rehabilitated in an in-hospital rehabilitation center, had a significantly shorter 
length of stay (LOS) compared to the group that rehabilitated in an external rehabilitation center. 
However, this was a retrospective cohort study that solely used LOS as a proxy for resource 
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consumption and therefore cannot be considered as a full economic evaluation. Furthermore, 
a Dutch study evaluated an integrated inpatient ‘Fast Track’ rehabilitation service for multi-
trauma patients. No significant effect differences were observed between the intervention and 
control group and results of the scheduled economic evaluation have not yet been published 
[42]. Another study evaluated the cost-effectiveness of three inpatient rehabilitation modalities 
(i.e. physically orientated, geriatrically orientated and routine treatment) in patients with hip 
fractures. Considering total costs one year after trauma, physically orientated rehabilitation 
showed to be more cost-effective than routine treatment. Though it was a robust study, the 
results were not generalizable to other trauma patients [43]. To the best of our knowledge the 
present study is the first to evaluate the cost-effectiveness of a transmural care model for the 
post-clinical rehabilitation of trauma patients.
strengths and weaknesses of the study
Important strengths of this study are the fact that it was the first to evaluate the cost-effectiveness 
of a new multidisciplinary transmural rehabilitation model for trauma patients, its use of a control 
group and its pragmatic design (i.e. daily practice is resembled as much as possible). Also, the 
study population covers a broad range in trauma patients (ISS ranging from 4 to 43). This is an 
important strength, as the majority of studies assessing HR-QOL, functional outcomes and costs 
after trauma, included only major trauma patients with an ISS>16 [39,44,45] or trauma patients 
with specific injuries (e.g. hip fractures or vertebral fractures) [46]. As our study population 
represents the whole spectrum from mild to severely injured trauma patients, the results are 
likely to be generalizable to the total trauma patient population (except patients with traumatic 
brain injury, which were excluded in this study). However, future research is necessary to explore 
whether specific trauma patient subgroups respond in a different way on the TTCM. 
The study also had some limitations. First, a controlled-before-and-after design, with a 
convenience control group measured only afterwards, was regarded as the most optimal research 
design within the available resources and within the possibilities of clinical practice. However, 
such non-randomized study designs are inherently susceptible to many types of bias, such as 
selection bias, recall bias, regression to the mean, the Hawthorne effect, and repeat testing 
bias [47]. Most likely in the present study is the occurrence of selection bias, meaning that 
the control group and intervention group are likely to differ in known and unknown etiological 
factors. As a consequence, it is not possible to rule out the possibility that the current findings 
are biased by baseline differences in group characteristics, and those that we were not able to 
measure due to the current study design in particular [15]. Even though we were able to correct 
for some of them in our analyses, a randomized controlled design or an observational design 
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with a propensity score matched control group would have likely produced more valid results. 
Amongst others, this is evidenced by the fact that after correcting the total cost difference 
for medical history, surgery, paid work, and working hours it changed from being positive to 
negative, albeit not statistically significant in both cases. Another potential form of bias is the 
possible influence of recall bias due to the use of retrospective questionnaires with varying 
recall periods. The assumption is that a longer recall period increases the change of recall bias 
due to difficulties in recollecting facts and events after an elongated period of time. As control 
group patients were asked to remember their resource use during the last 9 months instead of 
during the last 3 months (which was the case for the intervention group), one might argue that 
the costs of the control group have a higher probability of being underestimated than those of 
the intervention group. However, as total societal costs were higher in the control group than in 
the intervention group, it seems unlikely that the use of retrospective questionnaires severely 
biased our results. A second shortcoming of the present study was the inability to include quality 
adjusted life years in the current economic evaluation, since utilities of the control group were 
only measured at one single time point. A third shortcoming is the relatively short time horizon of 
the clinical trial. Short time horizons are common in trial-based economic evaluations, as longer 
follow-ups are typically not feasible within a trial setting. One should bear in mind, however, that 
an intervention’s cost-effectiveness observed within a trial may be substantially different from 
its longer-term cost-effectiveness. To deal with this limitation, the intervention’s longer-term 
cost-effectiveness can be estimated using modelling techniques [48].     
Finally and inherent to all economic evaluations, is the fact that the current results may not be 
generalizable to other countries due to differences in healthcare systems across countries. Also, 
despite extensive efforts to limit the amount of missing data, 56% of all participants had some 
missing cost data and 24% had some missing effect data. Although missing data are generally 
unavoidable in clinical studies and economic evaluations in particular, and multiple imputation 
techniques were used for filling in missing values, a complete dataset would have produced 
more valid and reliable results. 
Implications for practice and further research
Decision-makers can use the present results to consider whether the TTCM provides “good value 
for money” at an acceptable probability of cost-effectiveness. Implementation of the TTCM in 
other level-1 trauma centers could be considered in the future, though a multicenter controlled 




The TTCM may be cost-effective compared with regular care, depending on the decision-makers 
willingness to pay and the probability of cost-effectiveness that they perceive as acceptable. 
However, a multicenter, and ideally randomized controlled trial, would be preferred to fortify 
the results of this pragmatic study.
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Supplementary Figure S4.1b Enrollment of intervention group participants.
* Cost data of all patients in the intervention group were used for economic evaluation.
Supplementary Figure S4.1a Enrollment of control group participants.
* Cost data of patients in cluster 4 were used for economic evaluation.
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Objective: The Transmural Trauma Care Model (TTCM) is an advanced rehabilitation model 
for trauma patients with at least one fracture. This study aimed to explore the extent to 
which the TTCM was implemented as intended and to identify barriers and facilitators 
associated with its implementation.
Methods: This mixed-method process evaluation was conducted alongside a controlled-
before-and-after study. The extent to which the TTCM was implemented as intended was 
quantitatively evaluated by assessing its reach, dose delivered, dose received, and fidelity. 
To explore the barriers and facilitators associated with the implementation of the TTCM, 
qualitative data were collected by conducting homogeneous focus groups among trauma 
patients, trauma surgeons, hospital-based physical therapists (HBPT) and primary care 
network physical therapists (PCNPT). A framework method was used for analyzing the 
focus groups. In doing so, the “constellation approach” was used to categorize barriers and 
facilitators into three categories; i.e. structure, culture, and practice. 
results: The TTCM’s reach was 81%, its dose delivered was 99% and 100%, and its dose 
received was 95% and 96% for the multidisciplinary TTCM consultation hours at the 
outpatient clinic for trauma patients and the primary care network physical therapists, 
respectively. Fidelity scores, indicating the extent to which the intervention protocol was 
followed by the care providers, ranged from 66% to 93% (e.g. whether a secured email was 
sent from the HBPT to the PCNPT after each multidisciplinary TTCM visit and vice versa). 
Various barriers and facilitators were identified. An important facilitator at the structural level 
was the “use of a secured email system”. The “absence of reimbursement for the HBPT at 
the outpatient clinic” was identified as a main barrier at the structural level. At the cultural 
level, the “shared decision-making process at the outpatient clinic” was identified as a 
facilitator and the fact that “care providers sometimes contradict each other” as a barrier. At 
the practical level, an “increased level of knowledge and skills” was identified as a facilitator 
and the “absence of awareness of the TTCM in other relevant departments” as a barrier. 
conclusion: This process evaluation showed that the TTCM was largely implemented as 
intended. Furthermore, various facilitators and barriers were identified that need to be 
considered when implementing the TTCM broadly. Some differences were found among 
stakeholders, but in general, they were of the opinion that if the barriers were overcome 
and a good working balance was achieved, the quality of care and patient satisfaction were 
likely to improve significantly after implementing the TTCM.
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bAckgrOund
Traumatic injury accounts for 9.6% of global mortality [1-3] and major trauma in particular, was 
found to be the most important cause of long-term functional limitations in adults younger 
than 45 years [4]. Traumatic injury mainly affects younger individuals and, as a consequence, 
accounts for the highest number of lost productive years of life compared with other conditions 
[5]. During the last two decades, mortality due to traumatic injury has decreased considerably 
with 15–25% [6-8]. Consequently, the focus of trauma care has moved from reducing mortality 
to improving quality of life and outcome, which in turn resulted in a growing interest in improving 
the quality of trauma rehabilitation [9].
To improve the rehabilitation process of trauma patients, we developed and implemented 
the Transmural Trauma Care Model (TTCM) at a level-1 trauma center in the Netherlands. The 
TTCM is an advanced rehabilitation model, consisting of a continuous feedback-loop, in which 
a multidisciplinary hospital-based team supervises a network of primary care network physical 
therapists (PCNPT) during the rehabilitation process of trauma patients [10]. Evidence on the 
effectiveness and cost-effectiveness of the TTCM compared to regular care has been published 
elsewhere [11,12]. Results showed that the TTCM was associated with better patient outcomes 
and that it may be considered cost-effective compared with regular care, depending on the 
decision-makers’ willingness to pay and the probability of cost-effectiveness that they perceive as 
acceptable.
It is recommended to conduct a process evaluation alongside clinical trials, as process evaluations 
can provide important information for interpreting their results [13-16]. On top of that, process 
evaluation results can be used to further improve the intervention and to facilitate the transition 
of research evidence into clinical practice [17,18]. In the field of trauma treatment and trauma 
rehabilitation, process evaluations are hardly performed. One mixed-method study assessed 
the relationship between participant-related factors and adherence to osteoporosis medication, 
vitamin D supplementation, and participation in physical activity in older patients with fragility 
fractures [19]. Moreover, a recent focus group study among trauma patients suggested that 
inadequate aftercare negatively influenced trauma patients’ perceived quality of life at least one 
year after trauma [20]. It is noteworthy, that the majority of patients participating in this study 
were aged >65 and that, to the best of our knowledge, process evaluations in younger patients 
with traumatic injury are lacking. 
Even though results suggest that the TTCM could improve patient outcomes and healthcare 
efficiency [11,12], it is less clear how to implement this model in practice. Amongst others, 
it is unknown how the TTCM could be implemented in other trauma regions with their own 
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structures, cultural norms and values, and practical routines [21]. These considerations led us 
to perform a process evaluation to assess the following research questions:
1. What is the reach, dose delivered, dose received, and fidelity of the TTCM?
2. What are the barriers and facilitators associated with the implementation of the TTCM?
MethOds
design
This process evaluation was conducted alongside a clinical trial evaluating the effectiveness and 
cost-effectiveness of the TTCM compared with regular practice using a modified controlled-
before-and-after design [22]. The clinical trial was conducted at the outpatient clinic for 
trauma patients of a level-1 trauma center (Amsterdam UMC, location VUmc, Amsterdam, The 
Netherlands). In this study, operatively and non-operatively treated trauma patients with at 
least one fracture, aged 18 years or older, were included. The trial is registered at the Dutch Trial 
Register (NTR5474). The medical ethics committee of Amsterdam UMC, location VUmc, decided 
that the Dutch Medical Research Involving Human Subjects Act (WMO) was not applicable 
to the present study (registered under number 2013.454). All participants gave informed 
consent. 
This process evaluation uses a mixed-methods design. That is, quantitative process evaluation 
data were collected from the intervention group participants’ electronic patient records to assess 
the TTCM’s reach, dose delivered, dose received, and fidelity. Additionally, qualitative data were 
collected by conducting focus groups among various stakeholders to explore the barriers and 
facilitators related with the implementation of the TTCM.
the transmural trauma care Model
Below, the TTCM is briefly described. A more detailed description of the TTCM is provided 
elsewhere [10]. The TTCM consists of four components, all of which are inextricably linked to 
one another.  
1. A multidisciplinary TTCM consultation hour at the outpatient clinic for trauma patients by a 
trauma surgeon and a trauma-specialized hospital-based physical therapist (HBPT). During 
the trauma patients’ outpatient visits, the trauma surgeon evaluated the bone- and wound-
healing process and acted as the chief consultant. The HBPT assessed physical function and 
acted as case manager throughout the rehabilitation process. During a shared-decision 
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making process, the trauma surgeon, HBPT and patient determined whether and when 
physical therapy in primary care was required.
2. Coordination and individual goal setting for each patient by the multidisciplinary hospital-
based team. The hospital-based team coordinated the patients’ rehabilitation process in 
primary care by repeatedly defining individual treatment goals in close cooperation with 
the patient. To support this process, 10 rehabilitation protocols were developed for the 
most common fractures (e.g. hip fractures, tibial plateau fractures). These protocols were 
customized for each individual patient by the HBPT.
3. A network of specialized primary care physical therapists. This “Network Trauma Rehabilitation 
VUmc” consisted of 40 PCNPTs all of whom worked in a primary care practice in the 
region of Amsterdam and were specifically trained to rehabilitate trauma patients (www.
traumarevalidatie.nl).  
4. Secure email traffic between the hospital-based physical therapist and the primary care 
network physical therapist. A secured email system (“Zorgmail”), developed for healthcare 
professionals, was linked to both the electronic patient records of the HBPT and the PCNPT, 
so that regular communication was guaranteed throughout the rehabilitation process.
Quantitative assessment 
The extent to which the TTCM was implemented as intended was explored by assessing four 
process evaluation components of Linnan and Steckler, including its reach, dose delivered, dose 
received, and fidelity [23]. Reach is defined as the proportion of the intended target audience that 
participated in the intervention (i.e. the proportion of potentially eligible trauma patients that 
eventually participated in the TTCM during the clinical trial period). Dose delivered is defined as 
the number of units of the intervention delivered (i.e. the proportion of intended multidisciplinary 
TTCM consultation hours that eventually took place at the outpatient clinic and the proportion of 
included TTCM participants that was eventually referred to a PCNPT). Dose received is the extent 
to which trauma patients actively engaged in the intervention (i.e. the proportion of included 
TTCM participants that eventually visited their scheduled multidisciplinary TTCM appointment 
at the outpatient clinic and the proportion of included TTCM participants that eventually visited 
the PCNPT they were referred to). Fidelity is defined as the extent to which the intervention 
was delivered as planned (i.e. the extent to which the intervention protocol was followed by 
the various care providers). Various fidelity scores were assessed (e.g. whether a secured email 
was sent from the HBPT to the PCNPT after each multidisciplinary TTCM visit and vice versa). A 
complete overview of all fidelity scores can be found in Table 5.1. To explore the four process 
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evaluation components, data were collected from the patients’ electronic patient records (e.g. 
the number of secured emails, the use of standardized referral forms, the setting of individual 
functional goals) and from the care providers’ schedules.
Qualitative assessment
Barriers and facilitators are defined as “factors that hampered or enhanced the implementation 
of an intervention”, respectively [24]. For exploring the barriers and facilitators associated with 
the implementation of the TTCM, homogeneous focus groups were conducted among trauma 
patients, trauma surgeons, HBPTs, and PCNPTs. Participants were selected purposively. This 
sampling method allows researchers to use their own judgement to select individuals who are 
able to provide in-depth information pertaining to the research questions. We choose for focus 
groups instead of in-depth interviews, because more in-depth information can be obtained from 
a group context, in which members influence each other (“the whole is greater than the sum of 
its parts) [25,26]. Another strength of focus groups is that they provide access to shared social 
meaning and norms and how these are enacted [27]. We opted for homogeneous focus groups 
to avoid existing professional and/or personal hierarchy structures (e.g. between surgeons and 
physical therapists and patients) to influence the results. Homogeneous focus groups create a 
save environment, in which participants are more likely to speak free and open [28]. Focus groups 
were conducted at a time and location convenient to the participants. Prior to the focus groups, 
participants were assured of confidentiality and were asked to provide informed consent. Focus 
groups were guided by two experienced qualitative researchers who were familiar with the TTCM, 
but were not involved in the TTCM as care provider. During each focus group, three round table 
discussions were held; the first aimed to identify possible facilitators, the second aimed to identify 
possible barriers, and the third aimed to complement and validate the barriers and facilitators 
identified in round one and two. During all round table discussions, a topic list was used as a guide. 
Every round started by asking participants to independently write down facilitators and barriers on 
post-it’s to frame the personal perspective of the participants and avoid groupthink. Subsequently, 
participants were free to discuss all topics they considered important. All focus groups were 
audiotaped and transcribed verbatim. 
Data preparation and analysis
Quantitative analysis 
To assess the reach, dose delivered, dose received, and fidelity of the TTCM, summary statistics 
were prepared using SPSS.
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Qualitative analysis
Focus group data were analyzed using the framework method. This is a hierarchical, matrix-based 
method for ordering and synthesizing qualitative data [29,30]. The framework method enables 
systematic exploration of the data while simultaneously maintaining an effective and transparent 
examination path [31]. In this study, an “analytical framework” was constructed iteratively from 
the research aims, existing literature, and the data derived from the focus groups. For constructing 
the analytical framework, the “constellation perspective” as described by Van Raak was used as 
theoretical framework [21]. The constellation approach will be described briefly below, followed 
by a stepwise description of the way the framework method was used for analyzing the data.
The constellation approach as theoretical framework
The constellation approach has its origins in organizational research, and assumes that a 
healthcare system consists of so-called constellations, defined as “a set of interrelated practices 
and relevant, interrelated, structuring elements that together both define and fulfill a function in 
the larger system”. The needs of healthcare systems are diverse and therefore the system consists 
of a multitude of nested complementing and competing constellations and (sub)constellations 
[32]. Within a constellation there is a continuous interaction between the three elements of the 
“structure, culture and practice triplet”, introduced by Rotmans and Loorbach in 200933 and 
adapted by Van Raak (Figure 5.1) [21]. These elements are:
Structure 
Structure consists of the physical structures and resources, enforced regulations and legal rights, 
economic resources and other material elements that structure behavior within a constellation. 
Culture 
Culture refers to the paradigms, norms and values and other immaterial elements that structure 
behavior in practices. 
Practice 
Practice involves the typical routines on the operational level, which are undertaken by the 
actors within the constellation.
Actors are the individuals (e.g. patients, physicians, managers), or groups (e.g. insurance 
companies, departments) that work or act in a certain constellation. Please notice that actors are 
not part of a constellation, but shape its culture and structure (and vice versa) through practice.
For the TTCM, several nested constellations can be recognized, for example, the outpatient 
clinic for trauma patients on the one hand and the primary care network practices on the 
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other hand. Moreover, both the hospital and the primary care network practices are part of a 
bigger constellation, in which insurers, and policy-makers act in a certain structure and culture. 
Dynamics, such as those created by the implementation of the TTCM provide an opportunity 
for change. When the change process leads to a fundamental shift in structure, culture, and 
practice, a transition of the constellation has occurred. In general, the driving force of change is 
the sense of urgency for change by “key actors” within a constellation [32]. These actors initiate 
and push for change on the structural, cultural, and practical level [34]. To achieve a transition 
the relevant actors need to develop a collective sense of urgency to change and they need to 
develop new competences (knowledge, attitude and skills). Scaling up involves implementing 
the results of niche experiments in the existing structure, culture and practice [35].
Stepwise procedure of the framework method to construct an analytical framework
We constructed an “analytical framework” iteratively from the literature and the focus group 
data. For building this analytical framework, the “constellation perspective” as described above 
was used as “theoretical framework”. The first step of the framework method [30] consisted 
Figure 5.1 The interaction between the three elements of the “structure culture and practice triplet” 
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of a verbatim “transcription” of the audiotaped focus groups, followed by the second step 
which was “familiarization” with the data by listening and rereading the transcripts. The third 
step was “coding”, and was aimed at classifying the data in such a way that it can be compared 
systematically with other parts of the data set. For this purpose, all transcripts were manually 
coded line by line by applying a paraphrase or label to relevant parts of the text (the “code”), 
using Microsoft Word. We started with open coding, meaning that anything that could be possibly 
relevant, was coded independently by two of the researchers, SW and MD. Subsequently, both 
researchers independently generated descriptive themes and subthemes. The fourth step was 
the “development of an analytical framework”, in which codes were grouped into categories on 
the structural, cultural, and practical level of the theoretical framework (i.e. the constellation 
approach). Subsequently, the final codes were developed through discussion between the two 
researchers. During these discussions, similar codes were grouped into main topics and subtopics 
in order to identify important themes (i.e. selective coding), resulting in the initial analytical 
framework. Then, both researchers independently coded all remaining transcripts of the focus 
groups using the initial framework. Subsequently, they met again and following discussion, revised 
the initial framework to incorporate new and refined codes. The process of refining, applying, 
and refining the analytical framework was repeated until no new codes were generated. 
Note that the process of developing the analytical framework was a combined deductive and 
inductive approach. On the one hand pre-selected themes and codes of Van Raaks’ theoretical 
framework were used (deductive), while on the other hand, themes and codes were generated 
from our own data (inductive). The final framework consisted of 16 themes, clustered into six 
categories (facilitators and barriers on the structural, cultural or practical level, respectively). In 
the fifth step, called “indexing”, both researchers systematically went through each transcript 
again, highlighting each meaningful passage of text and selecting and attaching an appropriate 
code from the final analytical framework. At this stage, each code was assigned an abbreviation for 
easy identification (e.g. FST1 = Facilitator Structural Theme 1). Indexing involves the comparison 
of data within and between focus groups. 
The sixth step is called “charting”, in which a spreadsheet was used to generate a framework 
matrix. During this stage, data are summarized by category and subsequently categorized into 
the matrix, followed by adding illustrative and interesting quotes from participants in the focus 
groups. During the seventh step, “interpretation of the data”, the framework matrix was used to 
interpret the data together with some notes that were made during the focus groups and the 
coding process. This interpretation process was an iterative process and relied on a consultation 
between both researchers about the relevance and strength of a theme. The intensity, frequency, 
persuasiveness, and contrast with which statements were made by the participants, determined 
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the value that was given to them. To ensure rigor and credibility of the findings, another researcher 
(JvD) reviewed the generated matrix and checked whether the selected quotes were of relevance 
to the themes. Disagreements were resolved by discussion. To guarantee quality of study reporting, 
the COREQ checklist was used (COnsolidated criteria for REporting Qualitative research) [36].
results
Quantitative results
An overview of the quantitative results of the process evaluation are presented in Table 5.1 and 
will be briefly discussed below.
table 5.1 Process evaluation components, definitions and scores
Component Definition Score (%)
Reach The proportion of potentially eligible trauma patients that eventually 
participated in the TTCM during the clinical trial.
80.6
Dose delivered The proportion of intended multidisciplinary TTCM consultation hours 
that eventually took place at the outpatient clinic for trauma patients.
99.3
The proportion of included TTCM participants that was eventually 
referred to a primary care network physical therapist.
100.0
Dose received The proportion of included TTCM participants that eventually visited 
their scheduled multidisciplinary TTCM appointment at the outpatient 
clinic for trauma patients. 
95.1
The proportion of included TTCM participants that eventually visited 
the primary care network physical therapist they were referred to.
96.4
Fidelity The use of the standardized referral form for the primary care network 
physical therapist.
89.2
Secured email was send from the hospital-based physical 
therapist to the primary care network physical therapist after each 
multidisciplinary TTCM visit.
92.8
Secured email was send from the primary care network physical 
therapist to the hospital-based physical therapist prior to each 
multidisciplinary TTCM visit.
75.9
Individual functional goals were set for the patient by the 
multidisciplinary hospital-based team during each multidisciplinary 
TTCM visit.
89.2
Specific feedback from the primary care network physical therapist 
to the hospital-based team whether the functional goals have been 
achieved or not (and why).
66.3
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Reach
Of the 1,993 trauma patients that were assessed for eligibility at the outpatient clinic for trauma 
patients between June 2014 and April 2015, 103 potentially eligible patients were identified. 
Reasons for not being eligible included (amongst others) sprains, orbital fractures, bone bruises 
or no need for physical therapy. Of the potentially eligible patients, 20 were excluded, because 
they did not provide informed consent (n=9), had no internet access (n=2), were not willing to 
participate (n=4), had other reasons (n=5). The remaining 83 patients were allocated to the 
TTCM (Figure 5.2). The reach of the TTCM was therefore 80.6% (83/103).
Figure 5.2 Reach of the TTCM.
Potentially eligible
(n=103)
Assessed for eligibility at outpatient clinic
(n=1,993)
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During the intervention period, 544 multidisciplinary TTCM consultation hours at the outpatient 
clinic were scheduled. During four of these multidisciplinary TTCM consultation hours, the HBPT 
was absent due to personnel shortage (n=1), illness of a care provider (n=2), and scheduling 
problems (n=1). Thus, the dose delivered of the multidisciplinary TTCM consultation hours was 
99.3% (540/544). During the intervention period, all of the 83 TTCM participants were referred 
to a PCNPT. Thus the dose delivered of primary care network physical therapy was 100%.
Dose received
During the intervention period, all of the 83 TTCM participants visited at least two of their 
scheduled multidisciplinary TTCM appointments at the outpatient clinic. The mean number 
of actual visits per participant was 4.7 (range 2–10). In total, 407 multidisciplinary TTCM 
appointments were scheduled, of which 387 visits eventually took place. Participants did not show 
up or canceled their appointment due to not having complaints anymore (n=4), being ill (n=10), 
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and other reasons (n=6). Thus, the dose received of the multidisciplinary TTCM visits was 95.1% 
(387/407). The proportion of participants that eventually visited the PCNPT they were referred 
to, was 80 out of 83, which made the dose received of this component of the TTCM 96.4%.
Fidelity
The extent to which the intervention protocol was followed by the various care providers was 
expressed in terms of several fidelity scores, all of which are shown in Table 5.1. Fidelity scores 
ranged from 66.3% (i.e. specific feedback from the PCNPT to the HBPT whether functional 




In total, 28 potential participants were purposively selected and invited to take part in the focus 
groups, including six trauma patients, six trauma surgeons, five HBPTs, and 11 PCNPTs. Of them, 
two trauma patients, two trauma surgeons, one HBPT, and one PCNPT declined to participate 
due to several reasons (e.g. not willing, not available). Finally, five homogeneous focus groups 
(FGs) took place, consisting of four trauma patients (FG1), four trauma surgeons (FG2), four 
HBPTs (FG3), and 10 PCNPTs (FG4 and FG5). 
Barriers and facilitators associated with the implementation of the TTCM
Various barriers and facilitators associated with the implementation of the TTCM were identified. 
(Table 5.2). 
In general, stakeholders perceived the TTCM to be an improvement from usual care, enhancing 
both the quality and efficiency of care. However, differences were observed among stakeholders. 
Below, identified barriers and facilitators will be discussed per level of the constellation approach 
separately. First, similarities and differences between the various stakeholders will be described, 
followed by the within-group differences per focus group.
Structural level
On the structural level, six overarching themes were identified, which were categorized into 
facilitators and barriers (Table 5.2). During all focus groups, the “communication structure of the 
TTCM”, including its use of a secured email system and standard referral forms, was mentioned 
as an important improvement compared with usual care. 
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The most frequently mentioned barrier on the structural level was “the absence of reimbursement 
for the HBPT at the outpatient clinic”. This is identified as an important barrier because it seriously 
hampers broader implementation of the TTCM. Another facilitator that was mentioned by all 
focus groups on the structural level was the “availability of guidelines for the most common 
fractures”. Some participants, however, thought that “these guidelines are too detailed and do 
not apply in case of a deviant course in fracture healing”.
Different structural aspects of the TTCM were considered more or less important by the various 
stakeholders. Trauma surgeons, for example, were pleased with the fact that there now was “a 
clear infrastructure and clear working agreements at the outpatient clinic”. They liked, for example, 
that they could briefly discuss the list of patients prior to the multidisciplinary TTCM consultation 
hour with the HBPT. They did mention, however, that feedback from the PCNPTs sometimes 
lingered with the HBPT and did not reach them. For the HBPTs, the “absence of reimbursement 
for the HBPT at the outpatient clinic” was the most important barrier, and was also mentioned as 
a barrier by most of the other stakeholders. Another frequently mentioned barrier by the HBPTs 
was “the occurrence of software failures”. PCNPTs indicated to be very satisfied with the “use of a 
standardized referral form” and with the fact that “the network practice receives an email from the 
HBPT when a new trauma patient is referred”. Furthermore, they highly appreciated the “functional 
goals they received from the HBPT for trauma patients after each visit at the outpatient clinic”.
“Yes, the referral form has become a lot more efficient. Which makes the care better. 
But certainly more efficient.” (trauma surgeon)
“The next goal was very clear for everyone, for the surgeon, for the patient, for the 
physical therapist in the hospital and for us. If that succeeds, we continue to the next 
goal and otherwise it will be evaluated and adjusted. This is a very clear structure, 
making the process very satisfying for everyone.” (PCNPT)
Patients were most satisfied with the fact that “the HBPT sets functional goals for trauma patients 
after each visit at the outpatient clinic”. This functional goal setting provided the trauma patients 
with clear expectations on their recovery and their expected outcome. 
The within-group differences on the structural level were negligible, meaning that the participants 




On the cultural level, five overarching themes were identified, which were further specified 
in subthemes, categorized into facilitators and barriers (Table 5.2). During all focus groups, 
the “shared decision-making process at the outpatient clinic” was mentioned as an important 
facilitator for the implementation of the TTCM. Another theme that was frequently mentioned 
during all focus groups was the “contact between the HBPT and PCNPT” with “the possibility 
of low-threshold contact between HBPT and PCNPT via email and telephone, in addition to the 
structural forms of communication” as most mentioned facilitator.
“Yes, you are now being encouraged to contact the hospital, the threshold has been 
lowered enormously.” (PCNPT)
The most mentioned barrier by all focus groups was that sometimes “care providers contradict 
each other”.
“You really have to achieve that balance, it is true that if you are very comfortable, 
you reinforce each other. But it is not good if the patient feels that we do not agree 
with each other.” (trauma surgeon)
Some differences between the focus groups were noteworthy. Trauma surgeons, for example, 
emphasized the importance of the “awareness of professional boundaries”, meaning that they 
perceived it to be important that the healthcare providers who are present during the outpatient 
consultations are aware of the boundaries of their own discipline. They sometimes found it hard 
to strike a balance in co-working with the physical therapist at the outpatient clinic. After an 
adequate balance was achieved, trauma surgeons were of the opinion that the quality of care 
and patient satisfaction increased significantly, and working closely with a HBPT became one of 
the most important assets of the TTCM.
“I also like that you can deliberate together, not out of uncertainty, but the fact that 
the hospital physical therapist is actively involved in the decision making process 
positively affects the patient.” (trauma surgeon)
The HBPT also perceived the “awareness of responsibilities and leadership” to be important. For 
them, it was at times complicated to adapt to their new role and position within the existing 
hierarchal culture of the hospital. Despite these challenges, the most important asset of the 
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TTCM according to the HBPTs was the fact that “care providers at the outpatient clinic now act 
as a team and are unambiguous”. 
“You must be able to adapt to the situation and to various trauma surgeons.” (HBPT)
PCNPTs most frequently indicated that they now felt like “a substantial part of the care chain”. That 
is, they now perceived themselves as a member of the trauma patients’ treatment team instead of 
working solitary, which was the case before implementation of the TTCM. Another facilitator that 
was frequently mentioned by the PCNPTs was “the possibility of low-threshold contact between 
HBPTs and PCNPTs via email and telephone, in addition to the structural forms of communication”.
Trauma patients were very pleased with the existence of a “shared decision-making process at 
the outpatient clinic”. For them, the experience of being involved in the decision-making process, 
and having a voice in formulating their own functional goals was of great importance. This is 
evidenced by the following quote of a participating patient:
“I really liked having a voice in formulating my own goals. During the visits there was 
time to think and talk about what is important to me, that I wanted to play tennis 
again. And whether it was actually achievable what I wanted. It really helped me to 
discuss these issues with the surgeon and the physical therapist.” (patient)
However, some of the trauma patients indicated to have “received conflicting statements regard-
ing prognosis by doctors who do not work according to the TTCM”, including those working at 
the emergency department or trauma ward of the hospital. This was therefore considered to 
be an important barrier to the implementation of the TTCM. 
Within the focus groups there were only minor differences among stakeholders. For example, 
some HBPTs indicated to prefer working with the same trauma surgeon every week, while others 
preferred to work with various trauma surgeons. The same applied for the trauma surgeons.
Practical level
On the practical level, five overarching themes were identified, which were further specified 
in subthemes, categorized into facilitators and barriers (Table 5.2). All healthcare providers 
indicated that they liked their “increased level of knowledge and skills” resulting from working 
with the TTCM. That is, many of them repeatedly stated that they learned a lot from the other 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Stakeholders differed in terms of the practical aspects of the TTCM that they considered to 
be of importance. Trauma surgeons and HBPTs were of the opinion that the “availability of 
a separate consultation room for the HBPTs” would improve their way of working. Then, the 
physical therapist could examine patients (e.g. for function-control or instructions), while the 
trauma surgeon could proceed to the next patient. 
“For example, I see a patient who comes for wound control without the hospital 
physical therapist. She does something behind the computer or already examines 
a new patient with a knee distorsion, and then I walk in later.” (trauma surgeon)
Trauma surgeons also indicated to have a “lower administrative workload” due to the TTCM, as 
the HBPT was now responsible for the communication with the PCNPTs. 
HBPTs, on the other hand, experienced a “higher administrative workload at the outpatient 
clinic”. That is, all HBPTs indicated that their workload increased due to their new role as case 
manager, but that working according to the TTCM also gave them energy because they perceived 
it to be inspiring. 
“That means that you have to prepare well, and that preparation takes quite a lot 
of time. So the TTCM takes more time than just being present at the outpatient 
clinic.” (HBPT)
The PCNPTs also indicated to have an “increased level of knowledge and skills” and “increased 
expertise in trauma rehabilitation” due to their involvement in the TTCM. As a consequence, 
they highly enjoyed working according to the TTCM. 
“Yes, I have seen a lot of ankle fractures lately and I noticed that I now have a better 
view of the course and whether it deviates or not. I recognize certain patterns. I 
used to have more difficulties with that before.” (PCNPT)
For them however, “the lack of guarantee on a high number of referrals” was an important 
barrier, because they prefer a continuous amount of new referrals, perceived from a business 
perspective. For trauma patients, an important barrier was the “absence of awareness of 
the TTCM at other relevant departments in the hospital (e.g. emergency department)”. As a 
consequence, they sometimes received conflicting information regarding their treatment and 
prognosis from physicians from other departments.
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“The doctor at the emergency department told me very crudely, that I would never 
regain full function again.” (patient)
The within-group differences were small for the trauma surgeons and HBPTs. For the PCNPTs, 
within-group differences were small as well, but depending of the number of new referrals they 
received during the intervention period, they were more or less satisfied with the TTCM. The 
within-group differences for trauma patients were negligible.  
discussiOn
The present paper describes the results of a process evaluation exploring the extent to which 
the TTCM, an advanced rehabilitation model for trauma patients, was implemented as intended, 
and identifying barriers and facilitators associated with its implementation. 
Results showed that the TTCM was largely implemented as intended, with a moderate reach 
(81%), a high dose delivered (99% and 100%) and high dose received (95% and 96%) for the 
multidisciplinary TTCM consultation hours at the outpatient clinic and the primary care network 
physical therapists, respectively. Moderate to high fidelity scores were found (66% to 93%), 
indicating the extent to which the intervention protocol was followed by the care providers. 
The fidelity scores regarding the secured email traffic from the PCNPTs to the HBPT provided 
the most room for improvement. That is, in 24% of the cases no secure email was sent to the 
hospital and in 34% of cases it was not clearly reported whether functional goals of the patient 
were achieved or not. 
Focus groups indicated that on the structural level, the “communication structure of the TTCM” 
was found to be an important theme, expressed in several facilitators, e.g. the “use of a secured 
email system”. The “absence of reimbursement for the HBPT at the outpatient clinic” was 
identified as a main barrier at the structural level. At the cultural level, the existence of a “shared 
decision making process at the outpatient clinic” was found to be an important facilitator, and the 
fact that “care providers sometimes contradict each other” to be a barrier. At the practical level, 
the “increased level of knowledge and skills” was an important facilitator and the “absence of 
awareness of the TTCM in other relevant departments” was recognized as a barrier. In general, 
stakeholders were of the opinion that if the barriers were overcome, the quality of care and 
patient satisfaction were likely to improve significantly after implementing the TTCM. 
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comparison with the literature
In trauma surgery and trauma rehabilitation, process evaluations are rare, and therefore an 
appropriate substantive comparison with the literature is difficult to perform. However, process 
evaluations have been described in adjoining fields. For example, we found a mixed-method 
study in older patients with fragility fractures assessing the relationship between patient-related 
factors and adherence to “healthy bone advices” (i.e. taking osteoporosis medication, and 
participate in physical activity). The qualitative interviews in this study suggested that feedback 
from case managers helped participants understand the underlying cause of their fragility 
fracture and helped them to adhere to the advices [19]. We found similar results regarding the 
role of the HBPT, who acted as case manager. Next to other components of the TTCM, having 
an appropriate case manager was found to be a crucial factor for successful implementation of 
the TTCM. Another process evaluation, which was conducted alongside a randomized controlled 
trial, evaluated the implementation of RESPOND [37]. This is a telephone-based falls prevention 
program including person-centered education and goal setting, designed for older patients 
visiting an emergency department after a fall, but not necessarily with a fracture. The results 
from this process evaluation, in which focus groups were held with participants and interviews 
were conducted with clinicians, provided detailed information to guide future implementation of 
RESPOND. One of the main findings was that implementation of the intervention was facilitated 
by the use of “positive and personally relevant health messages” [37]. Parts of the RESPOND 
intervention program are comparable with the TTCM (e.g. personal goalsetting), whereas 
the scope of the TTCM differed from RESPOND (i.e. trauma rehabilitation versus prevention). 
Furthermore, a recently published focus group study among trauma patients, aiming to describe 
their perceived quality of life at least one year after trauma, found that inadequate aftercare 
negatively influenced the trauma patients’ perceived quality of life.20 In contrast to the present 
study, however, this focus group study was of descriptive nature and was not aimed at identifying 
facilitators and barriers of an intervention. While the aforementioned process evaluations are 
meaningful and important in their own field, they differ in terms of their design, population and 
intervention and are therefore not entirely comparable. However, they all confirm or suggest 
that various elements of an intervention such as the TTCM, aiming to improve rehabilitation and 
outcome after (major) trauma, are of great importance and that its implementation should be 
evaluated quantitatively as well as qualitatively, as we did in this study.
Strengths and limitations
This study has several strengths. First, to the best of our knowledge, this is one of the first studies 
to apply qualitative research methods in the field of trauma rehabilitation. The use of a mixed-
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methods approach enabled us to assess both the implementation of the TTCM as well as its 
associated barriers and facilitators [38]. Second, we chose for five homogeneous focus groups, 
including a broad range of stakeholders, which had several advantages. That is, five is the optimal 
number of focus groups for analysis according to the literature [39]. It is important for a broad 
range of stakeholders to have a voice in the focus groups in order to obtain a maximum amount 
of information necessary to optimize the possible implementation of the TTCM. Moreover, the 
use of homogenous focus groups created a save environment, in which participants were most 
likely to speak free and open [28]. Third, data derived from the focus groups were analyzed 
systematically, using a well-founded theoretical model (i.e. the framework method) [29,30]. 
This method enabled a systematic exploration of the data, while simultaneously maintaining 
an effective and transparent examination path [31]. Finally, to optimize the implementation of 
the TTCM, reflection meetings for the HBPTs were held during the implementation phase of 
the TTCM. These meetings were valuable in gaining insight to their new role, and in matching 
professional responsibilities and borders.
The study also had some limitations. Participants of the focus groups were purposively selected 
and participated voluntarily, which may have resulted in participants being more content with 
the TTCM than the average care provider and/or trauma patient. This could have resulted in an 
overestimation of positive opinions regarding the TTCM, especially in the focus group with trauma 
patients (FG5). Another limitation is the absence of healthcare decision-makers and insurers 
in the focus groups, we therefore lack input from a relevant group of stakeholders regarding 
the theme “financial structures” on the structural level. Furthermore, we probably could have 
obtained more detailed information if we had conducted interviews in addition to the focus 
groups, since in-depth interviews can provide more detailed information on specific topics [25].
Implications for future implementation and further research
Information derived from the current process evaluation can be used to further improve the 
TTCM and to enable the transition of research evidence into clinical practice [17,18]. The TTCM 
seems feasible in practice and was implemented as intended for nearly all participants (i.e. 
appropriate reach, dose delivered, dose received and fidelity). Important needs for a successful 
implementation of the TTCM were “having an appropriate communication structure” and 
“reimbursement for the HBPT at the outpatient clinic” on the structural level, the presence of a 
“shared decision-making process at the outpatient clinic” on the cultural level, and an “increased 
level of knowledge and skills” on the practical level. Additionally, we know from the literature that 
other important needs for successfully scaling up and deepening of a new practice include: 1) 
the establishment of coalitions among strategically chosen parties; 2) transparent organizational 
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structures; 3) a clear division of responsibilities; 4) a change in mind set; and 5) an appropriate 
legal and financial framework [35,40]. When we specify these needs, complemented with the 
results of the current process evaluation, the following recommendations for implementation 
and scaling up of the TTCM can be made:
1. Form a steering group with all stakeholders to take everyone’s interests into account.
2. Describe clear organizational structures for care providers at the outpatient clinic and for 
primary care network physical therapists (e.g. communication pathways and templates for 
standardized documentation).
3. Describe duties and responsibilities of the participating care providers in a manual and 
organize training courses for the primary care network physical therapists.
4. Organize reflection meetings with stakeholders (homogeneous as well as heterogeneous) 
per trauma center and respect local differences.
5. Arrange an appropriate and structural embedded reimbursement system for the hospital-
based physical therapist, who acts as case manager within the TTCM.
As mentioned above, an important limitation of the current study is the lack of input from 
healthcare decision-makers and insurers. Their input is important because a structurally 
embedded reimbursement system for the HBPT is required for a successful implementation 
of the TTCM. Consequently, a final recommendation for future research is to include these 
stakeholders in the focus groups, or to conduct semi-structured interviews with them to obtain 
a complete overview of facilitators and barriers for implementation of the TTCM. 
cOnclusiOn
This process evaluation showed that the TTCM was largely implemented as intended. Various 
barriers and facilitators were found to be associated with the implementation of the TTCM. 
Moreover, some differences were found among stakeholders, but in general, they were of the 
opinion that if the barriers were overcome and a good working balance was achieved, the quality 
of care and patient satisfaction would improve significantly after implementing the TTCM. 
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background: The presence of one or more comorbidities, multiple injuries, and age have 
been found to be associated with functional outcome and quality of life in trauma patients. 
However, the associations between fracture and treatment-related factors (e.g. fracture type 
and surgical technique) and disease-specific health-related quality of life (HR-QOL), functional 
outcomes and societal costs at longer-term follow-up are not well known. Therefore, the 
aim of the present study was to assess which fracture and treatment-related factors are 
associated with disease-specific HR-QOL, functional outcome, and societal costs in trauma 
patients with at least one fracture 9 months after their first outpatient visit.
Methods: The current study was embedded within the TTCM-trial. Trauma patients with 
at least one fracture were considered eligible. Data on the fracture and treatment-related 
factors surgery (yes/no), fracture type (intra-articular/extra-articular), fracture localization 
(upper extremity/lower extremity/other), and fracture treatment (intramedullary nail/
open reduction internal fixation [ORIF]/conservatively) were collected at baseline. Data 
on outcomes were collected 9 months after baseline. OLS regression analyses were 
performed to assess the association of each fracture and treatment-related factor (i.e. 
independent variables) with disease-specific HR-QOL, functional outcome, and societal 
costs (i.e. dependent variables), while correcting for receiving the TTCM (yes/no), the 
case-mix variables age, gender, and comorbidity, and for the other independent fracture 
and treatment-related factors. 
results: In total, 140 trauma patients were included in the analysis. Having a fracture of the 
lower extremity was found to be associated with a lower disease-specific HR-QOL after 9 
months compared to the reference category patients (i.e. patients with a vertebral fracture 
or multi-trauma patients) (MD 10.09; 95% CI 2.18 to 18.00). Having an upper extremity 
fracture was associated with a better functional outcome compared to patients from this 
reference category (MD -19.12; 95% CI -31.65 to -6.59). Having had a surgery instead of 
conservative treatment was associated with lower societal costs. On the other hand, being 
treated with ORIF was associated with higher societal costs. Fracture type was not associated 
with any of the outcomes. 
conclusions: Of the investigated fracture and treatment-related factors, a fracture of the 
lower extremity was associated with lower disease-specific HR-QOL and a fracture of the 
upper extremity was associated with better functional outcome, both compared to the 
reference category. Surgical treatment was associated with lower societal costs compared 
to conservative treatment. However, ORIF was associated with higher societal costs when 
compared to conservative treatment, whereas intramedullary nailing was not. Future 
studies should focus on confirming these associations and understanding their underlying 
mechanisms in order to be able to design effective initiatives to improve trauma patients’ 
HR-QOL and functional outcome and to reduce their societal costs.
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bAckground
Traumatic injury is a major global health problem and one of the main causes of death and 
disability worldwide [1,2]. They cost the global population about 300 million years of healthy life 
per year [3]. On top of that, traumatic injuries are associated with high healthcare and societal 
costs, and are one of the five most costly medical conditions worldwide [4,5]. In recent years, 
mortality rates due to traumatic injury decreased significantly, mainly as a result of a better quality 
and organization of care [6]. Consequently, however, a growing number of trauma patients suffer 
from long-term disability [3,7-9], which in turn has a significant impact on their health-related 
quality of life, functional outcome, and costs [10-13].
Well-known predictors of long-term disability after trauma are the presence of one or more 
comorbidities [14], multiple injuries [15], frailty [16], and age [17,18]. Furthermore, it is 
recognized that severity of the injury, the presence of a comorbidity and having a fracture of the 
lower extremity predict higher healthcare costs [19,20]. However, associations between fracture 
and treatment-related factors, such as fracture type and surgical techniques, and outcomes, 
such as disease-specific health-related quality of life (HR-QOL), functional outcomes, and costs, 
are not well known [21-23]. This is important because trauma patients extensively differ with 
respect to the impact and origin of their trauma, which may, in turn, impact the severity of their 
injuries, their treatment, and hence their recovery [24]. 
Studies assessing the association between fracture and treatment-related factors and disease-
specific HR-QOL, functional outcome, and costs are rare, and those that have been conducted 
provide conflicting results. To illustrate, some studies found the occurrence of intra-articular 
fractures, a higher ISS, and having multiple fractures to be associated with poorer functional 
outcomes and a reduced disease-specific HR-QOL compared with patients not having these 
characteristics [25-27], while other studies did not find any of these associations [28-30]. 
Moreover, it remains unclear whether the type of fracture treatment (i.e. nailing or plating) is 
associated with disease-specific HR-QOL, functional recovery, and/or costs [23].
Given the aforementioned uncertainties in combination with the increasing number of surviving 
trauma patients, there is a need to better understand the association between fracture and 
treatment-related factors and outcomes, such as disease-specific HR-QOL, functional outcome, 
and costs. Knowledge about these associations could help clinicians in achieving better patient 
outcomes and providing more cost-effective healthcare. Therefore, the current study aimed to 
assess which fracture and treatment-related factors are associated with disease-specific HR-





To assess which fracture and treatment-related factors are associated with disease-specific 
HR-QOL, functional outcome, and societal costs, data of the TTCM-trial were used. This trial 
was performed at a Dutch level-1 trauma center (Amsterdam UMC, location VUmc). The TTCM-
trial is a controlled-before-and-after study that aimed to evaluate the cost-effectiveness of the 
Transmural Trauma Care Model (TTCM) compared with usual care. The TTCM is a multidisciplinary 
transmural rehabilitation model for trauma patients aiming to improve patient outcomes by 
optimizing the organization and quality of trauma patients’ rehabilitation process [31]. In contrast 
to a true controlled-before-and-after study, only the intervention group was prospectively 
followed in the TTCM-trial, while control group data were collected cross-sectionally. That is, 
the TTCM-trial’s control group consisted of 4 independent clusters of patients, who were either 
measured at baseline, 3, 6, or 9 months after their first consultation at the outpatient clinic for 
trauma patients. More details on the TTCM-trial’s design and results can be found elsewhere 
[31-33]. For the purpose of the current study, only the participating trauma patients’ baseline 
and 9-month follow-up data of both the intervention group participants and the 9-month control 
cluster participants were used. The medical ethics committee of the VUmc approved the present 
study and decided the Dutch Medical Research Involving Human Subjects Act (WMO) was not 
applicable (registered under number 2013.454). Written informed consent was obtained from 
all participants, and the TTCM-trial was conducted according to the Declaration of Helsinki.
Patients
More detailed information on the recruitment strategy can be found elsewhere [31]. In brief, 
both operatively and non-operatively treated trauma patients were included, irrespective of 
whether or not they were admitted to the hospital. To be eligible for the TTCM-trial, patients 
had to meet the following inclusion criteria: having at least one traumatic fracture, being aged 
18 years or older, and being able to fill out online questionnaires. Patients were excluded if 
they met any of the following criteria: pathological fractures, traumatic brain injury, cognitive 
limitations, not speaking Dutch, rehabilitation process in a tertiary care facility, living outside 
the catchment area of the hospital.
Independent variables
Independent variables consisted of both fracture and treatment-related factors as well as case-
mix variables for which the analyses were corrected. All of these variables were based on data 
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from the national trauma registry and electronic patient files and will be discussed into more 
detail below. 
Fracture and treatment-related factors
• Surgery (yes/no): For every patient it was defined whether he or she underwent surgery or 
whether he or she was treated conservatively. 
• Fracture type (intra-articular/extra-articular): Every fracture was assessed by a radiologist 
and classified as either being an intra-articular or an extra-articular fracture. Intra-articular 
fractures were defined as all fractures involving a joint space, whereas extra-articular 
fractures as all fractures not involving a joint space. All vertebral fractures were classified 
as intra-articular fractures. 
• Fracture localization (upper extremity/lower extremity/other): For every patient, it was 
assessed whether they had one or more fractures located in one single extremity. If so, 
they were categorized as either having an upper extremity fracture or a lower extremity 
fracture. Patients with vertebral fractures and multi-trauma patients (i.e. having at least 
fractures in two or more regions) were referred to as “other” in the current study and served 
as reference category. 
• Fracture treatment (intramedullary nail/open reduction internal fixation [ORIF]/conserva-
tively): For every patient, their fracture treatment was classified as either involving an 
intramedullary nail, an ORIF, or being conservative. Conservatively treated patients served 
as reference category. 
Case-mix variables 
Data on the following case-mix variables were collected: age (years), gender (male/female) and 
comorbidity (none/chronic illness/musculoskeletal disease). Additionally, for every participant it 
was described whether they received the TTCM intervention or not in order to be able to correct 
for the fact that the current data were collected as part of a controlled trial. 
dependent variables
Dependent variables consisted of disease-specific HR-QOL, functioning, and societal costs. All 
of them were assessed using online questionnaires administered 9 months after the trauma 
patients’ first visit at the outpatient clinic for trauma patients. All of these dependent variables 




Depending on the diagnosis, patients were asked to complete one of the following standardized 
Patient-Reported Outcome Measures (PROMS) assessing disease-specific HR-QOL:
• Patients with upper extremity fractures: The Disabilities of the Arm, Shoulder and Hand 
questionnaire (QuickDASH). The Dutch version of the QuickDASH is a shortened version of 
the 30-item DASH and consists of 11 items (five-point scale) with higher scores indicating 
more complaints/limitations. The Quick-DASH can be used instead of the DASH with similar 
precision in upper extremity disorders [34]. The QuickDASH is performing well with substantial 
evidence supporting reliability and validity [35].
• Patients with lower extremity fractures: The Lower Extremity Functional Scale (LEFS). The 
LEFS is a questionnaire containing 20 questions about a person’s ability to perform everyday 
tasks. The maximum score is 80 with a higher score indicating better function. The LEFS is a 
valid tool compared to the SF-36 [36] with fair-to-good accuracy in discriminating between 
participants with and without improvement [37].
• Patients with multiple fractures and/or more locations: The Groningen Activity Restriction 
Scale (GARS). The GARS is an 18-item questionnaire with four response categories, measuring 
the degree of self-reliance of people. The severity of functional limitations can be mapped out 
using the instrument in which higher scores indicate more limitations in everyday activities. 
The psychometric properties of the GARS are very good in patients with rheumatoid arthritis 
and older adults [38-42].
• Patients with vertebral fractures: The Roland Morris Disability Questionnaire (RMDQ). This 
questionnaire is a self-administered disability measure consisting of 24 items, containing two 
answering categories (yes/no). The overall score ranges from 0 to 24 in which higher scores 
indicates greater levels of disability. The Dutch RMDQ showed good reliability in patients 
with chronic low back pain, with an ICC of 0.91 [43].
An overall disease-specific HR-QOL score (DSQOL-OA) was calculated by converting the total 
scores of the questionnaires mentioned above to a scale from 0–100, with higher scores 
representing more functional problems (and thus a lower disease-specific HR-QOL).
Functional outcome
Functional outcome was measured using the Patient-Specific Function Scale (PSFS) [44]. Patients 
had to identify three important activities that they are having difficulties with and were asked to 
rate their current level of difficulty associated with each activity on a 0–100 mm visual analog 
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scale (VAS) ranging from 0 (“able to perform activity at same level as before injury or problem”) to 
100 (“unable to perform activity”). Only the activity that was first mentioned by the patient was 
used for analysis. Note that higher scores represent more functional problems. The PSFS showed 
good reliability and responsiveness in various patient groups with musculoskeletal disorders (e.g. 
in patients with chronic low back pain [45] and patients after a total knee arthroplasty [46]).
Societal costs
Societal costs included TTCM, health care, absenteeism, presenteeism, and unpaid productivity 
costs. TTCM costs included all costs related to implementing and administering the TTCM (i.e. 
on average, EUR272 per patient (SEM=4)) [47,48]. All other cost categories were assessed 
using online cost questionnaires, supplemented by hospital records if available (e.g. for imaging 
procedures). Costs were measured for the complete 9-month follow-up duration using three 
3-monthly questionnaires with 3-month recall periods and one 9-monthly questionnaire with a 
9-month recall period for the intervention and control group, respectively. Health care utilization 
included the use of primary care (e.g. consultations at the general practitioner or physical 
therapist) and secondary care (e.g. consultations at the outpatient clinic for trauma patients, 
hospitalization) as well as the use of medication. Dutch standard costs were used to value health 
care costs [48]. Medication use was valued using the G-standard of the Dutch Society of Pharmacy 
[49]. Absenteeism was assessed using the “PROductivity and DISease Questionnaire” (PRODISQ). 
Patients were asked to report their total number of sick leave days [50]. Absenteeism was 
valued using age- and gender-specific price weights [48]. Presenteeism was defined as reduced 
productivity while at work and was assessed using the “World Health Organization Health and 
Work Performance Questionnaire” (WHO-HPQ) [34]. Presenteeism was valued using age- and 
gender-specific price weights as well [48]. Unpaid productivity losses were assessed by asking 
patients for how many hours per week they were unable to perform unpaid activities, such as 
domestic work, school and voluntary work. A recommended Dutch shadow price was used to 
value unpaid productivity [48]. All costs were presented in Euros and converted to the same 
reference year (i.e. 2014) using consumer price indices. Discounting of costs was not necessary 
due to the 9-month follow-up period [51].
data analysis
Descriptive statistics were used to describe patient characteristics and fracture and treatment-
related factors at baseline. Missing data were imputed using multivariate imputation by chained 
equations [52]. The imputation model included variables related to the “missingness” of data, 
all fracture and treatment-related factors and case-mix variables as well as all available midpoint 
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and follow-up disease-specific HR-QOL, functional outcome, and cost measure values [52]. Ten 
complete data sets were created in order for the loss-of-efficiency to be below 5% [53].
Ordinary Least Squares regression analyses were performed to assess the association of each 
fracture and treatment-related factor (i.e. independent variables: surgery, fracture type, fracture 
localization and fracture treatment) with disease-specific HR-QOL, functional outcome, and 
societal costs (i.e. dependent variables). To deal with the highly skewed nature of cost data, 95% 
confidence intervals were estimated using Bias Corrected and Accelerated Bootstrapping, with 
5,000 replications, when societal costs were the dependent variable. For the three dependent 
variables, the following four models were performed: 
• Model 1: 
Crude analysis, meaning that the dependent variable in question was only regressed upon 
one of the independent variables.
• Model 2: 
Adjusted for receiving the TTCM (yes/no).
• Model 3: 
Adjusted for receiving the TTCM (yes/no) and for the case-mix variables age, gender, and 
comorbidity.
• Model 4: 
Adjusted for receiving the TTCM (yes/no), for the case-mix variables, and for the other 
independent fracture and treatment-related factors.
Please note that model 4 serves as the final model, whereas models 1 to 3 were run and presented 
to show the impact of the various independent variables on the study results.  
Statistical analyses were performed using IBM SPSS Statistics for Windows version 26.0 (IBM 
Corporation) for the dependent variables disease-specific HR-QOL and functional outcome and 
STATA version 12 for the dependent variable societal costs. Statistical significance was set at p>0.05.
results
Patients
A total of 3,664 trauma patients was assessed for eligibility. Most of them turned out to be not eligible 
because they did not have a fracture or had a minimal fracture of for example, the orbita, costa 
or digit. Of the remaining 758 potentially eligible patients, 473 were excluded for various reasons, 
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including them not being willing to participate and not having access to the internet. Another 145 
patients were excluded from the analyses, because they did not belong to the intervention or the 
9-month control cluster of the TTCM-trial. The remaining 140 patients were included as participants 
in the present study. Further details on the enrollment procedure (including reasons for exclusion 
and loss to follow-up) can be found in the publication regarding the cost-effectiveness of the TTCM, 
in which the same dataset was used for analyses [33]. An overview of all patient characteristics 
and fracture and treatment-related factors of the included participants can be found in Table 6.1.
Disease-specific HR-QOL
Table 6.2 provides an overview of all models assessing the association between fracture and 
treatment-related factors and disease-specific HR-QOL. In the final model, which is corrected 
for having had the TTCM (yes/no), the case-mix variables, and the other fracture and treatment-
related factors, having a fracture of the lower extremity was found to be statistically significantly 
associated with a lower disease specific HR-QOL after 9 months compared with having a vertebral 
fracture or multi-trauma (Model 4: 10.09; 95% CI 2.18 to 18.00). Please note that this beta is 
positive, because higher scores indicate a lower disease-specific HR-QOL. None of the other 
fracture and treatment-related factors were found to be associated with disease-specific HR-
QOL after 9 months in the final model (Table 6.2).
Functional outcome
Table 6.3 provides an overview of all models assessing the association between fracture and 
treatment-related factors and functional outcome. In the final model, having an upper extremity 
fracture was associated with a better functional outcome compared to having a vertebral fracture 
or multi-trauma (Model 4: -19.12; 95% CI -31.65 to -6.59). Please note that this beta is negative, 
because higher scores indicate a lower functional outcome. None of the other fracture and 
treatment-related factors were found to be associated with functional outcome after 9 months 
in any of the models (Table 6.3).
societal costs
Table 6.4 provides an overview of all models assessing the association between fracture and 
treatment-related factors and societal costs. In the final model, having had a surgery was found to 
be statistically significantly associated with lower societal costs during the patients’ first 9 months 
after their first visit at the outpatient trauma clinic compared to conservative treatment (Model 
4: -1,770; 95% CI: -3,276 to -433). Furthermore, fracture treatment with ORIF was statistically 
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significantly associated with higher societal costs compared to conservative treatment (Model 
4: 1,651; 95% CI: 245 to 3,237), whereas fracture treatment with an intramedullary nail was 
not. The variables fracture type and fracture localization were found to be not associated with 
societal costs (Table 6.4).  
table 6.1 Patient characteristics, trauma characteristics and outcomes
Patient characteristic
Mean (SD) or frequency (%)
All participants 
(N=140)
Case-mix variables Age (years) 46.3 (16.8)








Received TTCM (yes) 83 (59.3%)





































Outcomes at 9 
months
Disease-specific HR-QOL (DSQOL-OA)***
Range 0–100 (higher score: lower HR-QOL) 
18.8 (16.5)
Functional outcome (PSFS)****
Range 0–100 (higher score: less function) 
25.0 (25.3)
Societal costs in Euros [mean (SEM)] 5,047 (422)
* ISS: Injury Severity Score; 
** ORIF: Open Reduction Internal Fixation; 
*** DSQOL-OA: Disease Specific Quality of Life Overall; 
**** PSFS: Patient-Specific Function Scale.
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Traumatic injury, and fractures in particular have a serious impact on patients’ everyday life, work 
and social activities [11,54] and poses a substantial economic burden to society [2,3]. Studies 
conducted to investigate the association between specific fracture and treatment-related fac-
tors (e.g. fracture type, surgical techniques) and disease-specific health-related quality of life 
(HR-QOL) and functional outcomes are rare and give conflicting results [25-30]. Moreover, the 
association of these factors with costs remains unclear. Therefore, the present study aimed to 
assess the association between fracture and treatment-related factors with disease-specific 
HR-QOL, functional outcome, and societal costs.
Study findings 
This study found fracture localization to be associated with disease-specific HR-QOL and functional 
outcome after 9 months, and the variables surgery and fracture treatment to be associated with 
societal costs during the first 9 months after the trauma patients’ first visit at the outpatient 
trauma clinic. To illustrate, lower extremity fracture patients’ disease-specific HR-QOL after 9 
months was 10.09 points higher on a 0–100 scale (i.e. indicating a lower disease-specific HR-
QOL) than that of patients with a vertebral fracture or multi-trauma). Furthermore, patients 
with an upper extremity fracture scored 19.12 points lower on a 0–100 scale (i.e. indicating a 
better functional outcome) than patients with a vertebral fracture or multi-trauma. Moreover, 
the societal costs of trauma patients who had surgery were on average EUR1,770 lower during 
the first 9 months after their first visit at the outpatient clinic for trauma patients compared to 
trauma patients who did not undergo surgery. ORIF, on the other hand, was associated with on 
average EUR1,651 higher societal costs compared to conservative treatment, and intramedullary 
nailing was not significantly associated with societal costs. Fracture type was not found to be 
associated with disease-specific HR-QOL, functional outcome, and societal costs. 
Most of the identified associations were in the expected direction, with for example fractures 
of a lower extremity being associated with less favorable outcomes after 9 months, such as a 
lower disease specific HR-QOL. However, it is noteworthy that surgery patients were found to 
have lower societal costs during the first 9 months after their first outpatient visit compared to 
trauma patients who did not undergo surgery. When interpreting these findings, one should 
bear in mind that surgery costs were not included in our societal cost estimate, because they 
occurred prior to the patients first outpatient visit. The finding that trauma patients who 
underwent surgery have lower societal costs after their first outpatient visit compared to those 
who did not, might be explained by the fact that one of the most important goals of a surgery 
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is achieving a situation, in which a patient can start exercising at an earlier stage, which may in 
turn lead to a quicker return to work and thus a decrease in societal costs.
Comparison with the literature 
Even though extensive research has been done on functional outcome and costs after major 
trauma [3,7-9,54], relatively few studies assessed which fracture and treatment-related factors 
are associated with disease-specific HR-QOL, functional outcome, and/or societal costs. Earlier 
studies that did assess one or more of these associations mostly included patients suffering 
from a specific type of fracture, instead of a broad range of fractures. To illustrate, Alexandridis 
et al. found various radiographic characteristics (e.g. Bohlers’ angle) of calcaneal fractures to be 
statistically significantly associated with HR-QOL, patient satisfaction, and complication rate [26] 
and Souer et al. found similar associations for intra-articular and extra-articular radial fractures 
with impairment and disability [28]. Moreover, a recent Dutch study found ORIF (i.e. volar 
plating) to be associated with lower societal costs when compared to conservative treatment 
(i.e. plaster immobilization) in patients with an extra-articular distal radial fracture [55], whereas 
we found the opposite result. Differences in study population (i.e. patients with a distal radial 
fracture versus all kinds of fractures) and study design (i.e. randomized controlled trial versus 
non randomized controlled trial) might explain this difference in results. 
Other authors only assessed the association of one trauma or fracture-related factor with a 
relatively small number of outcomes. For example, Chiu et al. assessed the association between 
fracture localization and a couple of outcomes (e.g. physical capacity and psychological well-
being), including HR-QOL. They found fracture localization to be associated with HR-QOL, with 
hip fractures being associated with the smallest improvements in physical HR-QOL during the 
first year after treatment. This is in contrast to our finding that upper extremity fractures were 
associated with the lowest disease-specific HR-QOL values. This difference might be explained by 
the fact that HR-QOL was conceptualized and measured differently in both studies (i.e. physical 
HR-QOL assessed using the WHO HR-QOL versus disease-specific HR-QOL assessed using different 
PROMS) and because both studies were conducted in different countries (i.e. Taiwan versus 
the Netherlands) [29]. Another recent study found ORIF to result in better functional outcomes 
compared to intramedullary nailing in patients with a shaft fracture of both forearm bones, 
whereas we found both to result in similar outcomes [23]. This difference in results might be due 
to differences in the study population (i.e. patients with a shaft fracture of both forearm bones 




The present study population included a broad range of trauma severity levels with an ISS ranging 
from 4 to 29. This is a strength, as our results are therefore generalizable to mild, moderate, 
and severe trauma patients, whereas the results of most other studies are only generalizable 
to multi-trauma patients who generally have an ISS>16 [54,56]. Another factor that improved 
the generalizability of our findings is that we included all kinds of fractures, whereas previous 
studies typically focused on one specific type of fracture, such as a proximal humeral fracture 
[25]. Another strength is our use of a wide range of outcomes instead of only one single outcome 
measure. 
Our study also had some limitations. First, our follow-up period was limited to 9 months, which 
is slightly shorter than the usual follow-up period when assessing functional outcome in trauma 
patients (up to 36 months) [57,58]. Second, we had a relatively small study population of 140 
participants. Consequently, we could not perform additional subgroup analyses to assess whether 
associations differ between subgroups (e.g. for older versus younger, or severely versus mildly 
injured trauma patients). Moreover, only 8 vertebral fracture and 16 multi-trauma patients 
were included. Consequently, the vertebral fracture patient group was too small to treat it as a 
separate fracture localization category in our analyses. Therefore, we decided to use an “other” 
group, including both vertebral fracture and multi-trauma patients, as reference category. This 
is not optimal, as disease-specific HR-QOL, functional outcome, and societal costs might differ 
between vertebral fracture and multi-trauma patients. However, we do not expect our decision 
to combine both groups of patients into one reference category to have severely biased our 
results, as a post-hoc analysis indicated that the associations for fracture localization did not 
extensively change when excluding vertebral fracture patients from our analyses (data not 
shown). Third, despite our efforts to limit the amount of missing data, we had some missing cost 
data and some missing effect data. Although missing data are generally unavoidable in clinical 
studies and we used multiple imputation techniques to fill in missing values, a complete dataset 
would have produced more valid and reliable results. A last limitation is the fact that the current 
study used clinical trial data, instead of data of large cohort of consecutive trauma patients. 
Hence, the study results might be influenced by the fact that some patients received the TTCM 
as well as the relative small sample size that is typical for a clinical trial. The possible influence 
of some patients receiving the TTCM was handled by correcting for receiving the TTCM in the 
final models. Moreover, we do not expect our study to be severely underpowered, because we 
even found statistically significant associations for the dependent variable societal costs, which 
typically requires relatively large sample sizes due to its highly skewed nature. 
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Future recommendations 
As indicated above, the sample size of our study was relatively small. To be able to perform 
stratified analyses (e.g. among older versus younger trauma patients), and to treat multi-trauma 
and vertebral fractures as a separate category for the variable trauma localization, a bigger dataset 
would be required. Such a dataset is ideally collected as part of a cohort study, instead of a study 
assessing the effectiveness and/or cost-effectiveness of a particular healthcare intervention, and 
preferably has a follow-up duration of more than 9 months. To achieve this, working together 
with other level-1 trauma centers is probably essential, because more trauma patients could 
then be included during the same time frame. Future studies might also focus on understanding 
the mechanisms underlying the identified associations. For example, if it is known what factors 
cause lower extremity fracture patients to have lower disease-specific HR-QOL after 9 months, 
we might develop and/or implement initiatives to improve trauma patients’ longer-term disease-
specific HR-QOL. A possible example of such an initiative might be the development of tailored 
rehabilitation pathways for different types of trauma patients, but further research into this 
area is needed to establish this. 
conclusIon
Of the investigated fracture and treatment-related factors, a fracture of the lower extremity 
was associated with lower disease-specific HR-QOL and a fracture of the upper extremity was 
associated with better functional outcome, both compared to the reference category. Surgical 
treatment was associated with lower societal costs compared to conservative treatment. 
However, ORIF was associated with higher societal costs when compared to conservative 
treatment, whereas intramedullary nailing was not. Future studies should focus on confirming 
these associations and understanding their underlying mechanisms in order to be able to design 
effective initiatives to improve trauma patients’ HR-QOL and functional outcome and to reduce 
their societal costs. 
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Objective: The rehabilitation of trauma patients in primary care is challenging, and there are 
no guidelines for optimal treatment. Also, the organization of care is not well-structured. The 
Transmural Trauma Care Model (TTCM) has been developed in the Netherlands, aiming to 
improve patient outcomes by optimizing the organization and quality of the rehabilitation 
process in primary care. A recent feasibility study showed that implementation of the TTCM 
at a Dutch level-one trauma center was feasible, patient outcomes were improved, and costs 
were reduced. The current study aims to assess the effectiveness and cost-effectiveness of 
the TTCM as compared to usual care in a multicenter trial.
Methods: A multicenter trial with a controlled before-and-after design will be performed 
at ten hospitals in the Netherlands. First, participating hospitals will include 322 patients in 
the control group, receiving usual care as provided in these specific hospitals. Subsequently, 
the TTCM will be implemented in all participating hospitals, and hospitals will include an 
additional 322 patients in the intervention group. The TTCM consists of a multidisciplinary 
team at the outpatient clinic (trauma surgeon and hospital-based physical therapist), an 
educated and trained network of primary care trauma physical therapists, and structural 
communication between them. Co-primary outcomes will investigate generic and disease-
specific health-related quality of life. Secondary outcomes will include pain, patient 
satisfaction, perceived recovery, and patient-reported physical functioning. For the economic 
evaluation, societal and healthcare costs will be measured. Measurements will take place 
at baseline and after 6 weeks, 3, 6, and 9 months. Analyses will be based on the intention-
to-treat principle. Missing data will be handled using longitudinal data analyses in the effect 
analyses and by multivariate imputation in the economic evaluation. 
conclusion: This trial with a controlled before-and-after design will give insight into the 
effectiveness and cost-effectiveness of the TTCM in a multicenter trial.
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IntrOductIOn
Trauma-related injury is one of the most common causes of death and disability worldwide [1]. 
Globally, trauma accounts for 9.6% of mortality in patients under 40 years of age [2]. In older 
age groups, it is one of the most important causes of death, behind cardiovascular disease 
and cancer [3,4]. In addition, trauma negatively influences a patient’s physical functioning and 
health-related quality of life (HR-QOL) [5-8]. Since trauma patients are typically relatively young, 
the associated loss of Disability-Adjusted Life Years (DALYs) is higher than in any other disease 
[1]. To illustrate, each year, traumatic injuries cost an estimated 300 million years of healthy life, 
translating into 11% of DALYs experienced worldwide [1]. 
The economic burden of trauma is high, and traumatic injuries rank among the five most costly 
medical conditions [9]. Globally, the lifetime cost of traumatic injuries has been estimated at 
$406 billion, of which the majority is due to increased absenteeism and lost productivity at 
work [9-11]. In the Netherlands, 79,573 patients were treated at trauma centers in 2017, and 
the total societal costs of traumatic injuries were estimated at EUR3.5 billion (EUR210/capita 
and EUR4,300/patient) [12,13]. 
An improved organization of pre- and in-hospital trauma care has led to a 9% to 25% decrease in 
mortality among severe trauma patients [14-17]. As further improvements in survival rates are 
likely to be small, the focus of trauma care shifted to other relevant outcomes of trauma, such as 
reduced morbidity, improved functioning, increased health-related quality of life and reduced costs 
[18-20]. Due to trauma’s significant clinical and economic impact, there has also been an increased 
interest in its rehabilitation process to improve patients’ generic and disease-specific quality of 
life. After discharge from a hospital, the majority of Dutch trauma patients rehabilitate in primary 
care (mostly treated by a physical therapist), and communication between primary and secondary 
care is minimal [21]. However, the organization of post-clinical trauma rehabilitation in primary 
care is challenging, and there are no (inter)national guidelines available [22]. Consequently, severe 
gaps exist between trauma patients’ transition from hospital to their home situation and return 
to society. For instance, research shows both, under- and overtreatment of trauma patients by 
non-experienced physical therapists in primary care and there is a lack of assessment of trauma 
patients’ physical functioning at the outpatient clinic [22-26]. 
The Transmural Trauma Care Model (TTCM) has been developed in the Netherlands, aiming to 
improve patient outcomes by optimizing the organization and quality of the rehabilitation process 
in primary care [27]. A recent feasibility study found implementation of the TTCM at a Dutch level-
one trauma center to be feasible, improve patient outcomes and patient satisfaction, and reduce 
costs [21,28]. However, due to some of the shortcomings of this feasibility (e.g. control group 
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measured only afterward, one hospital), a larger study is needed to obtain more reliable data on 
the effectiveness and cost-effectiveness of the TTCM. Therefore, a prospectively followed control 
group will be included in this study and patients will be recruited at several participating hospitals 
(both University medical centers and regional hospitals), increasing the representativeness 
of the study population and thereby the generalizability of the results. Moreover, during the 
feasibility study, the implementation of the TTCM was evaluated and adjusted by means of a 
process evaluation [27]. This has led to substantive and logistical improvements to the TTCM, 
which will all be incorporated in this study, for example, a manual describing clear organizational 
structures, duties and responsibilities of the participating care providers, and the inclusion of 
the entire range of severity of fracture(s) treated by the trauma surgeon independent of where 
they will rehabilitate. Please note that in contrast to the feasibility study, patients rehabilitating 
in tertiary care will now be included.
Therefore, this study aims to assess the effectiveness and cost-effectiveness of the improved 
version of the TTCM as compared to usual care in a multicenter trial with a true controlled before-
and-after design. Given the current situation of the Dutch healthcare system and the complexity 
of the intervention this design was considered to be the most optimal design for assessing the 
(cost)-effectiveness of the TTCM, which will be described in detail below.
We hypothesize that the TTCM improves generic and disease-specific health-related quality 




The effectiveness and cost-effectiveness of the TTCM compared to usual care will be evaluated 
in a multicenter trial with a controlled before-and-after design. 
Inclusion procedures will be identical for both study groups and will take place during the patients’ 
first consultation with a trauma surgeon at the outpatient clinic of the participating hospitals. 
Per hospital, a local research assistant will be responsible for the selection of potentially eligible 
patients and the daily coordination of the trial. Potentially eligible patients will be selected by 
the local research assistant prior to their first consultation with the trauma surgeon. The trauma 
surgeon will subsequently inform potentially eligible patients about the study during their first 
consultation. If patients are interested in participating, they will be asked to meet the local 
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research assistant to get further oral and written information about the study. After re-assessing 
the patients’ eligibility, patients can sign the informed consent form after a minimum reflection 
period of 1 hour. If patients prefer a more extended reflection period, they will be contacted 
by phone by the local research assistant at a date and time convenient to the patient. After 
receiving the patients’ signed informed consent form, patients will be included in the study. 
They will receive an e-mail containing a link to the baseline questionnaire through a secured 
e-mail system following the General Data Protection Regulation (Dutch: Algemene verordening 
gegevensbescherming). 
During the inclusion period for the control group, 322 patients will be recruited, and they will 
receive usual care and will be followed for a total of nine months. After this control period, the 
TTCM will be implemented in all of the participating hospitals during a so-called implementation 
phase. The research team of Amsterdam UMC, location VUmc will coordinate and supervise 
the implementation process. Implementation procedures will be hospital-specific, taking into 
account local differences, to guarantee a successful implementation [29,30]. Subsequently, 
during the inclusion period for the intervention group, 322 patients will be recruited and they 
will receive the TTCM. Follow-up of the intervention group will also be nine months. A graphical 
representation of the study design is provided in Figure 7.1. Due to the nature of the intervention, 
























Patients older than 16 years with one or more fracture(s) as a result of a trauma, who have 
received medical treatment at an emergency department or have been admitted to a hospital 
will be invited to participate. Patients with traumatic brain injury, pathological fractures, severe 
psychopathology, cognitive limitations, insufficient knowledge of the Dutch language, as well as 
patients living in an institution or refusing to sign informed consent and second opinions will be 
excluded. Please note that in contrast to the feasibility study, patients rehabilitating in tertiary 
care will now be included.
Treatment conditions
In this trial, pre- and in-hospital trauma care will remain unchanged and will be in line with the 
Dutch guidelines for the network of acute care (Landelijk Netwerk Acute Zorg) [31]. In brief, 
these guidelines recommend the existence of good national and regional network(s) consisting 
of involved chain partners and professionals to promote the optimal accessibility of acute care. 
Acute care takes place within the whole care chain that starts with the emergency call and ends 
with the rehabilitation process. Eleven Dutch hospitals have been designated as trauma centers, 
and form the backbone of the national network. These trauma centers are an important platform 
for the coordination of acute care chains in their region.
Control group
Control group patients will receive usual rehabilitation care as provided by the participating 
hospitals prior to the implementation of the TTCM. Usual care may slightly differ across 
hospitals, and trauma surgeons perform post-clinical consultations individually. Based on the 
clinical judgment of the trauma surgeon, a patient might be referred to a physical therapist in 
primary care, but there is no standardized policy for these referrals, nor is there a network of 
specialized primary care trauma physical therapists and communication between primary and 
secondary care is minimal [21]
Intervention group
Patients in the intervention group will receive the TTCM, as developed and described earlier 
(21). In the TTCM, a multidisciplinary team consisting of a trauma surgeon and a specialized, 
hospital-based physical therapist will examine patients during their first outpatient consultations 
and will coordinate their rehabilitation process. 
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The TTCM consists of four main elements [21]: 
1. Intake and follow-up consultations by a multidisciplinary team at the outpatient clinic.
This team consists of a trauma surgeon and a specialized hospital-based physical therapist. The 
trauma surgeon is responsible for medical procedures (e.g. indicating surgery, fracture- and 
wound-healing), whereas the physical therapist will assess physical function (e.g. mobility).
2. Coordination and individual goal setting.  
The hospital team will coordinate the rehabilitation process, and the hospital-based physical 
therapist will act as a case manager throughout the rehabilitation process. Following a shared 
decision-making process, treatment goals will be formulated at a functional level for each 
patient. Besides, ten previously developed rehabilitation protocols for the most common 
fractures will support this process.
3. An educated and trained network of primary care trauma physical therapists.
The ‘trauma rehabilitation primary care physical therapy network’ will consist of 20 to 40 
physical therapists, per hospital, depending on the size and catchment area of the specific 
hospital. All network physical therapists will receive a three-day training program which 
content is validated by the central research team. The training will focus on fracture treatment, 
fracture rehabilitation, and recognizing complications. Furthermore, the working agreements 
within the TTCM will be explained during the course. In addition, internal training days and 
network meetings will take place regularly.
4. Secured e-mail traffic between hospital-based physical therapists and network physical 
therapists. 
A secured e-mail system will enable a well-structured interaction between hospital-based 
physical therapists and network physical therapists, allowing them to exchange patient data 
more efficiently and in a safe way according to agreed timeframes. 
Sample size calculation
To detect a difference in generic quality of life of 0.057 [SD=0.15] as measured by the EQ-5D-5L 
with α=0.025, a power=90%, an Intracluster Correlation Coefficient of ICC=0.01, assuming an 
expected cluster size of 50, and an anticipated drop-out of 20%, 322 patients will be needed per 
group, equaling a total of 644 patients. We will assess the difference found between the two 
groups from the perspective of a clinically relevant difference. Based on previous publications 
[32,33], we assume that 0.057 [SD=0.15] is the minimum clinical relevant difference for health-
related quality of life. A between-group difference of 10% in improvement of disease-specific 
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quality of life is assumed to be clinically relevant. If one of the co-primary outcomes shows a 
clinically relevant difference in favor of the intervention, TTCM will be considered effective. 
Therefore, we accounted for multiple testing of the two co-primary outcomes by using an α of 
0.025 [34]. It should be noted, however, that all available outcome measurements will be taken 
into account when interpreting the results.
Outcomes
At baseline, various relevant patient and trauma characteristics will be measured, including:  
Patient characteristics
Age (years), gender (woman/man), educational level (low/middle/high), country of birth, 
medical history (none/chronic illness/musculoskeletal disease), self-reliance (independent/
dependent), marital status (living together/alone), personal injury claim (injury process: yes/no), 
illness perceptions and patient expectations (Somatic Pre-Occupation and Coping Questionnaire 
[SPOC questionnaire]). The SPOC is a questionnaire assessing the impact of patients’ beliefs on 
functional recovery, and consists of 27 questions in four domains, including somatic complaints, 
coping, energy, and optimism. The SPOC questionnaire is a valid measurement of illness beliefs 
and attitudes in patients with lower extremity injuries and is highly predictive of their long-term 
functional recovery [35,36].
Trauma characteristics
Injury Severity Score (ISS) [37], type of trauma (traffic/fall/sport), fracture region (upper extremity 
fracture/lower extremity fracture/vertebral fracture/multi-trauma), fracture typing (open/closed, 
intraarticular/ extra-articular, stable/ unstable, comminutive (yes/no), peripheral nerve injury 
(yes/no), multiple fractures within one region (yes/no), weight-bearing policy (full weight-bearing/ 
partially weight-bearing/ non weight-bearing), treatment (operatively/conservatively), length of 
hospital stay (days), discharge destination (home/home with support/institution). 
Follow-up measures will include co-primary outcomes, secondary outcomes, and cost measures, 
including:
Co-primary outcomes
The co-primary outcomes are generic and disease-specific quality of life. Co-primary outcomes 
will be measured at baseline, 6 weeks, 3 months, 6 months, and 9 months.
153
Study protocol of the TTCM multicenter trial
7
Generic quality of life will be measured using the EQ-5D-5L. Utility values ranging from 
0 (equivalent to death) to 1 (full health) will be estimated using the Dutch tariff [38]. For 
the economic evaluation, quality-adjusted life-years (QALYs) will be calculated using linear 
interpolation between measurement points. 
Depending on the diagnosis, disease-specific quality of life will be measured using one of the 
following four standardized Patient-Reported Outcome Measures [PROMS]: 
• Upper extremity: QuickDASH DLV (Disabilities of the Arm, Shoulder, and Hand) [39,40];
• Lower extremity: Lower Extremity Functional Scale (LEFS) [41];
• Multiple fractures and/or more locations: Groningen Activity Restriction Scale (GARS) [42,43];
• Vertebral fractures: The Roland Morris Disability Questionnaire (RMDQ) [44,45].
An overall score of the disease-specific quality of life PROMS is calculated by converting the 
overall scores of the aforementioned questionnaires to a scale from 0–100, with higher scores 
representing less functional problems.   
Secondary outcomes 
Secondary outcomes include functional status (Patient-Specific Functional Scale PSFS), pain 
(11-point NPRS), patient satisfaction (11-point NRS), perceived recovery (7-point Global Perceived 
Effect Scale) and patient-reported health based on physical functioning (PROMIS-PF SF (-UE)). 
All secondary outcomes will be measured at baseline, after 3 months, 6 months, and 9 months. 
A detailed description of the outcomes, including references, can be found in Appendix 7.1. 
Societal and health care costs
For the economic evaluation, societal and healthcare costs will be estimated. Societal costs include 
intervention, healthcare, informal care, unpaid productivity, absenteeism, and presenteeism 
costs. Healthcare costs only include costs accruing to the formal Dutch healthcare sector. Resource 
use data will be collected using cost questionnaires administered at baseline, 3, 6, and 9 months 
follow-up. All costs will be valued in accordance with the Dutch Manual of Costing [46]. 
A detailed description of the co-primary and secondary outcomes, as well as the measurement 
and valuation of societal and healthcare costs, can be found in Appendix 7.1. An overview of all 
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Process evaluation
To evaluate the implementation of the TTCM, a mixed-method process evaluation will be 
performed. Quantitative data contribute to understanding why and if an intervention (i.e. TTCM) 
has its intended impact [47]. By using qualitative data, stakeholders’ experiences including barriers 
and facilitators, may be reviewed in more detail to modify the TTCM for future implementation. 
Following the recommendations of Linnan and Steckler, quantitative data on the TTCM’s reach, 
dose delivered, dose received, and fidelity will be collected from electronic patient records [48]. 
These data will be registered in the control group using the following process variables: number 
of post-clinical consultations of the trauma surgeon, discharge location (home/rehabilitation 
setting), referral to primary care yes or no and if so number of sessions attended by a patient 
at the primary care physical therapist. In the intervention group the following process variables 
will be registered: is the outpatient consultation provided by a trauma surgeon and a physical 
therapist (yes/no), discharge location (home/rehabilitation setting), referral to primary care yes 
or no, is the standardized referral form used (yes/no), are the functional goals described (yes/no), 
are e-mails exchanged between hospital physical therapist and network physical therapist (yes/
no), agreed timeframes of e-mails exchanged between hospital physical therapist and network 
physical therapist apprehended (yes/no) and the number of sessions attended by a patient at 
the primary care physical therapist. 
For the qualitative part of the process evaluation, focus groups and semi-structured interviews 
with stakeholders (e.g. patients, trauma surgeons, physiotherapists, insurance representatives) 
will take place to identify possible facilitators and barriers associated with the implementation 
of the TTCM. Focus groups and interviews will be analyzed using a framework method [49,50] 
with data mapped onto different levels of the ‘constellation perspective” (i.e. structure, culture, 
practice) (Van Raak, 2010).  
data analysis
Analyses will be based on the intention-to-treat principle. Missing data will be handled using 
longitudinal data analyses for clinical outcomes and using Multivariate Imputation by Chained 
Equations (MICE) for the economic evaluation.  
Clinical outcomes
The TTCM’s effect on both co-primary outcomes will be analyzed using a linear mixed model 
using the participants’ responses at baseline, at 6 weeks, 3 months, 6 months, and 9 months. 
In these analyses, the hospital level, as well as that of the patient and time of measurement, 
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will be taken into account. The effects of interest are the difference between groups at each 
time point, as well as the overall effect of the TTCM over time. The non-randomized nature of 
the study will be accounted for using propensity score weights [51,52]. Propensity scores are 
defined as the “conditional probability of receiving a treatment given the patients’ pre-treatment 
characteristics”. In this study, propensity scores will be calculated based on the patients’ baseline 
characteristics that differed between groups and those that will be associated with the patients’ 
baseline primary effect measure values. The estimated propensity scores will be used as sampling 
weights in the analyses. Continuous secondary outcomes will be analyzed, as outlined above. 
For dichotomous secondary outcomes, we will use a generalized mixed model (logit link) with 
the same multilevel structure, and the effects of interest are the difference between groups at 
each time point as well as the overall effect of the TTCM over time. Again, the non-randomized 
nature of the trial will be accounted for using propensity score weights. 
Economic evaluation
To account for the possible clustering of data, cost and effect differences will be estimated using 
linear mixed models. Within these analyses, the non-randomized nature of this study will again 
be accounted for using propensity score weights, but now propensity scores will be calculated 
based on the patients’ baseline characteristics that differ between groups and those that are 
associated with the patients’ baseline primary effect and cost measure values. To deal with the 
highly skewed nature of cost data, 95% CIs around the differences in costs will be estimated 
using Bias Corrected and Accelerated bootstrapping, with 5,000 replications. Incremental 
Cost-Effectiveness Ratios (ICERs) will be calculated by dividing the difference in costs by that in 
QALYs (cost-utility) and in co-primary outcomes (cost-effectiveness). Bootstrapped incremental 
cost-effect pairs will be plotted on cost-effectiveness planes [53]. A summary measure of the 
joint uncertainty of costs and effects will be presented using Cost-Effectiveness Acceptability 
Curves (CEACs) [54]. One-way sensitivity analyses will be performed to test the robustness of the 
results. The assumptions being varied in these sensitivity analyses will be determined over the 
course of the study. Analyses will be performed in STATA, using a level of significance of p<0.025. 
dIscussIOn
The current study is a comprehensive multicenter study, albeit non-randomized, aimed at 
assessing the effect of the TTCM, a patient-centralized multidisciplinary outpatient rehabilitation 
model, compared to usual care in patients with at least one fracture due to trauma.
157
Study protocol of the TTCM multicenter trial
7
comparison with literature
A review of multidisciplinary rehabilitation in multiple trauma patients emphasized the lack of 
high-quality studies on the effectiveness of rehabilitation [22]. Also, there is uncertainty about 
the recommended questionnaires in trauma patients and a core outcome set of questionnaires 
for trauma patients is missing. Hoffmann et al. (2014) stated that there is no general classification 
for measuring disability or health outcomes following trauma [26]. 
Strengths and limitations
Following the recommendation of Hoffman et al. to use the ICF as a framework for measuring 
health outcomes among trauma patients, we will use a comprehensive measurement strategy 
to describe the whole range of trauma’s impact on function, disability, and health including 
all relevant domains of the International Classification of Functioning, Disability and Health 
[55]. In this study, we will include trauma patients in ten hospitals from different regions in the 
Netherlands. Furthermore, we will include the entire range of severity of fracture(s) treated by 
the trauma surgeon, independent of where they will rehabilitate. As a consequence, we expect 
the results to be generalizable to the general Dutch (trauma patient) population. Furthermore, 
we will perform a process evaluation to analyze all perspectives of the implementation.     
However, there are also some methodological considerations. From a methodological point of 
view, a randomized controlled trial would have been the most optimal design for assessing the 
(cost-)effectiveness of the TTCM. Given the current situation of the Dutch healthcare system and 
the complexity of the intervention, however, such a design was not feasible for several reasons. 
First, the TTCM is organized at a hospital level, making it impossible to randomize individual 
trauma patients. Second, for a true randomization “effect”, and in order to be able to use the 
appropriate statistical analyses for cluster RCTs, at least 30 clusters should be included [56]. In 
our case, that would have meant that we needed to perform the study in at least 30 hospitals, 
which was financially and practically not feasible given the constrains of this study. Third, 
suitable hospitals were less inclined to participate in the proposed study if they would have been 
randomized across study conditions, because one of their main reasons for participation was the 
prospective implementation of the TTCM. Some researchers may argue that a stepped wedge 
design may have been used to overcome this barrier, but we were of the opinion that such a 
design would have led to contamination, because many patients in the control group would have 
then likely received some of their follow-up consultations after their hospital started providing 
the TTCM. Moreover, there is (some) overlap in the catchment areas of the participating hospitals 
(and therefore in primary care networks of specialized primary care trauma physical therapists). 
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This may lead to even more contamination if the 2 hospitals with overlapping catchments areas 
deliver both treatment conditions at the same time. Given these considerations, we decided 
to use a controlled before-and-after design instead. To minimize the possibility of selection 
bias, we decided to collect data on a large number of patient and trauma characteristics at the 
baseline [57] and to adjust for relevant patient and trauma characteristics in the analysis using 
propensity score weight [51,52].
A second limitation of the study could be its impossibility to identify which element of the TTCM 
is responsible for possible effects since the TTCM as a whole will be evaluated. Therefore we will 
perform a mixed-methods process evaluation contribute to understanding why an intervention 
(i.e. TTCM) has its intended impact’ and in which domain this went as planned or not [47].
Implications for physiotherapy practice
This research will provide insight into the effectiveness and cost-effectiveness of the TTCM. 
We expect the results to be generalizable to the general Dutch (trauma patient) population. 
Data will be analyzed in 2023. If found to be (cost-)effective, the TTCM can be implemented 
nationally, and the rehabilitation of patients with at least one fracture due to trauma will be 
more efficient and effective. 
Ethics approval and consent to participate
The medical ethics committee of the VUmc assessed the present study (registered under number 
A2019.459 (2019.419)). Before participation, all participants will provide informed consent 
according to the Declaration of Helsinki. 
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This project is funded by ZonMw (grant number 80-85200-98-91009).
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The co-primary outcomes are generic and disease-specific quality of life. Both co-primary 
outcomes will be measured at baseline, 6 weeks, 3 months, 6 months, and 9 months.
Generic quality of life
Generic quality of life will be measured using the EQ-5D-5L, which consists of five questions 
representing five health dimensions; mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. Using the Dutch tariff, the patients’ EQ-5D-5L health states will be converted into 
a utility score ranging from 0 (dead) to 1 (full health). For the economic evaluation, quality-adjusted 
life-years (QALYs) will be calculated using linear interpolation between measurement points. The 
EQ-5D shows excellent psychometric properties in trauma patients with one or more fractures [1,2].
Disease-specific quality of life
Depending on the diagnosis, disease-specific quality of life will be measured using one of the 
following four standardized PROMS: 
• Upper extremity: QuickDASH DLV (Disabilities of the Arm, Shoulder, and Hand)
The Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire is a shortened 
version of the 30-item DASH [3]. The results of Gummesson et al. indicate that the QuickDASH 
can be used instead of the DASH with similar precision in upper extremity disorders [4]. The 
QuickDASH consists of 11 items of symptoms and limitations of activities. The central issue 
here is the degree of complaints or restrictions throughout upper extremity during the 
past week. The patient answers the questions based on a 5-point scale with higher scores 
indicating more complaints/limitations. This test is performing well with substantial evidence 
supporting reliability and validity [5]. 
• Lower extremity: Lower Extremity Functional Scale (LEFS)
The Lower Extremity Functional Scale (LEFS) is a questionnaire containing 20 questions about a 
person’s ability to perform everyday tasks. The maximum score is 80. The lower the score, the 
more significant the disability. The LEFS is a valid tool as compared to the SF-36 [6] with fair-
to-good accuracy in discriminating between participants with and without improvement [7]. 
• Multiple fractures and/or more locations: Groningen Activity Restriction Scale (GARS)
The Groningen Activity Restriction Scale (GARS) is a scale for measuring the degree of self-
reliance of people. Eighteen items relating to activities of daily living are included in the 
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questionnaire. The severity of a disability can be mapped out using the instrument in which 
higher scores indicate more limitations in everyday activities. The psychometric properties 
of the GARS are very good in patients with rheumatoid arthritis and older adults [8-12]. 
• Vertebral fractures: The Roland Morris Disability Questionnaire (RMDQ)
This questionnaire is a self-administered disability measure in which higher numbers reflect 
greater levels of disability on a 24-point scale. The Dutch RMDQ showed excellent reliability 
in patients with chronic low back pain, with an ICC of 0.91. Calculating limits of agreement 
to quantify the stability, a large amount of natural variation (+/- 5.4) is relative to the total 
scoring range of 0 to 24 [13-15]. 
An overall disease-specific quality of life score of the PROMS is calculated by converting the 
overall scores of the aforementioned questionnaires to a scale from 0–100, with higher scores 
representing less functional problems.
secondary outcomes
Patient-specific Functional Scale (PSFS)
The Patient-Specific Functional Scale (PSFS) is a self-reported, patient-specific outcome measure 
designed to assess functional change, primarily in patients presenting with musculoskeletal 
disorders. Patients are asked to identify three to five important activities they are unable to 
perform or are having difficulty with as a result of their problem. In addition to identifying the 
activities, patients are asked to rate, on an 11-point scale, the current level of difficulty associated 
with each activity (0 = impossible, 10 = possible). The PSFS is a valid, reliable, and responsive 
outcome measure for patients with a large number of clinical presentations [16,17].  
Numeric pain rating scale (NPRS)
The Numeric Pain Rating Scale (NPRS) is a measure of subjective intensity of pain in adults. The 
11-point numeric scale ranges from ‘0’ (no pain) to 10 (“worst pain imaginable”). The patients 
are asked to indicate the numeric value on the segmented scale that best describes their pain 
intensity. There is an excellent correlation between NPRS and Visual Analog Scale (VAS) in a 
hospital/ emergency population (r=0.094, 95% CI=0.93–0.95) [18]. 
Patient satisfaction (11-point NRS)
The patient satisfaction questionnaire is a questionnaire containing five questions about patient 
satisfaction components related to the TTCM: 1) total treatment, 2) treatment at the outpatient 
clinic, 3) treatment in primary care, 4) collaboration between practitioners from the hospital team 
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and 5) collaboration between the hospital team and the primary care physical therapist. Patient 
satisfaction is scored using an 11-point numeric rating scale ranging from 0 (very dissatisfied) 
to 10 (excellent). 
Perceived recovery (7-point Global Perceived Effect Scale)
Based on the Global Perceived Effect (GPE), the patient’s opinion about its recovery is measured. 
The GPE consists of one item that needs to be answered on a 7-point scale. Intraclass correlation 
coefficient values of 0.90–0.99 indicate excellent reproducibility of the GPE scale [19]. 
Patient-Reported Outcomes Measurement Information System (PROMIS-PF SF 10a or PROMIS-
PF-UE 7a)
The Patient-Reported Outcomes Measurement Information Systems (PROMIS-PF SF 10a or 
PROMIS-PF-UE 7a) are instruments measuring patient-reported health based on physical 
functioning and physical functioning of the upper extremity. The questionnaires show good 
psychometric properties for cross-sectional use within different (patient) populations [20,21]. 
Choice of measurement of patient-reported health depends on trauma location: 
• lower extremity/ vertebral fractures/ multiple fractures, more locations: PROMIS-PF SF 10a
• upper extremity: PROMIS-PF-UE 7a
Economic evaluation
For the economic evaluation, societal as well as healthcare costs will be estimated. Societal costs 
include all costs related to the TTCM, irrespective of who pays or benefits. Healthcare costs only 
include costs accruing to the formal Dutch healthcare sector. Intervention costs will be micro-
costed to accurately estimate the real costs of the intervention to the health system and society 
[22]. Cost questionnaires based on the iMCQ (iMTA Medical Consumption Questionnaire), iPCQ 
(iMTA Productivity Cost Questionnaire), and WHO-HPQ (World Health Organization Health and 
Work Performance Questionnaire) will be administered at baseline, 3, 6 and 9 months follow-up 
to collect data on healthcare utilization, the use of informal care, absenteeism, presenteeism, 
and unpaid productivity losses [23]. 
Health care utilization includes the use of primary care (e.g. consultations with the general 
practitioner or physical therapist) and secondary care (e.g. consultations at the outpatient clinic 
for trauma patients, hospitalization) as well as the use of medication. Dutch standard costs will 
be used to value healthcare utilization [23]. Medication use is valued using information from 
the website http://www.medicijnkosten.nl. Absenteeism will be assessed by asking patients to 
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report their total number of sick leave days [24]. Absenteeism will be valued using gender-specific 
price weights [23)] Presenteeism is defined as reduced productivity while at work [25], will be 
measured using items from the WHO-HPQ and the iPCQ, and will be valued using gender-specific 
price weights [23]. Unpaid productivity losses will be assessed by asking patients for how many 
hours per week they were unable to perform unpaid activities, such as domestic work, school, 
and voluntary work. Informal care will be assessed by asking patients how many hours per week, 
they received help from family or friends. A recommended Dutch shadow price will be used to 
value unpaid productivity and informal care [23]. All costs will be presented in Euros and will be 
converted to the same reference year using consumer price indices. Discounting of costs is not 
necessary due to the 9-month follow-up period [26].
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This thesis described the development and evaluation of the Transmural Trauma Care Model 
(TTCM) that aimed to improve trauma patients’ outcomes after mild, moderate or severe injury 
by refining the organization and quality of their rehabilitation process. The primary aim of this 
thesis was to assess the effectiveness and cost-effectiveness of the TTCM within a controlled-
before-and-after study. Secondary aims included the assessment of the implementation of 
the TTCM by exploring its reach, dose delivered, dose received, and fidelity, supplemented by 
identifying possible barriers and facilitators associated with its implementation. Furthermore, 
an additional study was conducted aimed at assessing the association of various fracture and 
treatment-related factors (e.g. fracture treatment, fracture localization and fracture type) with 
disease-specific HR-QOL, functional outcome, and societal costs. In this general discussion, the 
main findings will be summarized and discussed followed by some methodological considerations 
regarding the internal and external validity of the findings. Finally, recommendations for clinical 
practice and future research will be presented, completed by a general conclusion of the thesis.
MaIN fINDINgs
study protocol
Chapter 2 described the development of the TTCM, complemented by a detailed description 
of the study design of the controlled-before-and-after study, which was aimed at assessing the 
effectiveness and cost-effectiveness of the TTCM compared to regular care, and a general outline 
of the process evaluation. The TTCM is an advanced transmural rehabilitation model for trauma 
patients, aiming to improve patient outcomes and reduce costs by optimizing the organization, 
content, and quality of the rehabilitation process. The TTCM consists of four components, namely: 
1) a multidisciplinary team at the outpatient clinic for trauma patients consisting of trauma 
surgeon and hospital-based physical therapist, 2) coordination and individual functional goal 
setting for each patient by the multidisciplinary hospital-based team, 3) a network of specialized 
primary care physical therapists, and 4) secured email traffic between the hospital-based physical 
therapist and the primary care network physical therapist. In the controlled-before-and-after 
study, trauma patients with at least one fracture who received the TTCM at the outpatient clinic 
of Amsterdam UMC, location VUmc, were compared with trauma patients who did not (i.e. 
regular care). Patients receiving the TTCM were prospectively followed for 9 months, whereas 
the control group consisted of 4 independent clusters of patients, who were either measured 
at baseline, 3, 6, or 9 months after their first consultation at the outpatient clinic. 
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Effectiveness of the TTCM
The effectiveness study in chapter 3 provides preliminary evidence that the TTCM is effective 
in improving patient-related outcome measures, such as disease-specific HR-QOL, functional 
status, and patient satisfaction among mild, moderate and severe trauma patients with at least 
one fracture compared with regular care. To illustrate, mean satisfaction about the collaboration 
between primary and secondary care was nearly 2 points higher on a 10-point scale at 6 months 
(MD 1.78; 95% CI 1.03 to 2.53) for patients treated with the TTCM compared to patients receiving 
regular care. Furthermore, the mean difference for functional status at 9 months was nearly 
21 points on a 100-points scale, favoring the TTCM group patients (MD -20.68; 95% CI -29.20 
to -12.16). Patients in the intervention group had statistically significant less pain at 6 and 9 
months than their control group counterparts (6 months: MD -0.87; 95% CI -1.44 to -0.29 and 
9 months: MD -0.84; 95% CI -1.38 to -0.31). No difference in generic HR-QOL, measured with 
the EQ-5D-3L, was found at any time point between TTCM group patients and control group 
patients. It is worth mentioning, however, that the identified mean differences on the EQ-5D-3L 
can possibly be regarded as clinically relevant at 6 months (MD 0.051; 95% CI -0.02 to 0.12) and 
9 months (MD 0.055; 95% CI -0.01 to 0.12), since both are comparable with estimates of the 
minimal clinical important differences (MICD) for the EQ-5D that were found in other patients 
with musculoskeletal disorders (i.e. ranging from 0.03 among patients with low back pain to 
0.52 in patients with recurrent lumbar stenosis [1,2].
Cost-effectiveness of the TTCM
The results of the economic evaluation in chapter 4 indicated that secondary healthcare costs and 
presenteeism costs were lower among patients treated with TTCM compared with those receiving 
regular care, while primary healthcare, medication, absenteeism, and unpaid productivity 
costs were higher among patients treated with TTCM compared with those receiving regular 
care. Total societal costs were lower among patients treated with TTCM compared with those 
receiving regular care, suggesting that implementation of the TTCM -on average- results in lower 
costs to society as a whole. However, of these aggregate and disaggregate cost differences, only 
the difference in secondary healthcare costs was statistically significant. For generic as well as 
disease-specific HR-QOL, pain, perceived recovery, and functional status, TTCM dominated the 
control condition, meaning that -on average- TTCM was less costly and more effective than usual 
practice. When considering the joint uncertainty surrounding costs and effects, the results imply 
that if decision-makers are not willing to pay anything per unit of effect gained, the TTCM has 
a relatively low probability of being cost-effective compared to usual practice (i.e. 0.54–0.58). 




of willingness-to-pay (e.g. to 0.95 at a willingness-to-pay of EUR700/point improvement on the 
NRS). Since it is unknown what decision-makers are actually willing-to-pay per unit of effect 
gained for the outcomes included in the analyses, we cannot make strong conclusions about the 
cost-effectiveness of the TTCM compared with usual practice. Nonetheless, the results of the 
present thesis can be used by decision-makers to consider whether they think that the TTCM 
provides “good value for money” at an acceptable probability of cost-effectiveness.
Process evaluation
Chapter 5 described the results of the process evaluation and showed that the TTCM was largely 
implemented as intended, with a moderate reach (81%), a high dose delivered, and a high dose 
received (95% to 100%). Moderate to high fidelity scores were found (66% to 93%), indicating 
the extent to which the intervention protocol was followed by the care providers. Additionally, 
various facilitators and barriers were identified that need to be considered when implementing 
the TTCM broadly. Focus groups among patients and health care providers indicated that the 
“communication structure of the TTCM” was found to be an important theme, expressed in 
several facilitators, such as “the use of a secured email system” and “the use of a standardized 
referral form”. Other frequently mentioned facilitators were the “shared decision making process 
at the outpatient clinic” and an “increased level of knowledge and skills”. For example, patients 
were satisfied to be involved in setting their own functional goals for their rehabilitation and 
care providers indicated to have learned from each other because of an increased level of 
collaboration due to the implementation of the TTCM. The “absence of reimbursement for the 
hospital-based physical therapists at the outpatient clinic” was identified as one of the most 
important barriers to the implementation of the TTCM. This indicates that it was hard to find 
resources for the additional physical therapist at the outpatient clinic, most likely because it was a 
new position, unknown by most of the decision-makers. Other barriers that are worth mentioning 
here, were the fact that “care providers sometimes contradict each other” and the “absence of 
awareness of the TTCM in other relevant departments of the hospital” (e.g. nurses and doctors 
at the emergency ward were not familiar with the TTCM and provided incomplete information). 
Association of fracture characteristics with HR-QOL, functional outcome and costs
Chapter 6 described the results of the study assessing the association between various 
fracture and treatment-related factors with disease-specific HR-QOL, functional outcome, and 
societal costs. This study was conducted using data of the TTCM trial. For the purpose of this 
association study, the participating trauma patients’ baseline and 9-month follow-up data of 
both the intervention group participants and the 9-month control cluster participants were 
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used. Ordinary Least Squares regression analyses were performed to assess the association of 
various fracture and treatment-related factors (i.e. surgery, fracture type, fracture localization 
and fracture treatment as independent variables) with respectively disease-specific HR-QOL, 
functional outcome, and societal costs (i.e. dependent variables), corrected for receiving the 
TTCM (yes/no), the case-mix variables age, gender and comorbidity, and the other independent 
fracture and treatment-related factors. Having a fracture of the lower extremity was found 
to be associated with a lower disease-specific HR-QOL after 9 months compared to patients 
with a vertebral fracture or multi-trauma (MD 10.09; 95% CI 2.18 to 18.00). Having an upper 
extremity fracture was associated with a better functional outcome compared to patients from 
the reference category (MD -19.12; 95% CI -31.65 to -6.59). Having had a surgery instead of 
conservative treatment was associated with lower societal costs. On the other hand, being 
treated with ORIF (open reduction internal fixation) instead of conservative treatment was 
associated with higher societal costs, whereas intramedullary nailing was not. Fracture type (i.e. 
intra-articular or extra-articular) was found not to be associated with disease-specific HR-QOL, 
functional outcome, and societal costs.
Study protocol of the multicenter trial
Chapter 7 described the study protocol of the multicenter trial that was initiated, funded and 
designed based on the results of chapter 3, 4, 5 and 6 of this thesis. This multicenter trial aims 
to assess the effectiveness and cost-effectiveness of an improved version of the TTCM compared 
to regular care in 10 Dutch hospitals using an improved design (i.e. both the intervention and 
control group are now prospectively followed). Main improvements made to the TTCM were 
broadening it to tertiary care (i.e. rehabilitation centers and homes for the elderly with a geriatric 
rehabilitation setting) and involving healthcare decision-makers at an earlier stage to discuss the 
reimbursement for the hospital-based physical therapists at the outpatient clinic.
METHOdOLOgiCAL COnSidERATiOnS
Various choices in the methodology of the presented studies and their limitations should be 
taken into account when interpreting their results. Most of the methodological issues have 
been discussed in the previous chapters, however some general remarks can be made and will 
be discussed below. 
The most important methodological issues of this thesis are related to the controlled-before-




3 and 4. The controlled-before-and-after study design has the potential to adversely affect the 
internal validity of the study findings [3], whereas the pragmatic set-up, in which daily practice 
was resembled as much as possible, facilitates the generalizability of the trial results to daily 
practice (i.e. external validity) [4]. Both of these issues will therefore be discussed into more detail 
below, followed by some additional methodological considerations regarding the TTCM trial, 
the process evaluation described in chapter 5 and the study assessing the association between 
various fracture and treatment-related factors with outcomes (chapter 6).
Study design, bias and internal validity
At the start of the TTCM trial, the controlled-before-and-after design was regarded as the most 
optimal research design within the available resources [5]. However, it was clear from the 
beginning, that measuring 4 independent control-clusters (i.e. baseline, 3, 6 or 9 months after 
patients’ first visit at the outpatient clinic) and comparing these clusters with one prospectively 
followed intervention group, would probably adversely affect the internal validity of the study 
findings. We considered the possibility of prospectively following a control group for 9 months 
prior to the implementation of the TTCM, but this was not possible due to the limited time 
frame and resources of the study. Moreover, randomization of participants was not possible, 
because the TTCM was implemented at the entire outpatient clinic for trauma patients at the 
same time, and therefore we could not create a control condition within our hospital. A cluster 
randomized controlled trial and a stepped wedged design were also considered, but both of 
these options were not possible given the previously mentioned constraints. In the multicenter 
trial, for which more resources were available, we made improvements to the design by using 
both a prospectively followed intervention and control group and we collected extensive baseline 
data in both groups to adjust for the possible influence of “selection bias” resulting from a non-
randomized design using propensity score weights [6]. 
The applied controlled-before-and-after design was susceptible to several kinds of bias. Examples of 
such kinds of biases are selection bias, repeat testing bias, regression to the mean, the Hawthorne 
effect, and recall bias. The most relevant biases to our study will be discussed in more detail below. 
First, selection bias was the most likely to occur, meaning that results might be biased due to the 
control clusters and intervention group having a different composition regarding various etiological 
factors [3]. Of the factors that we did measure, we observed some meaningful baseline differences 
in age (i.e. mean age 43 years versus 50 years for intervention group patients and control group 
patients respectively) and admission to hospital (75% of intervention group patients were admitted 
to the hospital, compared to an average of 51% in the four control group clusters). In our analyses, we 
tried to deal with possible confounding factors by adjusting for factors that changed the regression 
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coefficients by more than 10%. One should bear in mind, however, that there might always be 
unmeasured factors that differ across both groups, for which the analyses have not been corrected 
because it was simply not possible. Second, repeat testing bias and regression to the mean are two 
types of bias that possibly occurred in our study, and if so, then specifically affected patients in the 
intervention group due to the repeated measurements in this group (i.e. the same questionnaires at 
baseline, 3, 6 and 9 months). Repeat testing bias occurs when patients remember the questions and 
try to perform better the next time they have to fill in the same question, however this bias is most 
likely to occur in performance based questionnaires and physical performance tests, whereas in our 
study questionnaires were aimed at registering actual functioning instead of “performing better” 
[3,7]. Regression to the mean is a statistical phenomenon that means that extreme outliers tend 
to become less extreme with repeated measurements. As our control group was measured more 
than once this might have occurred in our study as well [8]. Third, the Hawthorne effect, meaning 
that patients’ awareness of being a study subject positively affects their behavior and sense of well-
being, possibly occurred in our study [9]. Our control group patients were only measured once and 
did not receive an intervention, whereas our intervention group was prospectively followed and 
received the TTCM. Therefore we expect this effect to be slightly bigger in our intervention group. 
However, the extent to which this effect differed between both groups is unclear. Moreover, patients 
and care providers could not be blinded, due to the content of the intervention. This may, similar 
to the Hawthorne effect, have led to an overestimation of the treatment effect of the TTCM. That 
is, patients knew which group they were in and what the aim of the study was and may therefore 
have given more positive answers. Fourth, we used retrospective cost-questionnaires with varying 
recall periods for the purpose of our economic evaluation, which may have led to recall bias. That 
is, the control group patients were asked to remember their resource use during the last 9 months, 
whereas intervention group patients were only asked to remember their resource use during the 
last 3 months. As the probability of recall bias increases with increasing recall periods one might 
expect the possible influence of recall bias to be bigger in the intervention group as compared to 
the control group. However, as total societal costs were higher in the control group than in the 
intervention group, it seems unlikely that the use of retrospective questionnaires severely biased 
our results by underestimating costs in the control group. Note that, for all clinical outcomes, the 
possible effect of recall bias is similar for both intervention group and control group and therefore 
not a noteworthy issue. 
Pragmatic set up and generalizability (external validity)
The pragmatic set-up of the study, in which daily practice was resembled as much as possible 




range of trauma severity levels in our study probably increases the generalizability of the TTCM to 
all kinds of trauma patients. However, it is also important to mention that our study population 
was rather small and was only recruited from one level-1 trauma center in the Netherlands, 
Amsterdam UMC (location VUmc). It is therefore not possible to draw strong conclusions about 
the generalizability of the current findings to other trauma centers and/or specific subgroups of 
trauma patients. Nonetheless we assume the results to have a fair chance of being generalizable 
to other academic hospitals with a similar population of trauma patients and a similar working 
atmosphere. However, the multicenter trial should bring more insight into the generalizability 
to all kinds of hospitals. We therefore included ten trauma centers from different regions of the 
Netherlands in the multicenter trial, including seven level-1 trauma centers and three level-2 
trauma centers. Among these 10 participating hospitals are 4 academic hospitals, 5 supra-regional 
hospitals and 1 small regional hospital. 
Another point which is inherent to all economic evaluations, is the fact that its results may not 
be generalizable to other countries due to differences in healthcare and social security systems 
across countries [10]. To illustrate, in the Netherlands most healthcare costs are borne by the 
government and/or by health insurance companies, whereas healthcare in the UK is mainly 
provided through the NHS (National Health Service) and freely available for all residents of the 
UK. However, under very strict conditions for recalculating costs, results of economic evaluations 
can be generalized from one country to another. These conditions include for example, a detailed 
description of the intervention and the resources, allocation of costs to various parties and 
detailed knowledge of the healthcare systems in the original studies [11]. 
Time horizon
Our follow-up period was limited to 9 months, which is shorter than the usual follow-up period 
when assessing functional outcome in trauma patients [12,13]. Such time horizons are typically 
longer than 9 months, because multi-trauma patients in particular, reach their optimal functional 
level somewhere between one and two years after their initial trauma [14]. However, this is 
not the case for mild and moderate trauma patients, who in general, recover more rapidly. This 
resulted in studies with a shorter follow-up period to measure functional outcome, for example 
Keene et al. used a 6-month follow-up period in patients with an unstable ankle fracture [15]. 
Though it is worth mentioning that many studies measuring (functional) outcome in trauma 
patients are of retrospective nature [16,17]. Furthermore, some might argue that our 9-month 
follow-up is probably not long enough to cover all costs and effects flowing from the intervention 
program (i.e. the TTCM), which is of importance when performing an economic evaluation 
[4]. Ideally, the time frame necessary to cover all costs is generally longer than the follow-up 
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needed to examine the effectiveness of an intervention [18]. To illustrate, trauma patients’ 
functioning can be at an acceptable level after 9 months, even when they have not yet been 
fully returned to work. If this is the case, the total societal costs of the intervention will likely be 
underestimated, because the cost of not returning to work even after achieving an acceptable 
level of functioning will then not be included in the analyses. To rule out such an underestimation 
of the total societal costs a longer follow-up period would have been preferable. However, since 
the majority of our study population consisted of mild and moderately injured trauma patients 
we do not expect the total societal costs to be severely underestimated and hence we feel that 
the 9-month follow-up period is of acceptable duration. Therefore, we also decided to use this 
follow-up period in the multicenter trial.
Study population and sample size
Our study population covers a broad range of trauma severity levels, with an ISS ranging from 4 
to 43 in patients with at least one fracture. Most previous studies assessing functional outcome 
after trauma mainly include major trauma patients with an ISS>16 and/or patients with only one 
specific type of fracture instead of trauma patients in general [19-22]. The results of the TTCM 
trial are therefore probably generalizable to mild, moderate, as well as severe trauma patients, 
whereas the results of previous studies were not. This is important because the TTCM is aimed 
at optimizing and refining the rehabilitation process for every single trauma patient, irrespective 
of their level of severity and type of trauma. 
Our study population was relatively small and not based on an a priori sample size calculation, 
which possibly made the study underpowered for some factors. For the multicenter trial we 
therefore performed a sample size calculation based on a clinically relevant difference of 10% 
for disease-specific HR-QOL and 0.057 for generic HR-QOL between the intervention and control 
group, resulting in a required sample size of 644 participants. As a consequence of our relatively 
small study population, we were also not able to perform additional subgroup analyses to assess 
whether effects and associations differed between subgroups, however the sample size of the 
multicenter trial will probably offer us the opportunity to do so.
Methodological issues regarding the process evaluation
Until now, well set-up process evaluations are rare in trauma research in general and in trauma 
rehabilitation research more specifically. In chapter 5 we used the “framework method” for 
analyzing the focus group data. This is a hierarchical, matrix-based method for ordering and 




al. [24]. In doing so, we were able to build a valuable matrix, in which facilitators and barriers 
were presented in a structured and systematic way. Using such a well-founded theoretical model 
for analyzing the data was one of the strengths of our process evaluation along with the use 
of a mixed-methods approach, in which qualitative as well as quantitative data were collected. 
On the one hand, qualitative data provided detailed insight into which factors facilitated or 
hampered the implementation of the TTCM, whereas quantitative data had the advantage of 
precisely measuring to which extent implementation succeeded or not. The most important 
methodological limitation of our process evaluation was the fact that patients were purposively 
selected, meaning that researchers used their own judgement to select individuals who are 
able to provide in-depth information related to the research questions. This may have resulted 
in an overestimation of positive opinions about the TTCM. Another limitation is the absence of 
healthcare decision-makers and insurers in the focus groups. As a consequence, we lack input 
from a relevant group of stakeholders regarding the financial issues in transmural healthcare 
systems like the TTCM, in which different types of financial structures and insurances are present 
(i.e. in primary and secondary care). Lacking input from healthcare decision-makers and insurers 
turned out to be one of the main problems when setting up our multicenter trial described in 
chapter 7 and they will therefore be present in the multi center trial’s process evaluation.
Methodological issues regarding the study assessing the association of fracture and 
treatment-related factors with outcomes
For assessing the association of fracture characteristics with disease-specific HR-QOL, functional 
outcome, and societal costs, we used data of the TTCM trial. However, using trial data is not 
optimal for studies assessing the association between independent variables other than that 
of an intervention versus a control. To gain more insight into the associations of fracture and 
treatment-related factors with disease-specific HR-QOL, functional outcome, and societal 
costs, a longitudinal cohort study would therefore be advised, with a follow-up duration of at 
least two years [13]. This two-year time frame is based on the ability to identify characteristics 
associated with long-term health status. Next to fracture and treatment-related factors, numerous 
sociodemographic elements should be taken into account when assessing the complex interaction 
with (functional) outcomes [25]. In chapter 6, however, we were only able to correct for the 
case-mix variables age, gender and co-morbidities. This was due to the fact that we had to rely 
on EPD data for this variables. Larger datasets containing a larger variety of sociodemographic 
variables will therefore be necessary. Such datasets will also offer more opportunities for 
subgroup analyses and might also give insight in understanding the mechanisms underlying 
the identified associations. 
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RECOMMEndATiOnS fOR fuTuRE RESEARCH
Most of the recommendations for future research have been discussed in chapter 3 to 7 as well as 
during the previous section of this general discussion. In brief, future studies aimed at assessing 
the effectiveness and cost-effectiveness of an intervention like the TTCM, are advised to use a 
pragmatic design as well, in which the circumstances under which the intervention took place is 
comparable with routine practice to improve the generalizability of their results (4). Moreover, a 
randomized controlled design would be the most optimal design from a methodological point of 
view when analyzing the effectiveness and/or cost-effectiveness of an intervention such as the 
TTCM. However, this was not feasible in the study described in chapter 3 and 4 as well as in our 
multicenter study and will likely be not feasible in most other studies aiming to assess the cost-
effectiveness of complex integrated care models that are developed based on empirical findings 
from daily practice. A “second best” is probably the use of a controlled-before-and-after design, 
such as our multicenter trial. However, to deal with the non-randomized nature of such a study 
it will be necessary to collect data on a large number of patient and trauma characteristics at 
baseline and to adjust for them in the analysis using propensity score weights [6,26].
In the TTCM trial we were not able to identify what components of the TTCM were responsible 
for the positive effects. That is, it remains unclear whether these effects were the result of an 
improved communication between primary and secondary care and/or whether they were the result 
of a better educated and more experienced network of primary care physical therapists. Future 
research, like our multicenter trial, can possibly provide more insight into whether specific TTCM 
components are accountable for specific effects and to assess which component works best for 
which type of trauma patient. However, we should also keep in mind that the multicenter trial 
will probably show that the strength of the TTCM is its integrated nature and that such thing as 
a critical ingredient does not exist in this rather complex intervention. Similar conclusions were 
also made in another study, assessing the cost-effectiveness of a complex intervention aimed at 
improving quality of care for frail older adults and subsequently improve their quality of life. This 
intervention included an integrated care model consisting of various integrated care components, 
like a geriatric assessment and tailored care plan, and multidisciplinary team consultations [27].
Another recommendation for future research is to include input from healthcare decision-makers 
and insurers when planning future studies aimed at implementing care models, like the TTCM. 
In our case this may this have led to better financial structures in general and reimbursement for 
the physical therapist at the outpatient clinic system in particular. Finally, as indicated above, a 
longitudinal cohort study with a larger sample size, more information on the sociodemographic 




be advised to gain more insight in associations of fracture and treatment-related factors with 
disease-specific HR-QOL, functional outcome, and societal costs [13]. Larger datasets will also 
offer more opportunities for subgroup analyses and might also give the possibility of building 
models to predict (functional) outcomes.
RECOMMEndATiOnS fOR CLiniCAL PRACTiCE
Based on the results described in this thesis, the TTCM seems feasible in practice and we found 
preliminary evidence that it is effective in improving patient-related outcome measures, such as 
disease-specific HR-QOL, functional status and patient satisfaction among mild, moderate and 
severe trauma patients. Since it is unknown what decision-makers are actually willing-to-pay per 
unit of effect, however, we cannot make strong conclusions about the cost-effectiveness of the 
TTCM compared with usual practice. As indicated above, information derived from this thesis 
was used to further improve the TTCM and to set up the multicenter trial aimed to assess the 
effectiveness and cost-effectiveness of an improved version of the TTCM compared to regular 
care, on a wider scale and using an improved design. Therefore, we do not recommend an 
immediate nationwide implementation of the TTCM, because resources are scarce and should 
not be used before stronger evidence on the effectiveness and cost-effectiveness of the TTCM is 
available [18]. We expect the first results of the current multicenter trial on TTCM’s effectiveness 
and cost-effectiveness in 2023. Information from the multicenter study will be important for 
healthcare decision-makers and politicians and will help them with deciding whether or not a 
broad implementation of the TTCM provides good “value for money” and if so, in building an 
appropriate legal and financial framework for this complex transmural healthcare intervention. 
However, based on the findings of the process evaluation described in chapter 5, we can already 
give some valuable and useful practical recommendations for the local implementation of the 
TTCM. Some of these recommendations have already been embedded in the multicenter trial 
and are described above and some of the recommendations are more relevant to future clinical 
practice. For a complete overview, all needs and recommendations for the possible nationwide 
implementation of the TTCM will be listed below (improvements already made to the TTCM in 
the context of the multicenter trial are marked with a *). 
• Form a steering group with all stakeholders to take everyone’s interests into account.
• Clearly describe clear organizational structures for care providers at the outpatient clinic and 




• Clearly describe duties and responsibilities of the participating care providers in a manual.*
• Organize training courses for the multidisciplinary teams at the outpatient clinic and for the 
primary care network physical therapists.*
• Organize reflection meetings with the local stakeholders (homogeneous as well as hetero-
geneous) during the implementation period.
• Arrange an appropriate and structural embedded reimbursement system for the hospital-
based physical therapist, who acts as case manager within the TTCM.
• Structure verbal and written information for trauma patients with minor fractures in 
brochures, so these type of patients probably do not need additional physical therapy in 
primary care.*
• Develop several rehabilitation pathways for mild, moderate and severe trauma patients 
respectively (but be aware that the main goal and strength of the TTCM is the individually 
tailored rehabilitation path).*
• Extent the network with physical therapists working in rehabilitation centers and geriatric 
rehabilitation settings.* 
To complete this section, we would like to express our wish of developing a nationwide 
network of trauma physical therapists, united in Network Trauma Rehabilitation Netherlands 
(NTN). Initiatives of building such an overarching organization are currently being developed in 
cooperation with several stakeholders (e.g. the Dutch network of acute care (Landelijk Netwerk 
Acute Zorg). Finally, it could be valuable to translate the TTCM to other patient groups, with 
a similar variability in severity and patient characteristics and being dependent of physical 
therapy for their rehabilitation (i.e. patients with complicated orthopedic problems or patients 
with acquired neurological disorders). For these patient groups, an improved coordination of 
their rehabilitation process and an improved communication structure between primary and 
secondary care might also be valuable. Please note that for some specific patient groups similar 
integrated care models already exist in the Netherlands (e.g. for patients with Parkinson’s 
disease and one recently developed for COPD patients). Although there are overlapping aspects, 
these care models differ from the TTCM, especially when it comes to the strict communication 
structure and the focus on individual functional goalsetting, which are main issues within the 
TTCM [28,29]. Collaboration with initiators of other integrated care models could help further 





In conclusion, this thesis shows that the TTCM seems feasible in practice and we found preliminary 
evidence that it is effective in improving patient-related outcome measures, such as disease-
specific HR-QOL, functional status and patient satisfaction among mild, moderate and severe 
trauma patients. Strong conclusions about the cost-effectiveness of the TTCM cannot be made, 
since it is unknown what decision-makers are willing-to-pay per unit of effect gained for the 
outcomes included in the analyses. Furthermore, lessons learned from the TTCM trial and its 
process evaluation were used to further improve the TTCM and to set up a multicenter trial 
aimed to assess the effectiveness and cost-effectiveness of an improved version of the TTCM 
compared to regular care, on a wider scale and using an improved study design. Results of this 
multicenter trial are expected in 2023 and will hopefully contribute to an individually tailored 
rehabilitation path for every single trauma patient in the Netherlands, supervised by closely 
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Traumatic injury is one of the main causes of death and disability worldwide and poses a 
substantial economic burden to society. Traditionally, the organization of trauma care focused 
more on pre-hospital and in-hospital care than on the rehabilitation phase, because the trauma 
patients’ survival was its first and most important goal. Since the organization of acute trauma 
care has improved and mortality due to traumatic injury has decreased, the focus of trauma 
care has shifted from reducing mortality to improving quality of life and outcome. This in turn 
resulted in a growing interest in improving the quality of trauma rehabilitation, which is the 
main focus of this thesis. 
Most trauma patients have one or more fractures due to their trauma. Trauma patients’ treatment 
depends on their fracture characteristics and other patient-related characteristics, such as age, 
comorbidity, health status, and activity level prior to the injury. Treatment can be conservative 
(e.g. with plaster or a limited weight-bearing policy) or surgical, which in most cases means 
intramedullary nailing or internal fixation with plates and screws. Trauma recovery generally 
proceeds in four phases, i.e. 1) the acute treatment phase, 2) the rehabilitation phase, 3) the 
adaption phase, and 4) the stable end situation. For physical therapists who treat trauma patients, 
it is important to deal with each phase of the recovery process in an appropriate way. In doing so, 
they will be able to give – within a certain margin – an estimate of a trauma patient’s length and 
outcome of the rehabilitation process. This is important, because it is recognized that managing 
trauma patients’ expectations is a critical element of their rehabilitation process and is necessary 
to achieve an optimal outcome. After being discharged from a hospital, the majority of Dutch 
trauma patients rehabilitates with the help of a primary care physical therapist. However, there 
is a lack of programs and guidelines for the rehabilitation of trauma patients following their 
medical treatment (i.e. in primary care), and it seems to be a rather unexplored area. Although 
it is recognized that post-clinical care organized in primary care networks of experienced and 
specialized healthcare providers results in better clinical outcomes, this was typically lacking for 
trauma patients prior to the start of this study. 
To bridge this gap, we developed and evaluated the Transmural Trauma Care Model (TTCM), 
an advanced transmural rehabilitation model for mild, moderate and severe trauma patients, 
aiming to improve patient outcomes and reduce costs by optimizing the organization, content, 
and quality of the rehabilitation process. The TTCM consists of four components, all of which are 
linked to one another, i.e. 1) a multidisciplinary team at the outpatient clinic for trauma patients, 
2) coordination and individual functional goal setting for each patient by the multidisciplinary 
hospital-based team, 3) a network of specialized primary care physical therapists, and 4) secured 
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email traffic between the hospital-based physical therapist and the primary care network physical 
therapist.
The primary aim of this thesis was to assess the effectiveness and cost-effectiveness of the TTCM 
within a controlled-before-and-after study. Secondary aims included the assessment of the 
implementation of the TTCM by exploring its reach, dose delivered, dose received, and fidelity, 
supplemented by identifying possible barriers and facilitators associated with its implementation. 
Additionally, data collected in the context of this study were used to explore the association of 
specific trauma- and fracture related factors with disease-specific HR-QOL, functional outcome, 
and costs and to further improve the TTCM.
Chapter 2 described the development of the TTCM, complemented by a detailed description 
of the study design of the controlled-before-and-after study, which – as indicated above – was 
aimed at assessing the effectiveness and cost-effectiveness of the TTCM compared to regular 
care. Furthermore, a general outline of the process evaluation was given. In the controlled-
before-and-after study, trauma patients with at least one fracture who received the TTCM at 
the outpatient clinic of Amsterdam UMC, location VUmc, were compared with trauma patients 
who did not (i.e. regular care). 
Chapter 3 investigated the effectiveness of the TTCM compared to regular care among trauma 
patients, in terms of health-related quality of life (HR-QOL), functional outcome, pain and 
patient satisfaction. Preliminary evidence was provided that the TTCM is effective in improving 
patient-related outcome measures, such as disease-specific HR-QOL, functional status, and 
patient satisfaction among mild, moderate, and severe trauma patients with at least one fracture 
compared with regular care. For example, the mean difference for functional status at 9 months 
was nearly 21 points on a 100-points scale, favoring the TTCM group. Furthermore, patients in 
the intervention group suffered from statistically significant less pain at 6 and 9 months than 
their control group counterparts.
Chapter 4 described the results of the economic evaluation and indicated that secondary 
healthcare costs and presenteeism costs were lower among patients treated with TTCM 
compared with those receiving regular care. On the other hand, primary healthcare, medication, 
absenteeism, and unpaid productivity costs were higher among patients treated with TTCM 
compared with those receiving regular care. Total societal costs were lower among patients 
treated with TTCM compared with those receiving regular care, suggesting that implementation 
of the TTCM – on average – results in lower costs to society as a whole. However, only the 
difference in secondary healthcare costs was statistically significant. For generic as well as 
disease-specific HR-QOL, pain, perceived recovery, and functional status, TTCM dominated the 
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control condition, meaning that – on average – TTCM was less costly and more effective than 
usual practice. These results imply that if decision-makers are not willing to pay anything per unit 
of effect gained, the TTCM has a relatively low probability of being cost-effective compared to 
usual practice (i.e. 0.54–0.58). However, this probability increased for all outcomes to relatively 
high levels with increasing values of willingness-to-pay. However, since it is unknown what 
decision-makers are actually willing-to-pay per unit of effect gained for the outcomes included 
in the analyses, we cannot make strong conclusions about the cost-effectiveness of the TTCM 
compared with usual practice. 
Chapter 5 described the results of the process evaluation and showed that the TTCM was 
largely implemented as intended, with a moderate reach (81%), a high dose delivered, and a 
high dose received (95% to 100%). Moderate to high fidelity scores were found (66% to 93%). 
Fidelity scores indicate the extent to which the intervention protocol was followed by the 
care providers. Additionally, various facilitators and barriers were identified that need to be 
considered when implementing the TTCM broadly. Focus groups among patients and health 
care providers indicated that the “communication structure of the TTCM” was found to be an 
important theme, expressed in several facilitators, such as “the use of a secured email system” 
and “the use of a standardized referral form”. Other frequently mentioned facilitators were the 
“shared decision-making process at the outpatient clinic” and an “increased level of knowledge 
and skills”. The “absence of reimbursement for the hospital-based physical therapists at the 
outpatient clinic” was identified as one of the most important barriers to the implementation 
of the TTCM. Another important barrier was the “absence of awareness of the TTCM in other 
relevant departments of the hospital”.
Chapter 6 described the results of the study assessing the association between various fracture 
and treatment related factors with disease-specific HR-QOL, functional outcome, and societal 
costs. This study was conducted using data of the TTCM trial. For the purpose of this association 
study, the participating trauma patients’ baseline and 9-month follow-up data of both the 
intervention group participants and the 9-month control cluster participants were used. Having a 
fracture of the lower extremity was found to be associated with a lower disease-specific HR-QOL 
after 9 months compared to patients with a vertebral fracture or multi-trauma. Having an upper 
extremity fracture was associated with a better functional outcome compared to patients from 
the reference category. Having had surgery instead of conservative treatment was associated 
with lower societal costs. Fracture type (i.e. intra-articular or extra-articular) was found not to 
be associated with disease-specific HR-QOL, functional outcome, and societal costs.
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Chapter 7 described the study protocol of the multicenter trial that was initiated, funded, and 
designed based on the results of chapter 3, 4, 5 and 6 of this thesis. This multicenter trial aims to 
assess the effectiveness and cost-effectiveness of an improved version of the TTCM compared to 
regular care in 10 Dutch hospitals using an improved design (i.e. both the intervention and control 
group are prospectively followed). Main improvements made to the TTCM were broadening it to 
tertiary care (i.e. rehabilitation centers and homes for the elderly with a geriatric rehabilitation 
setting) and involving healthcare decision-makers at an earlier stage to discuss the reimbursement 
for the hospital-based physical therapists at the outpatient clinic.
Chapter 8 presents an extensive discussion of our studies, the choices we made with respect to 
their methodology as well as their limitations that should be taken into account when interpreting 
the results. The most important methodological issues of this thesis are related to the controlled-
before-and-after study design as well as the pragmatic set-up of the TTCM trial. The controlled-
before-and-after study design has the potential to adversely affect the internal validity of the 
study findings, whereas the pragmatic set-up, in which daily practice was resembled as much as 
possible, facilitates the generalizability of the trial results to daily practice. Additionally, various 
methodological issues regarding the process evaluation and the study assessing the association 
between various fracture and treatment related factors with outcomes were discussed. This 
chapter was completed with recommendations for further research and a complete overview 
of valuable and useful practical recommendations for the local implementation of the TTCM.
In conclusion, this thesis shows that the TTCM seems feasible in practice and we found preliminary 
evidence that it is effective in improving patient-related outcome measures, such as disease-
specific HR-QOL, functional status and patient satisfaction among mild, moderate and severe 
trauma patients. Strong conclusions about the cost-effectiveness of the TTCM cannot be made, 
since it is unknown what decision-makers are willing-to-pay per unit of effect gained for the 
outcomes included in the analyses. Furthermore, lessons learned from the TTCM trial and its 
process evaluation were used to further improve the TTCM and to set up a multicenter trial 
aimed to assess the effectiveness and cost-effectiveness of an improved version of the TTCM 
compared to regular care, on a wider scale and using an improved study design. Results of this 
multicenter trial are expected in 2023 and will hopefully lead to a nationwide implementation 
of the TTCM and thus contribute to an individually tailored rehabilitation path for every single 





Traumatisch letsel is letsel als gevolg van een ongeval en is één van de belangrijkste doodsoorzaken 
wereldwijd. Daarnaast heeft een groot aantal traumapatiënten last van (blijvende) beperkingen 
in fysiek functioneren. Traumatische letsels leiden tot hoge medische en niet medische (verzuim)
kosten en zijn derhalve een substantiële economische last voor de samenleving. Historisch gezien 
richt de traumazorg zich vooral op de acute fase, dat wil zeggen de acute opvang “op straat”, snel 
vervoer naar het juiste ziekenhuis en een adequate behandeling tijdens de ziekenhuisopname. 
Voor de revalidatiefase was minder aandacht, het overleven van de patiënt stond immers voorop. 
De organisatie van acute traumazorg is in de laatste decennia echter sterk verbeterd en het 
sterftecijfer als gevolg van een trauma is als direct gevolg daarvan met 15–25% gedaald. De 
aandacht kon daarom worden verlegd van het terugdringen van mortaliteit naar het verhogen van 
de kwaliteit van leven van traumapatiënten en het verbeteren van hun functionele uitkomsten. Dit 
heeft weer gezorgd voor een groeiende interesse in het optimaliseren van het revalidatieproces 
van traumapatiënten, wat het onderwerp is, dat in dit proefschrift centraal staat.
De meeste traumapatiënten hebben één of meerdere breuken, welke adequaat behandeld die-
nen te worden. De behandeling hangt af van de specifieke kenmerken van de breuk, maar ook 
van patiëntspecifieke factoren, zoals leeftijd, comorbiditeit, gezondheid en de mate van activiteit 
voorafgaand aan het letsel. De behandeling kan conservatief zijn (bijvoorbeeld met gips of een 
beleid van beperkt belasten) of chirurgisch, bijvoorbeeld met een mergpen of fixatie met platen 
en schroeven. Het herstel na een (ernstig) trauma verloopt doorgaans in vier fasen: 1) de acute 
behandeling, 2) de revalidatiefase, 3) de adaptatiefase, en 4) de stabiele eindsituatie. Voor fysio-
therapeuten is het tijdens de behandeling van traumapatiënten belangrijk om in elke fase van het 
herstel accuraat te handelen. Ervaren en geschoolde traumafysiotherapeuten zullen – binnen zekere 
marges – een schatting kunnen geven van zowel de duur als de uitkomst van het revalidatieproces 
van de traumapatiënt. Dit is relevant omdat verwachtingsmanagement bij traumapatiënten een 
cruciaal element is tijdens hun revalidatieproces en noodzakelijk voor een optimaal verloop. Na 
ontslag uit het ziekenhuis revalideert het merendeel van de Nederlandse traumapatiënten met 
behulp van een eerstelijns fysiotherapeut. Niettemin lijkt de revalidatie van traumapatiënten met 
fracturen in de eerste lijn betrekkelijk onbekend terrein; specifieke programma’s en richtlijnen voor 
de revalidatie van traumapatiënten zijn schaars, terwijl deze voor het acuut medisch handelen wel 
bestaan. Hoewel wordt erkend dat post-klinische zorg die is georganiseerd in eerstelijns netwerken 
van ervaren en gespecialiseerde zorgverleners betere functionele resultaten oplevert (bijvoorbeeld 
voor patiënten met de ziekte van Parkinson), ontbreekt dit soort zorg voor traumapatiënten.
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Om deze kloof te dichten hebben we in Amsterdam UMC, locatie VUmc, het Transmurale Trauma 
Care Model (TTCM) ontwikkeld en geëvalueerd. Het TTCM is een geavanceerd transmuraal 
revalidatiemodel voor traumapatiënten, dat zowel toepasbaar is op licht- als zwaargewonde 
patiënten. Het doel van dit revalidatiemodel is het verbeteren van de functionele uitkomsten 
van de traumapatiënt en het reduceren van zorg- en verzuimkosten door het optimaliseren van 
de organisatie, de inhoud en de kwaliteit van het revalidatieproces. Het TTCM bestaat uit vier 
componenten die onlosmakelijk met elkaar verbonden zijn: 1) een multidisciplinair team op de 
polikliniek voor traumapatiënten (bestaande uit traumachirurg en klinisch fysiotherapeut), 2) 
coördinatie van de revalidatie en het stellen van individuele functionele doelen voor elke patiënt 
door het multidisciplinaire ziekenhuisteam, 3) een netwerk van gespecialiseerde eerstelijns 
fysiotherapeuten, en 4) beveiligd e-mailverkeer tussen de fysiotherapeut in het ziekenhuis en 
de eerstelijns fysiotherapeut.
Het hoofddoel van dit proefschrift was het onderzoeken van de effectiviteit en kosteneffectiviteit 
van het TTCM in een gecontroleerde voor-na studie. Een nevendoelstelling was het onderzoeken 
van de implementatiegraad van het TTCM. Dat wil zeggen, in hoeverre werd het revalidatiemodel 
geïmplementeerd zoals gepland en wat waren factoren die de implementatiegraad positief 
dan wel negatief beïnvloedden? Daarnaast werden de data uit dit onderzoek gebruikt om de 
associatie te onderzoeken tussen specifieke fractuurkenmerken en drie afhankelijke uitkomsten 
(ziektespecifieke kwaliteit van leven, functionele uitkomst en maatschappelijke kosten).
Samenvatting per hoofdstuk
Hoofdstuk 2 beschrijft het ontstaan en de ontwikkeling van het TTCM en geeft een gedetailleerde 
beschrijving van het studieprotocol van de gecontroleerde voor-na studie, die als doel had de 
effectiviteit en kosteneffectiviteit van TTCM in vergelijking met reguliere zorg te onderzoeken 
in traumapatiënten met tenminste één fractuur. Ook wordt de opzet van de kwalitatieve studie 
(procesevaluatie) in dit hoofdstuk beschreven. 
Hoofdstuk 3 beschrijft de effectiviteit van het TTCM in vergelijking met reguliere zorg in 
traumapatiënten met tenminste één fractuur op de uitkomsten kwaliteit van leven, functie, pijn en 
patiënttevredenheid. Voorlopig bewijs werd verkregen dat het TTCM effectief was in vergelijking 
met reguliere zorg in traumapatiënten met tenminste één fractuur voor patiëntgerelateerde 
uitkomstmaten, zoals ziektespecifieke kwaliteit van leven, functie en patiënttevredenheid. 
Zo toonde de resultaten van de lineaire regressieanalyse bijvoorbeeld na 9 maanden een 
significant verschil van 21 punten in het voordeel van de TTCM-groep aan (op een schaal van 
100 punten) voor functionele status. Bovendien hadden patiënten in de interventiegroep op zes 
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en negen maanden na inclusie statistisch significant minder pijn dan patiënten die reguliere zorg 
kregen.
Hoofdstuk 4 beschrijft de resultaten van de economische evaluatie en laat zien dat de tweedelijns 
gezondheidszorgkosten lager zijn voor de groep die behandeld is volgens het TTCM vergeleken 
met patiënten die niet volgens het TTCM behandeld werden. Ook de “ervaren effectiviteit” 
op de werkvloer was hoger voor de TTCM-groep en de daaraan gerelateerde kosten daarom 
lager. Aan de andere kant bleken de kosten voor eerstelijns gezondheidszorg hoger in de TTCM-
groep vergeleken met de groep die reguliere zorg kreeg en was het ziekteverzuim hoger in de 
TTCM-groep evenals de kosten voor het niet kunnen uitvoeren van onbetaald werk. De totale 
maatschappelijke kosten bleken echter lager te zijn in de TTCM-groep dan in de controlegroep, 
wat lijkt te betekenen dat het TTCM gemiddeld gezien leidt tot lagere kosten voor de maatschappij 
als geheel. Opgemerkt moet worden dat van de bovengenoemde verschillen in kosten alleen 
het verschil in tweedelijns gezondheidszorgkosten significant was. Voor andere uitkomstmaten, 
te weten ziektespecifieke kwaliteit van leven, pijn, ervaren herstel en functie, domineerde de 
TTCM-groep de controlegroep, wat gemiddeld genomen betekent dat het TTCM minder kost en 
effectiever is dan reguliere zorg. Kosteneffectiviteitscurves geven aan dat wanneer beslissers in 
de zorg niet bereid zijn om een bedrag per punt verbetering op de uitkomstschalen te investeren, 
de kans klein (te weten 0.54 tot 0.58) is dat het TTCM kosteneffectief is ten opzichte van reguliere 
zorg. Deze kansen stijgen echter fors voor elke uitkomstmaat bij een toegenomen bereidheid tot 
betalen door de beslissers in de zorg. Omdat niet bekend is wat beslissers in de zorg daadwerkelijk 
willen betalen per punt verbetering op de uitkomstschalen is het vooralsnog niet mogelijk sterke 
conclusies te trekken over de kosteneffectiviteit van het transmurale revalidatiemodel TTCM ten 
opzichte van reguliere zorg.
Hoofdstuk 5 toont de resultaten van de procesevaluatie en laat zien dat de implementatie van 
TTCM grotendeels verliep zoals we hadden beoogd, zo was het bereik van het TTCM 81%, en werd 
de interventie in 95% tot 100% van de gevallen daadwerkelijk geleverd. De interventieprotocollen 
en werkafspraken werden redelijk tot goed nageleefd door de diverse zorgverleners met scores 
van 66% tot 93%. Bovendien werden door middel van homogene focusgroepen onder patiënten 
en zorgprofessionals factoren geïdentificeerd die de implementatiegraad van het TTCM positief 
dan wel negatief beïnvloedden. Duidelijk werd dat de “communicatiestructuur binnen het TTCM” 
een belangrijk thema is, zo werd bijvoorbeeld “het gebruik van een beveiligd e-mailsysteem” 
en “het gebruik van een gestandaardiseerd verwijzingsformulier” als positief ervaren door 
zorgverleners in zowel de eerste als tweede lijn. Andere frequent genoemde sterke punten van het 
TTCM waren “het gezamenlijke besluitvormingsproces in de polikliniek” en het “hogere niveau van 
kennis en vaardigheden door binnen TTCM te werken”. Het “ontbreken van financiële middelen 
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voor de klinisch fysiotherapeut op de polikliniek” werd als belangrijke hindernis genoemd voor 
de implementatie van TTCM. Een andere vaak genoemde barrière was “de onbekendheid met 
TTCM op andere afdelingen van het ziekenhuis, zoals bijvoorbeeld de SEH”.
Hoofdstuk 6 beschrijft de resultaten van het onderzoek waarin de associatie onderzocht 
werd tussen specifieke fractuurkenmerken en drie afhankelijke uitkomsten (ziektespecifieke 
kwaliteit van leven, functionele uitkomst en maatschappelijke kosten), waarbij gecorrigeerd 
werd voor het ontvangen van de interventie (TTCM) en voor diverse case-mix variabelen (o.a. 
leeftijd en geslacht). Voor dit onderzoek werden data van interventiegroepdeelnemers en 
deelnemers uit het 9-maanden controlecluster uit de eerder genoemde gecontroleerde voor-
na studie gebruikt. Van al deze deelnemers werden baselinegegevens en de follow-up data op 
9 maanden gebruikt voor analyse. Het hebben van een breuk in de onderste extremiteit bleek 
geassocieerd te zijn met een lagere ziektespecifieke kwaliteit van leven ten opzichte van de 
patiënten in de referentiecategorie (met een wervelfractuur of meerdere letsels). Daarentegen 
bleek het hebben van een fractuur in de bovenste extremiteit juist met een betere functionele 
uitkomst geassocieerd te zijn in vergelijking met de referentiecategorie. Tenslotte vonden we 
dat operatief ingrijpen geassocieerd werd met lagere maatschappelijke kosten ten opzichte 
van conservatieve behandeling. Type fractuur (intra- of extra-articulair) bleek met geen van de 
uitkomsten geassocieerd te kunnen worden. 
Hoofdstuk 7 beschrijft het onderzoeksprotocol van de multicenterstudie die werd geïnitieerd, 
gefinancierd en ontworpen op basis van de resultaten van hoofdstuk 3, 4, 5 en 6 van dit 
proefschrift. De multicenterstudie heeft als doel de effectiviteit en kosteneffectiviteit van een 
verbeterde versie van het TTCM te onderzoeken ten opzichte van reguliere zorg in tien Nederlandse 
ziekenhuizen. We maken daarbij gebruik van een geoptimaliseerd onderzoeksdesign. Dit betekent 
dat nu zowel de interventiegroep als de controlegroep prospectief wordt gevolgd, terwijl in de 
effectiviteits- en kosteneffectiviteitsstudies die in de eerdere hoofdstukken van dit proefschrift 
beschreven worden, slechts de interventiegroep prospectief werd gevolgd. Verbeteringen binnen 
het TTCM maakten het revalidatiemodel ook functioneel in de derde lijn (revalidatiecentra en 
instellingen met een geriatrische revalidatie-afdeling). Ook werden meerdere stakeholders, zoals 
beleidsmakers en beslissers in de zorg, in een eerder stadium betrokken waardoor bijvoorbeeld 
het gebrek aan financiële middelen voor de klinisch fysiotherapeut op de polikliniek een serieus 
aandachtspunt werd.
Hoofdstuk 8 geeft een overzicht van de belangrijkste bevindingen van ons onderzoek, en gaat in 
op de methodologische keuzes die we gemaakt hebben. De beperkingen die gepaard gaan met 
deze keuzes worden besproken, evenals de belangrijkste punten waarvan men zich bewust moet 
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zijn bij het interpreteren van de resultaten. De voornaamste methodologische issues hebben 
betrekking op het design van de gecontroleerde voor-na studie en daarnaast de pragmatische 
aanpak van de TTCM-trial. Het gekozen design beïnvloedt mogelijk de interne validiteit van 
onderzoeksresultaten op een negatieve manier, terwijl de pragmatische aanpak, waarin de 
alledaagse praktijk zoveel mogelijk werd benaderd, mogelijk de generaliseerbaarheid van de 
resultaten positief beïnvloedt. 
De methodologische beschouwingen worden afgesloten met het kritisch bespreken van de 
methodiek en de resultaten van respectievelijk de procesevaluatie en de studie waarin de 
associatie onderzocht werd tussen specifieke fractuurkenmerken en drie afhankelijke uitkomsten 
(ziektespecifieke kwaliteit van leven, functionele uitkomst en maatschappelijke kosten). Tot slot 
worden aanbevelingen voor vervolgonderzoek gedaan en wordt een overzicht gegeven van 
praktisch toepasbare aanbevelingen voor de klinische praktijk en het implementeren van het 
TTCM in andere ziekenhuizen en regio’s.
Conclusie
Concluderend toont dit proefschrift aan dat het implementeren van TTCM praktisch haalbaar 
is. Daarnaast is er voorlopig bewijs gevonden dat TTCM effectief is in vergelijking met reguliere 
zorg in traumapatiënten met tenminste één fractuur voor wat betreft patiëntgerelateerde 
uitkomstmaten, zoals ziektespecifieke kwaliteit van leven, functie en patiënttevredenheid. 
Sluitende conclusies over de kosteneffectiviteit van TTCM kunnen niet worden getrokken, omdat 
niet bekend is wat beslissers in de zorg daadwerkelijk willen betalen per punt verbetering op 
de diverse uitkomstmaten. 
Tot slot werd lering getrokken uit de beschreven trialresultaten en uit de resultaten van de 
procesevaluatie. De gevonden verbeterpunten werden gebruikt om het TTCM verder te 
optimaliseren. Vervolgens werd een multicenterstudie opgezet om op een grotere schaal en met 
een verbeterd design de effectiviteit en kosteneffectiviteit van de geoptimaliseerde TTCM-versie 
te kunnen onderzoeken. De resultaten van de multicenterstudie worden in 2023 verwacht en 
zullen hopelijk leiden tot landelijke implementatie van TTCM en op die manier bijdragen aan 




Dit project is begonnen met een praktische vraag vanuit de spreekkamer: “hoe bieden we 
traumapatiënten een optimale revalidatie, zonder onnodige vertraging en met een duidelijk 
doel”. Dat de vraag beantwoord is, dat er een proefschrift ligt, dat ons zorgmodel inmiddels 
breed gedragen wordt en dat we vervolgonderzoek doen in de vorm van een multicenterstudie, 
is dankzij de inzet van velen. Al deze mensen wil ik op deze plek danken voor hun inspanningen, 
vertrouwen en geduld.
Allereerst wil ik de patiënten bedanken die belangeloos hebben meegewerkt aan dit onderzoek 
in een moeilijke fase van hun leven. Dankzij jullie inzet en input kunnen we niet alleen de 
traumapatiënten uit Amsterdam UMC een betere revalidatie bieden, maar de komende jaren 
gaan we hopelijk deze zorg voor alle traumapatiënten in Nederland beschikbaar maken. Speciale 
dank aan Co, Steve, Gideon, Mette, Dore, Bob, Gerdina, Martijn en Frank voor de foto’s die 
jullie mij hebben gestuurd van jullie “optimale functie” na een lange revalidatie. Het proefschrift 
is door jullie beeldverhalen echt gaan leven.
De uiterst gevarieerde samenstelling van ons TTCM projectteam maakte dat de bijeenkomsten 
nooit saai waren. Een mix van sportfanaten, creatieve geesten, gastronomen en muziekliefhebbers, 
met als grootste gemene delers een tomeloze ambitie en hart voor de patiënt:
Edwin Geleijn, collega, vriend, sparringpartner, en natuurlijk paranimf. Wat begon als een leuk 
idee tijdens één van onze geanimeerde woon-werk fietstochtjes, groeide uit tot een volwassen 
zorgmodel en dito onderzoek. Jouw lef en innovatieve inborst en mijn inhoudelijke drive bleek 
een gouden combinatie. We werkten van meet af aan hard aan dit project en namen nooit een 
blad voor de mond en dat was heerlijk werken. Dit resultaat hebben we samen bereikt en daar 
ben ik je dankbaar voor. 
Hanneke van Dongen, copromotor, ik had me geen betere dagelijkse begeleider kunnen wensen; 
snel, slim, accuraat, maar bovenal ontspannen en grappig. We gaven elkaar ruimte, maar pakten 
ook op hoog tempo door als het moest. Jouw input heeft dit proefschrift op alle vlakken naar 
een hoger niveau getild. Je kennis van methodologie, statistiek en economische evaluaties is 
onmisbaar geweest voor het onderzoek en dan ben je ook nog eens een taalkundig wonder. 
Heel veel dank en ik hoop dat jullie nog vaak in onze “tuin” komen plonzen met de kleine man!
Frank Bloemers, copromotor, heel veel dank voor jouw enthousiasme. Je hebt je vanaf de 
allereerste dag van dit project ten volle ingezet om de nieuwe aanpak van de grond te krijgen. 
Keer op keer brak je een lans voor een multidisciplinaire aanpak, steeds beredenerend vanuit 
het belang van de traumapatiënt. Jouw mailtjes, telefoontjes en aanwezigheid op de vele 
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bijeenkomsten openden deuren en slingerden de motoren aan. Ik hoop de laatste schakel van 
de traumaketen samen met jou verder op de kaart te zetten in Nederland.
Raymond Ostelo en Vincent de Groot, promotoren, dank voor jullie inzet en input op vele 
momenten. Jullie weten gas te geven op het moment dat het nodig is en los te laten als dat 
effectiever blijkt. Ik vond dat prettig werken en heb veel van jullie geleerd. Raymond, dank dat 
jij direct enthousiast en vol vertrouwen instapte, toen Edwin jou een aantal jaar geleden vroeg 
om het wetenschappelijk fundament onder onze plannen te leggen. En geweldig dat jouw 
inspanningen er toe hebben geleid dat er nu een multicenterstudie loopt. Vincent, heel fijn 
dat jij bereid was om ondanks je drukke werkzaamheden als tweede promotor op te treden. 
Jouw snelle, effectieve en constructieve manier van werken heeft de gang erin gehouden en op 
cruciale momenten tot goede beslissingen geleid. Daarnaast heb je mijn persoonlijke ambities 
en groei volop ondersteund in je rol als afdelingshoofd.
De leden van de beoordelingscommissie, prof.dr. K.D.P.W.B. Nanayakkara, prof.dr. I.B. Schipper, 
prof.dr. J.E. Bosmans, prof.dr. P.J. van der Wees en prof.dr. C.K. van der Sluis, dank ik hartelijk 
voor het vlot en kritisch lezen van mijn proefschrift. Dat de onderzoeken en het transmurale 
zorgmodel vanuit zo’n breed perspectief beoordeeld zijn, waardeer ik zeer. 
Rosalie Huijsmans, als mijn directe leidinggevende heb je dit onderzoek en mijn persoonlijke 
ontwikkeling altijd gesteund. Het was fijn zo’n krachtige persoonlijkheid achter me te hebben 
staan. Ik denk dat jij een van de weinigen bent, die het volledige “kleurenspectrum” dat tijdens 
dit onderzoek de revue heeft gepasseerd, kan overzien. Jouw inlevingsvermogen is groot en je 
tactische zetten zijn vrijwel altijd raak. Ik dank je voor alles wat je in de afgelopen jaren voor me 
hebt gedaan en betekend. 
Mijn vakgroep, mijn buddy’s. Jullie geduld, flexibiliteit en incasseringsvermogen was groot en 
onmisbaar. De afgelopen jaren zijn veel vakgroep-uren naar dit onderzoek gegaan. Voor ons 
allemaal een enorme investering, maar ook een prachtig gezamenlijk product, waaraan iedereen 
op zijn eigen manier heeft bijgedragen. Hiervoor wil ik jullie persoonlijk bedanken: 
Maaike Schothorst coördineerde de dataverzameling en pleegde honderden telefoontjes, ik heb 
heel veel waardering en respect voor je precisie, vasthoudendheid en inzet op de traumapoli’s. 
Josien Jongejan wist keer op keer op keer op creatieve wijze onderzoeksuren vrij te plannen, 
dank voor al het puzzelen, de groene bril en je grote hart. Pauline Manni, sparringpartner en 
sportmaatje, wat werk je hard en wat waardeer ik je inzet en doorzettingsvermogen. Waar 
anderen stoppen ga jij door. Wat vaker samen een rondje hardlopen in het bos zou misschien 
goed zijn voor ons beiden! Lydia Köster en Bouke Hepkema, jullie weten niet beter dan dat er een 
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fysiotherapeut naast de traumachirurg zit op de poli, maar zo gewoon is dat niet in Nederland. 
Mede dankzij jullie inzet en harde werken kunnen we verder bouwen! In jullie zie ik jonge collega’s 
die niet bang zijn om in het diepe te springen en vol enthousiasme nieuwe uitdagingen zoeken 
en aangaan. Ik ben trots op jullie. Madelon Fennet, fijn dat je ons bent komen versterken!
Laurens Migchelsen, onze pater familias en mijn goede vriend! Jij symboliseert voor mij de hele 
vakgroep. Ik vind het geweldig dat je je voor de volle 100% hebt ingezet om dit project tot een 
succes te maken. Toen we net begonnen op de traumapoli’s was dat best spannend en het is 
mooi om te zien dat deze nieuwe werkwijze je zoveel plezier geeft. Ik ben blij dat je namens de 
hele vakgroep mijn paranimf wilt zijn.
Op deze plek wil ik ook twee oud-collega’s bedanken die aan de wieg van mijn ontwikkeling als 
traumafysiotherapeut hebben gestaan. Rik van Hooff heeft mij alle fijne kneepjes van het vak 
bijgebracht en gaf mij veel ruimte om met vallen en opstaan te leren wat traumarevalidatie echt 
betekent. Ik had me geen betere mentor kunnen wensen. Karin Hekman, samen kwamen we het 
“ortho-traumateam” versterken met onze ambities en dromen, wat was het leuk samenwerken 
en wat hebben we een hoop bereikt. Jij bouwde Schoudernetwerk Nederland en bent inmiddels 
eigenaar van een florerende praktijk. En zowaar lees je nu het dankwoord van mijn proefschrift . 
Julia Ratter, wat hebben we een geluk met jou als promovenda op de TTCM-Trial! Het is 
ongelooflijk hoe jij je vastbijt in dit onderzoek. Je gaat recht op je doel af. Ondanks onverwachte 
pandemische tegenslagen en bureaucratische vertragingen lig je gewoon op schema en loopt 
de trial als een trein. Dank voor je vrolijkheid en inzet en ik kijk uit naar de resultaten van de 
TTCM-Trial en natuurlijk naar jouw proefschrift. 
Al mijn andere collega’s van de afdeling revalidatiegeneeskunde wil ik natuurlijk ook 
bedanken. Wat een leuke afdeling hebben we, zoveel disciplines bij elkaar! Er is veel wederzijdse 
belangstelling en support, “in good times and bad times”. Fijn dat ik bij jullie hoor. In het bijzonder 
dank ik alle fysio’s en oud-fysio’s van de andere vakgroepen (neuro, inspanning en kinderen). 
Er gaat veel veranderen, maar ik hoop dat de verbondenheid blijft! 
Maartje Terra, Leo Geeraedts, Jaap Deunk, Charlotte Lameijer, Wietse Zuidema en Frank 
Bloemers, traumachirurgen van Amsterdam UMC, locatie VUmc! Ik dank jullie voor de bereidheid 
in het diepe te springen en fysiotherapeuten toe te laten in de spreekkamer. Voor iedereen was 
het in eerste instantie wennen en bijschaven, met af en toe een gezonde discussie, maar bovenal 
samenwerken aan de beste nabehandeling voor onze patiënten. Inmiddels zetten jullie je volop in 
als ambassadeur van onze werkwijze. Altijd bereid om een scholing te verzorgen of te participeren 
in onze infofilm. En zoals Wietse treffend in deze film zei: “uiteindelijk is de patiënt de winnaar”. 
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Alle fysiotherapeuten van Netwerk Traumarevalidatie VUmc wil ik enorm bedanken! De brug 
tussen de eerste en tweede lijn is geslagen. Patiëntenbelang stond altijd voorop, jullie open, 
positieve en leergierige houding bleek geweldig goed te werken, 1000 keer beter dan iedere 
fysiotherapeut op zijn eigen eiland! 
Heleen Beckerman, jouw bijdrage aan het effectartikel was waardevol. Professioneel heb je 
me stukken verder geholpen en je aanmoedigingen waardeer ik enorm. Marianne Donker, 
jij hebt mij begeleid bij het schrijven van het leukste artikel uit dit proefschrift. Je kennis van 
verandermanagement maakt de procesevaluatie goed leesbaar én bruikbaar in de praktijk. 
Gogem Topcu, from the University of Nottingham, it was very inspiring to meet you! I learned a 
lot and you encouraged me to bring my qualitative research skills to a higher level. I look forward 
to work together again in our multicenter study. 
Michael Wijnberg, Milou Rossenaar en Vincent van Vliet leverden als studenten een substantiële 
bijdrage aan het onderzoek. Veel dank voor jullie inzet en goed te zien en te horen dat jullie alle 
drie goed terecht gekomen zijn als respectievelijk huisarts, kosteneffectiviteitsexpert en collega-
fysiotherapeut. Waar zo’n stage al niet goed voor is!
Dankzij het enthousiasme van Frank Duijff, het arbeidsethos en de oneindige ICT-kennis van 
Sander Assendelft is de studie van de grond gekomen. Het was naast effectief, vooral heel leuk 
en enerverend om met FysioRoadmap samen te werken! 
Frans Lanting van het Nederlands Paramedisch Instituut wil ik bedanken voor de effectieve en 
goede samenwerking. De cursus “Traumachirurgie en Fractuurbehandeling” blijft onverminderd 
populair bij fysiotherapeuten, dus voorlopig zijn we nog niet van elkaar af en daar ben ik blij om.
Asako Takahashi en Regina The van Zorgkeuzelab, het was inspirerend om samen met jullie en de 
werkgroep de keuzehulp “herstel na botbreuk” te schrijven. En Asako wat heb je de afbeeldingen 
in mijn proefschrift mooi gemaakt, dank je wel voor je hulp en tips! 
Renate Siebes en Wendy Schoneveld hebben geweldig werk afgeleverd met de layout en 
de cover van het proefschrift. Super hoe jullie mijn vage ideeën tot een perfect eindresultaat 
hebben gesmeed. 
Familie en vrienden, ik geloof dat ik niet heel veel ins & outs van dit onderzoek heb gedeeld 
met jullie. Voor mij was het “gewoon werk” en daarnaast was er vooral het “echte leven” om 
met jullie te delen. 
Lieve pa en ma, ik ben blij dat we dit feest samen kunnen vieren en dank jullie voor een mooie, 
avontuurlijke jeugd, waarin ik alle kansen kreeg en heb geleerd dat niks onmogelijk is. Heel fijn 
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dat nu de kinderen zo genieten van de logeerpartijtje en gezelligheid bij opa en oma. Selma en 
Emo, lieve zus en broer! Ondanks onze drukke levens en jonge gezinnen weten we elkaar altijd te 
vinden, dank dat jullie er voor mij zijn. Selma, tijdens het schrijven van dit proefschrift heb je me 
vaak wijze raad gegeven, heel veel dank daarvoor! Mijn lieve tante Joke ben ik dankbaar, je huis 
staat altijd voor ons open en zolang ik me kan herinneren kom ik logeren en doen we leuke dingen 
samen. Fijn dat ik af en toe een paar dagen kon komen schrijven tussen je “juttersvondsten”.
Lieve Reinold, wat missen we Jacobine, maar wat ben ik blij dat onze gezinnen zo verbonden 
zijn. Ik vergeet nooit meer de intense en liefdevolle tijd waar we doorheen zijn gegaan, Jac blijft 
voor altijd in ons hart. Jacco en Wendy dank voor onze vriendschap die niet veel woorden nodig 
heeft, maar staat als een huis. 
Vriendinnen uit Maastricht, dat we elkaar nog steeds zien, spreken en appen in allerlei samen-
stellingen zegt genoeg. Het was een prachttijd en jullie zijn prachtmeiden met prachtgezinnen! 
Laten we maar snel weer eens een feestje vieren Marion, Martine, Ineke, Inge en Pia.
Twee proefschriften, twee sportcarrières, drie kinderen, en bijna 20 jaar samen. En nog steeds 
één. Natuurlijk. Ergens vol voor gaan is ons niet vreemd. Gelukkig is het klip en klaar dat ons gezin 
altijd op 1 staat. Daarom hoeft er in dit dankwoord ook niet gezegd te worden dat er nu maar 
eens tijd moet komen voor elkaar, voor de kinderen, voor ontspanning, voor reizen, voor sporten, 
of voor wat dan ook. We plukken de dag. Elke dag opnieuw is het fijn thuiskomen bij jou. Dank 
je wel lieve Daniël, voor wie je bent, voor wat je doet, voor wat je me gegeven hebt, voor alles.
Mijn lieve Rink, grote jongen, wat ben ik trots (en stiekem een beetje jaloers) op jouw toewijding 
en inzet bij alles wat je doet. Of het nu school of sport betreft, jij gaat er vol voor en bent ook 
nog eens heel gezellig en behulpzaam! Saartje, mijn lieve stoere meisje, wat werk je hard en wat 
ben je al zelfstandig. Je houdt ons bij de tijd en we genieten volop van de sociale manier waarop 
je in het leven staat. Je stevent af op een mooie voetbalcarrière en papa en mama zijn beretrots 
op je! Siem, mijn lieve dondersteen, wat geef jij ons een plezier. Voor scherpe observaties en 
goede grappen moeten we bij jou zijn. Heerlijk om er zo’n creatieve en ondernemende jongen 
bij te hebben die ongeremd hutten bouwt, buiten speelt en een hoofd vol weetjes heeft.
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